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1.1 DEPRESSION IN THE ELDERLY
Depressive disorders are among the largest groups of disorders contributing to the 
burden of disease in our western society, only outnumbered by cardiovascular disease. 
About one out of fi ve persons will suff er from some form of depressive disorder. In 
general, people are oft en familiar with the symptoms of depression, and the subject has 
received increasing attention in lay conversation and literature during the past decades. 
However, for scientifi c purposes, it is hard to give a clear defi nition of depression and the 
concept has been subject to changes in defi nition. Th e current diagnosis and classifi ca-
tion of psychiatric disorders is based on the 4th edition of the Diagnostic and Statistical 
Manual (DSM-IV) (see tables 1 and 2) of the American Psychiatric Association (APA) or 
the criteria of the 10th edition of the International Classifi cation of diseases (ICD) of the 
World Health Organization (WHO) (APA 1994; WHO 1992).
Th e main symptoms of this syndrome are persistent sadness and anhedonia. Further-
more, there may be a range of cognitive and physical symptoms.
Th ere are numerous factors that hamper the recognition and diagnosis of depression 
by GP’s in the elderly compared with younger populations (van Marwijk et al. 1996).
 Th e most important of these are the fact that most of the symptoms are not specifi c for 
depression and the absence of an external criterion for the diagnosis. Another explana-
tion for the low number of cases detected by GP’s is attribution bias. Elderly patients 
themselves are likely to mention their co-morbid physical health problems fi rst, consid-
ering it inappropriate to discuss emotional problems with their GP. Th e complementary 
Table 1: DSM-IV criteria for Mood Disorder Due to …[Indicate the General Medical Condition] (293.83)
A. A prominent and persistent disturbance in mood predominates in the clinical picture and is characterized by either 
(or both) of the following:
1. depressed mood or markedly diminished interest or pleasure in all, or almost all , activities
2. elevated, expansive or irritable mood
B. There is evidence from the history, physical examination or laboratory fi ndings that the disturbance is the direct 
physiological consequence of a general medical condition.
C. The disturbance is not better accounted for by another mental disorder [e.g. Adjustment Disorder With Depressed 
Mood’ in response to the stress of having a general medical condition].
D. The disturbance does not occur exclusively during the course of a delirium.
E. The symptoms cause clinically signifi cant distress or impairment in social, occupational, or other important areas 
of functioning.
Specify type:
With Depressive Features: if the predominant mood is depressed, but the full criteria are not met for a Major 
Depressive Episode
With Major Depressive-Like Episode: if the criteria are met (except criteria D) for a Major Depressive Episode
With Manic Features: if the predominant mood is elevated, euphoric, or irritable
With Mixed Features: if the symptoms of both mania and depression are present but neither predominates
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reaction of the GP is to focus on the physical problem or to attribute the depressive symp-
toms to this physical health problem (Hasin & Link 1988). Of course, a good clinical and 
diagnostic procedure takes time, something that GP’s oft en lack. Apart from these major 
explanations for low recognition, some other potential factors are provided in table 3. 
Estimates of the prevalence of depression in elderly subjects vary widely. Th is vari-
ance is merely the result of various defi nitions and study-populations. Th e use of a clear 
defi nition and appropriate diagnostic instruments will lead to more consistent results. 
Arranged according to level of caseness, major depression is relatively rare among the el-
derly (prevalence 1.8%), minor depression is more common (prevalence 9.8%), whereas 
all depressive syndromes that are supposed to be clinically relevant show an average 
prevalence of 13.5% (Beekman et al. 1999). Th e prognosis of depression in the elderly is 
poor (Beekman et al. 2002). Medical burden increases the risk of developing depression 
Table 2: DSM-IV criteria for Major Depressive Episode
A. Five (or more) of the following symptoms have been present during the same 2-week period and represent a 
change from previous functioning: at least one of the symptoms is either (1) depressed mood or (2) loss of interest 
or pleasure.
Note: Do not include symptoms that are clearly due to a general medical condition, or mood-incongruent delusions 
or hallucinations.
1.  Depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g. feels sad or 
empty) or observation made by others (e.g. appears tearful).
2.  Markedly diminished interest or pleasure in all, almost all, activities most of the day, nearly every day (as indicated 
by either subjective account or observation made by others).
3.  Signifi cant weight loss when not dieting or weight gain (e.g. a change of more than 5% of body weight in a 
month), or decrease or increase in appetite nearly every day.
4.  Insomnia or hypersomnia nearly every day.
5.  Psychomotor agitation or retardation nearly every day (observable by others, not merely subjective feelings of 
restlessness or being slowed down).
6.  Fatigue or loss of energy nearly every day.
7.  Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly every day (not 
merely self-reproach or guilt about being sick).
8.  Diminished ability to think or concentrate, or indecisiveness, nearly every day (either by subjective account or as 
observed by others).
9.  Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specifi c plan, or a suicide 
attempt or a specifi c plan for committing suicide.
B. The symptoms do not meet criteria for a Mixed Episode.
C. The symptoms cause clinically signifi cant distress or impairment in social, occupational, or other important areas 
of functioning.
D. The symptoms are not due to the direct physiological effects of a substance (e.g. a drug of abuse, a medication) 
or a general medical condition (e.g. hypothyroidism).
E. The symptoms are not better accounted for by Bereavement, i.e. after the loss of a loved one, the symptoms 
persist for longer than 2 months or are characterized by marked functional impairment, morbid preoccupation with 
worthlessness, suicidal ideation, psychotic symptoms, or psychomotor retardation.
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and this concerns particularly minor depression (Beekman et al. 1997a). An increased 
risk is found among subjects suff ering from rheumatic disease, chronic pulmonary dis-
ease, but especially among subjects suff ering from some form of cardiovascular disease 
(Beekman et al. 1995). Strokes are associated with the greatest risk for developing clini-
cally relevant depression (Beekman et al. 1998). Depression in patients suff ering from 
stroke and myocardial infarction is associated with poor outcome as indicated by higher 
levels of mortality, higher incidence of new vascular events and higher incidence of sub-
sequent cognitive decline (Baldwin et al. 1993; Penninx et al. 2001; Penninx et al. 1998b; 
Pohjasvaara 2002; van Ojen 1995). Th e presence of a ‘vascular’ aetiology of depression is 
probably associated with a more chronic course of the depressive disorder (Beekman et 
al. 1997b; Mast et al. 2004a) and might be a predictor for a poor response to antidepres-
sant medication (Fujikawa et al. 1996). Th ese fi ndings are of major signifi cance for clini-
cians dealing with elderly patients suff ering from depression as they have considerable 
implications with respect to treatment and provide insight into the pathogenesis of the 
depressive syndrome itself. 
1.2 CEREBROVASCULAR DISEASE
Cerebrovascular disease can manifest itself in diff erent ways, but by far the best known is 
stroke. Approximately 80% of strokes are ischemic and 20% hemorrhagic. Th e main sub-
ject of this thesis will be ischemic vascular disease of the brain. Cardiovascular disease 
is the most important burden of illness in western society nowadays. It is not only the 
major cause of death, but also of disability. Th e highest incidence of ischemic stroke is in 
later life, between the ages of 60-80 years, although it is not restricted to these ages. Th e 
prevalence of stroke in the Netherlands is around 170/100.000 and the incidence stands 
at 30,000 patients per year (van Kooten & Koudstaal 1998). 
Table 3: Factors hampering the recognition and diagnosis of depression in the elderly (12)
Depression related Multitude of symptoms
No symptoms specifi c for depression
No ‘golden standard’
Patient related Comorbidity: physical illness, dementia
Attribution bias
Doctor (GP) related Time constraints
Lack of expertise and experience
Professional beliefs and attitudes
Fear of stigmatization
Ageism
Interaction related Demanding and hostile communicative style of depressed patients, leading to 
withdrawal and rejection by doctors
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Apart from symptomatic stroke, so-called silent brain infarcts are frequently seen on 
cerebral scans (MRI or CT) in the elderly and they appear to be more frequent in elderly 
subjects with depression and dementia (Vermeer 2002). Cerebral white matter lesions are 
also frequently observed and probably result from cerebral small vessel disease. Arterial 
hypertension and older age increase the prevalence and severity of such lesions (Vermeer 
et al. 2002; de Leeuw et al. 2001).
1.3 POST-STROKE DEPRESSION
Th e incidence rate of post-stroke depression (PSD) varies from around 8% in population 
based studies to around 40% in patients attending specialized in-patient facilities (Robin-
son et al. 1984a; Stern & Bachman 1991). Explanations for these divergent fi ndings are 
similar to those regarding depression in the elderly described above. Especially in the 
early years of research on PSD, much emphasis was put on lesion location, beginning 
with the work of Robinson and co-workers who found that subjects with a lesion located 
in the frontal left  cortex were more prone to developing PSD than others (Robinson 
et al. 1982; Starkstein et al. 1987). Moreover, they stated that the severity of depressive 
symptoms depends on the distance of the vascular lesion to the frontal pole. Since then, 
an overwhelming amount of work has been published on this subject, some confi rm-
ing his hypothesis, others not. Carson (2000) has reviewed the evidence and shown that 
there are no clear diff erences in the risk of developing depression between right- or left -
sided lesions. Probably the exact location and the interference with special circuits are 
of more importance for developing depression than the simple subdivision into left  or 
right. High incidence rates of depression aft er stroke has led to research into the effi  cacy 
of antidepressant medication, not only as a therapeutic strategy but also as a prophylactic 
one (Finkel et al. 1999; Palomaki 1999; Robinson et al. 2000). Th e fi ndings in this line of 
research have also been controversial and benefi t of antidepressant treatment in recovery 
from stroke may depend on the identifi cation of specifi c subgroups of patients and the 
optimal timing of treatment.
1.4 VASCULAR DEPRESSION
In clinical practice, patients with a fi rst onset of depression in later life are regarded as 
a specifi c entity. Age-of-onset as a specifi c marker was mentioned by Conwell (1989) 
in the late 1980’s. Th e arbitrary age separating the late from the early-onset subjects 
was set at 60 years old. Th e so-called ‘late-onset depression’ (LOD) is primarily thought 
to be an organic depression with vascular lesions and neuronal degeneration as major 
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causes (Burvill et al. 1989; Salloway et al. 1996; Holroyd & Duryee 1997). Silent lesions on 
MRI have frequently been found in elderly subjects with depressive symptoms, without 
stroke-like symptoms (Fujikawa et al. 1993). Some authors have labelled the (vascular) 
depressive syndrome a ‘pre-stroke depression’, suggesting that clinical stroke would soon 
follow. Th e concept of vascular depression is actually very old. Around 1900, the German 
psychiatrist Gaupp already mentioned ‘atherosclerotic depression’, a concept that was 
later recognized by Bleuler. Th e revival of this concept was boosted by the development 
of new imaging techniques which made it possible to improve the ‘golden standard’ for 
the concept of ‘vascular depression’. Some called this ‘new’ group “MRI defi ned vascular 
depression”, with the vascular lesions on MRI as the obligatory fi nding (Krishnan et al. 
1997). For clinical practice, it would be more useful if these patients could be recognized 
in daily, routine observation by their clinical characteristics. Some authors have proposed 
criteria for this vascular depression syndrome (Alexopoulos et al. 1997a; Alexopoulos et 
al. 1997b). Th ese are outlined in table 4. 
1.5 SOURCES OF CONFUSION
1.5.1 Measures of depression
Although depression comprises various symptoms that are traditionally grouped in dif-
ferent clusters, the concept of depression as a single syndrome that represents a fi nal 
Table 4: Proposed criteria for Vascular Depression
Cardinal features 1.  Clinical and/or laboratory evidence of vascular disease or vascular risk factors. Clinical 
manifestations may include history of stroke or transient ischemic attacks, focal 
neurologic signs, atrial fi brillation, angina, history of myocardial infarction, carotid bruit, 
hypertension and hyperlipidemia. Laboratory fi ndings may include signifi cant white 
matter hyperintensities at the territory of the perforating arteries, infarcts, or evidence 
of carotid occlusion or stenosis of the Willis circle arteries
2.  Depression onset after 65 years of age or change in the course of depression after 
the onset of vascular disease in patients with early–onset depression; development of 
more frequent and persistent depressive episodes
Secondary features 1.  Cognitive impairment consisting of but not limited to disturbance of executive 
functions, i.e. planning, organizing, sequencing, and abstracting
2.  Psychomotor retardation
3.  Limited depressive ideation, e.g. guilt
4.  Poor insight
5.  Disability
6.  Absence of family history of mood disorders
* The cardinal features are expected in all patients. The secondary features may present in most but not all patients 
with “vascular depression”.
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common pathway, defi ned by a broad range of biological as well as psychological factors, 
has become widely accepted in recent decades (Parker 2000). Because of the overlap of 
both symptomatology and pathophysiology of depression and vascular disease of the 
brain, renewed discussion has arisen with regard to basic concepts in psychiatry. Espe-
cially in subjects in whom a specifi c cause is presumed, specifi c clinical profi les may be 
detected. Until now, most investigators have applied the currently-accepted guidelines 
and classifi cation, mostly the DSM. Th is may have hampered the recognition of new, 
(a)typical forms of PSD. Most authors report ‘major’ and more prevalent ‘minor’ depres-
sive disorder, according to DSM-criteria (Eastwood et al. 1989; House et al. 1990). Low 
mean-scores on the Hamilton Rating Scale for Depression (HAM-D) indeed suggest 
that it may only concern incomplete or minor depressive states. Clustering of symptoms 
into specifi c symptom dimensions may increase the likelihood of an organic, familial 
and possibly genetic aetiology (Korszun et al. 2004). Some studies have investigated 
specifi c neuropsychiatric syndromes caused by stroke. Caplan et al. (1990) studied the 
behavioural consequences of infarcts involving the caudate nucleus. Cognitive and be-
havioural abnormalities were frequent, and included abulia, agitation and hyperactivity, 
contralateral neglect, and language abnormalities. Th e syndrome of akinetic mutism 
was found in patients with vascular damage of the frontal lobe or an interruption of 
the complex frontal subcortical circuits (Nagaratnam et al. 2004). Some authors have 
focused on individual symptoms of depression and have tried to fi nd correlations with 
vascular lesion location. Dysphoria as a sign of depression was found to be more frequent 
in patients with lesions of the parietal and occipital cortex, and ‘insomnia’ was associated 
with lesions in the infero-frontal cortex (Stern & Bachman 1991). Emotional indiff erence 
is a sign that is oft en found in patients with a lesion of the non-dominant hemisphere, 
described by some investigators as the syndrome of aprosodia (Ross 1981).
1.5.2 Temporal relationship
In most studies on the relationship between vascular disease and depression, time course 
is a varying factor. In some studies, mean-time since stroke varied from six months to 
more than 10 years. It has been suggested that depression has its major peak prevalence 
around six months aft er stroke and that in its natural course it will clear aft er one year, al-
though follow-up is oft en incomplete and some patients remain depressed aft er two years 
(Robinson et al. 1984b; Robinson et al. 1987). Emery and Oxman (1992) suggested that 
in late life there is a spectrum of cognitive and aff ective disorders, including depression, 
dementia and parkinsonism, which are interrelated. Th is idea could be transferred to the 
vascular pathogenesis in the sense that diff use vascular lesions will give rise to diff use 
neuronal degeneration and hence will lead to the same spectrum of cognitive, aff ective 
and psychomotor disorders (Steff ens et al. 2003).
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1.5.3 Study populations
Th ere are major diff erences in study design and population that infl uence the results of 
studies on cerebral vascular disease and depression. Homogeneity of the cohort is one of 
the major problems. Not only do subjects diff er with regard to age at onset, number of 
previous episodes and duration of the index episode, but they also show variation in type 
of vascular event and disease-management. Some studies included in-patients in highly 
specialized, tertiary settings with oft en complex and refractory symptoms, while other 
reports are on more ‘regularly’ referred patients, leading to selection bias. Th e problem of 
attrition bias is oft en encountered in population-based studies. Attrition is selective, usu-
ally in the sense that the most severely aff ected subjects drop out of the study more oft en 
than the healthier ones. In studies on the relationship between depression and cerebro-
vascular disease, selection bias will usually favor a strong relationship, whereas attrition 
bias works in the opposite direction. Figures on the prevalence of vascular depression 
and PSD show that, indeed, the highest numbers are found in clinical studies as opposed 
to population-based studies (Robinson et al. 1984b; Stern & Bachman 1991).
1.5.4 Other etiological factors
Besides the biological and medical consequences of stroke and vascular disease of the 
brain, there are of course also major psychosocial factors that should be addressed. Th e 
sudden loss of functional abilities which will give rise to fears, despair and mourning. Th e 
uncertain outcome, with risk of persisting handicap and loss of independence and more-
over, the chance of recurrence of (an even more) devastating stroke, can be intimidating. 
Changes in social roles are inevitable and this may present new problems for patients and 
their relatives. Premorbid personality traits might be a potential vulnerability factor for 
the development of PSD (Aben et al. 2002). In the end, PSD and vascular depression are 
like most psychiatric disorders so-called complex disorders. Th is means that there will 
not be a single cause, but a causal chain or number of such causal chains. Th ese inter-
related chains may involve genetic, environmental, social and biological risk factors, and 
none of these factors can be fully understood on its own, but only in the context of all the 
others. In this thesis, I have made a restriction by focusing on the biological factors.
1.6 AIMS OF THE STUDY AND OUTLINE OF THIS THESIS
Th e general aim of this study was to identify specifi c symptom profi les in depressed pa-
tients with vascular risk factors and more specifi cally vascular damage of the brain. A 
phenomenological approach was chosen because for clinical practice it can be of major 
signifi cance in detecting depressed subjects with vascular risk-factors, without the use 
of invasive investigations. Not only may the subsequent recognition of subjects with a 
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vascular risk contribute to preventing further vascular risks, but the improvement of the 
psychiatric diagnostic procedure may also lead to an adaptation of treatment strategies 
and fi nally to an improvement in the quality of life of subjects with vascular and post-
stroke depression.
In this thesis the following questions are addressed:
1. What is the diagnostic value of the HAM-D for subjects who suff ered from stroke? 
Can this instrument be used for the purpose of screening and diagnosis of depression 
in these patients?
2. Is there a distinct clinical symptom profi le of depression for patients who suff er from 
severe vascular brain disease?
3. Are the aff ective and cognitive sequelae of vascular brain damage interrelated? 
4. Can “vascular depression” be recognized as a distinct entity in the general population 
based on clinical depressive symptoms?
To answer these questions, data from multiple sources was used. First, a clinical sample 
of patients was used from a study designed to investigate the role of vascular factors 
in dementia at the section of Neurovascular Diseases of the Erasmus Medical Center 
Rotterdam (van Kooten et al. 1998). In this group of patients, a thorough psychiatric 
work-up was done to determine the co-occurrence of depression and dementia in this 
post-stroke group. First, we studied the psychometric properties of a frequently-used 
rating scale for depression, the HAM-D. We compared the psychometric properties for 
patients who suff ered from stroke, Parkinson’s and Alzheimer’s disease and found out 
that there might be disease-specifi c cut-off  scores. In the next two chapters, we studied 
the occurrence of depression in patients who suff er from vascular dementia, describing 
the clinical profi les of this depressive disorder and looking at the relationship between 
these patients’ aff ective and cognitive features. A second study on elderly subjects with 
early dementia and depression is described in chapter 5. Th is study, using data from the 
Nijmegen Study on Depression in Dementia also addresses the interrelationship between 
cognitive and aff ective features. For chapters six and seven, we have used data from two 
large, representative samples of community-dwelling elderly persons, the Amsterdam 
Study of the Elderly (AMSTEL) and the Rotterdam Study (ERGO). Th e AMSTEL study 
was a prospective study that started in 1990 and assessed mental health problems, medi-
cal diagnoses and demographic characteristics of non-institutional individuals in the 
65-84 age bracket who lived in the city of Amsterdam (Schoevers et al. 2000a). Th e aim 
of the Rotterdam Study is to investigate determinants of chronic and disabling diseases. 
Th e study started in 1990, when all inhabitants 55 years and older of Ommoord, a district 
of Rotterdam, the Netherlands, were invited to participate. Th is study is still in progress 
and has entered its fourth follow-up stage. Alongside mental health and demographic 
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characteristics, much eff ort was made in identifying physical disorders, including MRI 
brain scanning and vascular risk-status in a large subgroup. In both groups, we have 
investigated the combination of depressive disorder and vascular risk factors, testing the 
vascular depression hypothesis. In chapter six, we have studied the symptom profi les of 
depression in subjects with a depressive disorder but with a distinct risk-factor profi le. 
We hypothesized that subjects with a higher vascular risk would show a profi le that better 
fi tted the vascular depression hypothesis than those with other somatic risk profi les. In 
chapter seven, we have tested the proposed criteria for Vascular Depression of Alexopou-
los in our two community samples. 

Chapter 2
Disease-specific properties 
of the HAMD in patients with 
Stroke, Alzheimer’s dementia 
and Parkinson’s disease
P. Naarding
A.F.G. Leentjens
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Journal of Neuropsychiatry and Clinical Neurosciences
2002;14:329-34.
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Disease-specifi c properties of the Hamilton Rating Scale for Depression
2.1 SUMMARY OF CHAPTER 2
To compare the psychometric properties of the HAMD in patients with stroke, Alzheim-
er’s Disease and Parkinson’s Disease, receiver operating characteristic (ROC) curves were 
plotted for each group. Th e concurrent validity of the HAMD with the DSM-IV criteria 
for major depressive disorder was high in each of these groups. However, optimal perfor-
mance of the HAMD requires the application of disease-specifi c cut-off  scores for screen-
ing, diagnostic and dichotomization purposes. Th ese disease-specifi c cut-off  scores were 
highest in PD and lowest in stroke patients, with AD patients falling in-between.
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Disease-specifi c properties of the Hamilton Rating Scale for Depression
2.2 INTRODUCTION
Th e Hamilton Rating Scale for Depression (HAMD) is a commonly used instrument in 
depression assessment and research (Hamilton 1960). In clinical practice, this instrument 
is of great value to assess the severity of depression in patients suff ering from depression 
without somatic comorbidity. Recently, we have evaluated the validity of the HAMD in 
patients suff ering from Parkinson’s disease (PD) (Leentjens et al. 2000). In patients with 
depressive symptoms and stroke, the validity of the HAMD has not yet been established, 
although depression rating scales are frequently used in all kinds of research into the 
prevalence and course of post stroke depression. Th ere are studies in which the validity of 
the HAMD is established in patients with AD (Vida et al. 1994). Other investigators have 
employed the HAMD to assess the severity of depressive symptoms in stroke patients 
and patients with AD, irrespective of the presence of major depression. It has also been 
used as a diagnostic scale to assess the presence of major depression in stroke and AD 
patients, and to dichotomize study populations into depressed and non-depressed pa-
tients, sometimes to exclude patients from clinical trials (Stern & Bachman 1991). Such 
use of the HAMD is only justifi ed if there is high concurrent validity with the criteria 
of the Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) for depres-
sive disorders (APA 1994). In addition, the HAMD score should have high positive and 
negative predictive value for major depression in these disorders. In patients with PD, 
the optimal cut-off  score for diagnostic purposes was 16/17, meaning that a score of 16 
or less indicates the absence of depression and a score of 17 or higher is indicative of the 
presence of major depression. For screening purposes it was 11/12 (Leentjens et al. 2000). 
Th e mean score of non-depressed PD patients was 8.4, which indicates that there might 
be a disease-specifi c threshold in this group of patients. In patients with AD the optimal 
cut-off  score was found at 7/8 for diagnostic purposes (Vida et al. 1994).
In order to assess whether disease-specifi c cut-off  scores should be applied for the 
HAMD in various neurological disorders, we compared the concurrent validity of the 
HAMD in relation to DSM-IV criteria for major depressive disorder in patients with 
stroke, AD and PD. Furthermore, we compared the psychometric performance of the 
HAMD as a screening and diagnostic instrument in these three neurological disorders.
2.3 PATIENTS AND METHODS
Data on the HAMD scores from patients of three diff erent study groups were compared. 
Th ese groups consisted of patients with stroke, Alzheimer’s dementia and Parkinson’s 
disease.
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First, HAMD results of 44 stroke patients who were included in the Dutch Vascular 
Factors in Dementia Study were analyzed. All were in-patients on a neurological ward. 
Details of the design and characteristics of this study are outlined elsewhere (Van Koo-
ten et al. 1998). Patients with TIA, cerebral infarction or intracerebral hemorrhage were 
included in this study. Patients with impairment of consciousness or severe aphasia that 
could preclude valid judgment of cognitive or aff ective disturbances were excluded. 
When possible the demented patients, and a random sample of non-demented patients 
were subjected to a psychiatric evaluation. Only these patients, of whom results on the 
HAMD were available, were included in this analysis. An indication of cognitive func-
tion was achieved using the Mini-Mental State Examination (MMSE) (Folstein et al. 
1975). Cognitive function was further assessed between 3 and 9 months aft er stroke. 
Th e diagnosis of dementia was based on the results of an extensive neuropsychological 
examination, clinical presentation and information from a close relative. A diagnostic 
panel consisting of two neurologists, a neuropsychologist and a trained physician made 
a fi nal judgement. For the diagnosis of dementia, the criteria of the DSM-III-R were 
used (APA 1987). Psychiatric examination was also performed between 3 and 9 months 
aft er the stroke. All evaluations were performed in the aft ernoon to prevent results be-
ing infl uenced by diurnal variations in mood. A DSM-IV diagnosis of major depressive 
disorder was made using the Schedule for Aff ective Disorders and Schizophrenia (SADS) 
(Endicott & Spitzer 1978). Th is is a semi-structured interview, which yielded the ‘golden 
standard’ diagnosis of major depression in this group. In addition, all patients, whether 
depressed or not, underwent a semi-structured interview in which the HAMD was ad-
ministered. 
Th e second studygroup comprised 85 patients with PD. Th ey were consecutive refer-
rals to the movement disorder clinic of Maastricht University Hospital. Th ey all met the 
criteria for PD as defi ned by de United Kingdom PD Society Brain Bank (UK-PDS-BB) 
(De Rijk et al. 1997). Cognitive function was assessed by the Mini-Mental Status Exami-
nation (MMSE). Physical disability was rated according to the Hoehn and Yahr staging 
system (Hoehn & Yahr 1967). Every patient underwent a protocollised mental status 
examination. A DSM-IV diagnosis of major depressive disorder was made in a structured 
interview with the aid of the Structured Clinical Interview for DSM-III-R (SCID-D). 
Th is diagnosis was considered the ‘golden standard’ for major depression in this popula-
tion (Spitzer et al. 1987). All the patients, depressed and non-depressed, underwent a 
semi-structured interview to obtain a score on the HAMD. Th e PD patients who met the 
DSM-IV criteria for dementia were excluded from further analysis. 
Th e third group comprised 274 patients with AD. Th ese were consecutive referrals to 
the Maastricht Memory Clinic of Maastricht University Hospital. Dementia was diag-
nosed according to DSM criteria, while Alzheimer’s disease was diagnosed according 
to the criteria of the National Institute of Neurological and Communicative Disorders 
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and Stroke/Alzheimer’s Disease and Related Disorders Association (NINCDS/ADRDA) 
(McKahnn et al. 1984). Th e HAMD was used as a symptom checklist to diagnose major 
depression according to the DSM-IV criteria. Th e cognitive status of 239 of the patients 
was also assessed using the MMSE.
2.4 STATISTICAL ANALYSIS 
In order to determine and compare the sensitivity and specifi city of the HAMD as a diag-
nostic instrument to diagnose major depression in stroke, AD and PD patients and to 
obtain optimal cut-off  scores, we plotted ‘receiver operating characteristic’ curves (ROC 
curves) for the HAMD scores from all three disorders (Murphy et al. 1987). Th ese curves 
yielded the ‘sensitivity’ versus ‘1 minus the specifi city’ for every possible cut-off  point. 
Th e optimal cut-off  point was determined visually by assessing which score combined 
maximum sensitivity with optimal specifi city. Th e area under the curve (AUC) is an 
indicator of the ability of the scale to distinguish between depressed and non-depressed 
patients. Optimal cut-off  scores were determined for each group of patients, including 
cut-off  scores that could be used for a screening, diagnostic and dichotomization (i.e. 
discriminating depressed from non-depressed patients) purposes. In order to deter-
mine whether the HAMD could be used as a predictive test for these three groups of 
patients, positive predictive (PPV) and negative predictive values (NPV) were calculated 
for diff erent cut-off  scores in the central range of the scale. Th e three ROC curves were 
compared in pairs with the Hosmer-Lemeshow goodness-of-fi t test (Hosmer et al. 1988). 
All analyses were performed with the Stata soft ware package, release 5 (StataCorp 1997, 
College station, Texas/USA) .
2.5 RESULTS
Th e average age in the PD group was lower than that in the other two groups: stroke 
patients 70.3 years (SD 16.2), AD patients 71.1 years (SD 8.8) and PD patients 67.3 years 
(SD 10.2). Although this reached statistical signifi cance, this diff erence in age does not, 
Table 1: Mean HAMD scores in patients with stroke, AD and PD with and without a depressive disorder
Mean ± SD (range)
Non-depressed Depressed
Stroke 3.6 ± 2.32 [0 – 11] 13.9 ± 4.56 [7 – 24]
Alzheimer’s disease 6.9 ± 4.00 [0 – 18] 15.1 ± 4.85 [8 – 26]
Parkinson’s disease 8.3 ± 3.87 [1 – 19] 18.1 ± 4.92 [7 – 29]
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in our opinion, refl ect any clinical relevance. Th e group of AD patients contained signifi -
cantly more women than the other two groups: stroke patients 36.4%, AD patients 59.5% 
and PD patients 40.0% (chi-square = 15.278, df 2, p < .001).
Mean scores on the MMSE for stroke patients, AD patients and PD patients were 19.18 
(SD 6.87, range 9–30), 18,96 (SD 5.80, range 0–29) and 27.76 (SD 1.82, range 23–30).
Twenty-three of the stroke patients fulfi lled criteria for dementia (52%). Th e PD pa-
tients had the following Hoehn and Yahr classifi cations: 8 stage I, 56 stage II, 17 stage III, 
4 stage IV and none stage V.
Th e prevalence of major depressive disorder was highest in the stroke group: 34.1%. In 
the AD group the prevalence was 22.6%, while in the PD group it was 23.5%. Th is diff er-
ence did not reach statistical signifi cance (chi-square = 2.743, df 2, p = 0.254).
Mean HAMD scores, ranges and standard deviations (SD) are listed in table 1 for the 
depressed and the non-depressed subgroups in each disorder. Frequency distribution 
Table 2a: Stroke (N=44). Sensitivity, specifi city, positive and negative predictive values at different 
cut-off scores for the 17 item Hamilton Rating Scale for Depression (PPV=positive predictive value, 
NPV=negative predictive value, *=maximum sensitivity and specifi city)
Cut-off 4/5 5/6* 6/7 7/8 8/9 9/10 10/11
Sensitivity 1.00 1.00 0.93 0.93 0.87 0.73 0.73
Specifi city 0.86 0.93 0.93 0.93 0.97 0.97 1.00
PPV 0.79 0.88 0.88 0.88 0.93 0.92 1.00
NPV 1.00 1.00 0.96 0.96 0.93 0.88 0.88
Table 2b: Alzheimer (N=243). Sensitivity, specifi city, positive and negative predictive values at different 
cut-off scores for the 17 item Hamilton Rating Scale for Depression (PPV=positive predictive value, 
NPV=negative predictive value, *=maximum sensitivity and specifi city)
Cut-off 6/7 7/8 8/9 9/10* 10/11 11/12 12/13 13/14
Sensitivity 1.00 0.95 0.90 0.86 0.77 0.68 0.52 0.45
Specifi city 0.64 0.71 0.79 0.84 0.90 0.92 0.95 0.96
PPV 0.45 0.49 0.55 0.61 0.69 0.71 0.74 0.76
NPV 1.00 0.98 0.97 0.95 0.93 0.91 0.87 0.86
Table 2c: Parkinson (N=85). Sensitivity, specifi city, positive and negative predictive values at different 
cut-off scores for the 17 item Hamilton Rating Scale for Depression (PPV=positive predictive value, 
NPV=negative predictive value, *=maximum sensitivity and specifi city)
Cut-off 9/10 10/11 11/12 12/13* 13/14 14/15 15/16 16/17
Sensitivity 0.95 0.85 0.80 0.80 0.75 0.70 0.70 0.60
Specifi city 0.72 0.79 0.85 0.92 0.92 0.96 0.99 0.99
PPV 0.51 0.55 0.62 0.76 0.75 0.82 0.93 0.92
NPV 0.98 0.94 0.93 0.94 0.92 0.91 0.91 0.89
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analysis showed that there were no missing scores in the central score range of the HAMD 
in the three groups of patients. 
Sensitivity, specifi city, PPVs and NPVs for diff erent cut-off  scores of the HAMD are 
shown in tables 2a-c for the patients with stroke, AD and PD, respectively. ROC curves 
for the three groups of patients are shown in the fi gures 1-3, respectively.
Th e cut-off  score for maximum discrimination (dichotomization) between depressed 
and non-depressed patients could be determined visually from the ROC curves as the 
point at which the highest sum of sensitivity and specifi city was reached. In the stroke 
group this point was reached at a cut-off  score of 5/6 (sensitivity 1.00, specifi city 0.93), 
in the AD group at 9/10 (sensitivity 0.86, specifi city 0.84) and in the PD group at 12/13 
(sensitivity 0.80, specifi city 0.92). Th e AUC was large in all three groups of patients, which 
indicates that the HAMD score has high concurrent validity with the DSM-IV criteria 
for major depressive disorder in these diseases. To be useful for diagnostic purposes, an 
instrument needs a combination of high specifi city and high PPV; this yielded higher 
cut-off  points than those for dichotomization. Once again there were diff erences between 
the three groups: Optimal cut-off  for diagnostic purpose was found in the stroke group at 
10/11 (specifi city 1.00, PPV 1.00). In the AD group, the optimal diagnostic cut-off  point 
was found at 13/14 (specifi city 0.96, PPV 0.76). In the PD group the point was found at 
15/16 (specifi city 0.99, PPV 0.93). To be useful for screening purposes an instrument 
needs a combination of high sensitivity and high NPV. Th ese requirements were met 
in all three groups of patients at low cut-off  scores. Th is cut-off  point was lowest in the 
stroke group: 5/6 (sensitivity 1.00, NPV 1.00). In the AD group, the optimal cut-off  point 
was found at 6/7 (sensitivity 1.00, NPV 1.00) and in the PD group at 9/10 (sensitivity 
0.95, NPV 0.98). Further ‘goodness-of-fi t’ analyses of the ROC curves revealed statisti-
cally signifi cant diff erences between the three groups. 
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Figure 1: Receiver Operating Characteristic (ROC) curve for the HAMD in patients with stroke (AUC = 
Area Under Curve)
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2.6 DISCUSSION
In this study we showed that the concurrent validity of the HAMD for DSM-IV major 
depression in stroke, AD and PD was high. However, optimal performance requires 
that diff erent cut-off  points are taken into consideration for each organic disorder. Th e 
prevalence of major depression in our three groups was comparable with that reported 
by others (Robinson 1997; Cummings 1992; Forsell & Winblad 1998). In agreement 
with our previous study on patients with PD (Leentjens 2000), in the present study, the 
non-depressed patients with stroke and AD had higher scores than non-depressed ‘nor-
mal’ individuals; the PD patients in our analyses had the highest scores. At low disease 
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Figure 2: Receiver Operating Characteristic (ROC) curve for the HAMD in patients with Alzheimer disease 
(AUC = Area Under Curve)
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Figure 3: Receiver Operating Characteristic (ROC) curve for the HAMD in patients with Parkinson’s 
disease (AUC = Area Under Curve)
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specifi c cut-off  points, the HAMD can be used as a screening tool in all three disorders. 
However, other, easier to administer self-report questionnaires may be more practical 
for this purpose as they do not require trained personnel. At higher cut-off  scores, the 
HAMD also proved to be useful as a diagnostic tool, with an optimum cut-off  point of 
10/11 for stroke, 13/14 for AD and 15/16 for PD. Th ere was no signifi cant diff erence 
in performance of the HAMD between the three organic disorders, when the disease-
specifi c cut-off  scores were used. As we described in the methods section, the stroke 
group consisted of demented ‘cases’ and non-demented ‘controls’. Th erefore, dementia 
was present in half of the stroke patients, whereas in stroke populations, the prevalence of 
dementia has been reported to be approximately 25% (Van Kooten et al. 1998; Tatemichi 
et al. 1993). Nevertheless our fi ndings indicate that diff erent organic disorders are associ-
ated with diff erent profi les of clinical mood syndromes. Th is is important, because the 
previously established cut-off  scores for ‘healthy individuals’ did not apply to our three 
groups of patients. When for example a clinical trial on the effi  cacy of antidepressants 
is conducted on patients with these disorders, adjusted cut-off ’s should be taken into 
account when selecting end-points to determine improvement during or aft er therapy. 
It is probably because of the somatic and psychomotor items that the fl oor score of the 
HAMD is higher in depressed patients with an organic disorder than in those without. 
Criticism could be given on the fact that we used data out of three diff erent studies 
and obtained psychiatric diagnosis in a diff erent way in these three studies. Although 
this is true we think that applying DSM-IV criteria to all three groups in a uniform way 
has minimalised the infl uence of this methodological shortcoming. Next, some concerns 
could be expressed on the problem of diagnosing depression in a group of patients with 
dementia. Although this is true, others have recently shown that depressive symptoms 
can be reliably scored with the HAMD in patients with AD and that they are signifi cantly 
related to an underlying depressed mood (Chemerinski et al. 2001). Another problem in 
studies such as this is that there is no solid ‘golden standard’ for psychiatric disorders. 
Because of the psychomotor and autonomous symptoms that accompany organic brain 
disease it may be easier to come to the DSM diagnosis of “major depressive disorder” in 
these patients. However, until now there is no suitable alternative for a ‘golden standard’ 
diagnosis of depression. In theory it is possible for patients with an organic brain disor-
der to have a high score on the HAMD, without showing any of the core symptoms of 
major depression. Th e high concurrent validity of the HAMD with the DSM-IV criteria 
for major depression showed that although this is theoretically possible, it is not a major 
clinical concern. Finally, we suggest that our fi ndings have to be validated with the results 
of other cohorts of patients with stroke, AD, and PD.
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2.7 CONCLUSION
Th e concurrent validity of the HAMD with the DSM-IV diagnosis of major depressive 
disorder is high for patients with stroke, AD and PD. However, optimal performance 
requires the use of disease-specifi c cut-off  points for screening, diagnostic and dichoto-
mization purposes. Both in clinical practice and in research design it is essential to take 
these disease-specifi c qualities of the HAMD into account. Th ese disease-specifi c quali-
ties should be established in other and preferable larger cohorts.
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3.1 SUMMARY OF CHAPTER 3
Aft er a stroke, cognitive, aff ective and behavioural disturbances are common. It has 
been suggested that the nature of aff ective symptomatology can help to diff erentiate 
organic from psychological depression. To study the presence of diff erent dimensions of 
depression in subjects with vascular dementia, cognitive and aff ective symptoms were as-
sessed in 78 stroke patients and a principal component analysis was performed on these 
symptoms. Also, a discriminant analysis was carried out to establish the contribution of 
diff erent symptoms on the diagnosis ‘depressive disorder’ and ‘dementia’. Th e principal 
component analysis revealed three distinct sub-syndromes: one with predominantly 
mood symptoms, one with essentially psychomotor symptoms, and one with vegetative 
symptoms. Mood, psychomotor and vegetative symptoms were all independently and 
strongly related to a diagnosis of major depressive disorder according to DSM-III-R cri-
teria. Th e psychomotor factor was also fi rmly associated with dementia.
Discriminant analysis gave further support for our conclusion that some of the de-
pressive features, in particular the psychomotor factor, are at least partly related to the 
organic brain damage from stroke.
Th e results indicate that diff erent dimensions of depression could be discerned in a 
group of stroke patients and that the symptom profi le of depression in these patients can 
be aff ected by the presence of dementia.
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3.2 INTRODUCTION
A variety of cognitive, aff ective and behavioural disturbances may be present in patients 
aft er a stroke (Sharpe et al. 1990; Tatemichi et al. 1993). Th ese disturbances, however, are 
not always recognised, and if so, oft en not correctly diagnosed. Th is may lead to diffi  cul-
ties during the rehabilitation process (Kotila et al. 1999). Furthermore these cognitive, 
aff ective and behavioural disturbances aft er stroke have complex relationships with each 
other, and cognitive dysfunction cannot be assessed properly without paying attention to 
the aff ective and behavioural symptoms.
Both psychological factors, such as loss of function and mobility and changes in in-
terpersonal relationships, and neurobiological brain changes may give rise to cognitive 
disturbances and symptoms of depression. Since it may have major implications for 
treatment, it is important to know whether cognitive and depressive symptoms have a 
predominantly psychological or neurobiological origin. It has been suggested from an 
epidemiological study that the nature of depressive symptomatology can help to diff er-
entiate organic from psychological depression. In this study, patients with a probable 
major organic aetiology for their depression showed a syndrome with the key symptoms 
irritability, psychomotor retardation, confusion and suicidal ideation (Oyen 1995). Also, 
Forsell demonstrated a subdivision of depression in the elderly, describing ‘low motiva-
tion’ and ‘low mood’ syndromes. Patients with predominantly ‘motivational’ symptoms 
more likely had an organic etiology for their depression (Forsell et al. 1993). Others 
replicated this fi nding (Janzing et al. 1999). Th us, the symptom profi le in stroke patients 
may be an indication of the involvement and relevance of an organic lesion for the de-
pression. 
In the present study we investigated whether subdivision of depressive disorder into 
diff erent dimensions would diff erentiate between post stroke depression and dementia. 
We therefore compared depressive symptoms of stroke patients with and without de-
mentia. Furthermore, we studied the contribution of individual depressive symptoms to 
a diagnosis of major depressive disorder in this patient population.
3.3 METHODS
3.3.1 Subjects
Th e subjects were recruited from the Rotterdam Stroke Databank (RSD), a prospective 
registry of patients with a transient ischaemic attack (TIA), cerebral infarction, or primary 
intracerebral haemorrhage that were admitted to the department of Neurology of the Uni-
versity Hospital Rotterdam. From March 1, 1993, until January 15, 1996, all consecutive 
patients who met the criteria for enrolment in the Dutch Vascular factors in Dementia 
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Study were included. Characteristics of the design and demographic variables of this 
study are outlined in detail elsewhere (Van Kooten et al. 1998). In short, patients had 
to be 55 years or older and to have had a TIA with neurological signs on examination, a 
cerebral infarction, or intracerebral haemorrhage. Patients were excluded when a reliable 
assessment of dementia could not be made because of aphasia (i.e., a score of less than 3 
on the Aphasia Severity Rating Scale from the Boston Diagnostic Aphasia Examination) 
(Goodglass and Kaplan 1983), severe sensory handicaps (e.g., deafness or blindness), per-
sistent impairment in consciousness, a history of severe psychiatric symptoms other than 
mood disturbances, or insuffi  cient command of the Dutch language. Additional reasons 
for exclusion were concomitant primary cerebral disorders, or severe co-morbidity with a 
short life expectancy. Informed consent according to institutional guidelines was obtained 
from all patients or from close relatives in case of impaired judgement in the patient. 
Th e “golden standard” diagnosis of dementia was based on the results of an extensive 
neuropsychological examination, clinical presentation and information from a close rela-
tive. A diagnostic panel consisting of two neurologists, a neuropsychologist and a trained 
physician made a fi nal judgement. All demented patients were scheduled for psychiatric 
examination. For the diagnosis of dementia, the criteria of the DSM-III-R were used (APA 
1987). In addition, a group of control patients randomly selected from the patients who 
did not fulfi l the criteria for dementia was subjected to the same psychiatric evaluation.
3.3.2 Cognitive evaluation
During hospital admission, an interview with a close relative and the score on the Blessed 
Dementia Scale (BDS) established premorbid cognitive functioning (Katzman et al. 1983). 
Education was categorised by the number of years of schooling completed. Between 3 and 
9 months aft er stroke onset, a neurologist assessed cognitive function, based on clinical 
observation, the information of a close relative, and the score on the BDS. In case of any 
suspicion of cognitive decline, patients were invited for an extensive neuropsychological 
examination, which is outlined in detail elsewhere (De Koning et al. 1998).
3.3.3 Psychiatric evaluation
All psychiatric evaluations were performed in the aft ernoon to prevent results being in-
fl uenced by diurnal variations in mood. Detailed information concerning former depres-
sive or other psychiatric episodes was obtained through an interview with the patients 
and/or their family or the general practitioner.
A DSM psychiatric diagnosis of major depressive disorder (MDD) was established with 
the aff ective part of the Schedule for Aff ective Disorders and Schizophrenia (SADS) (En-
dicott & Spitzer 1978). Th is is a semi-structured interview, which not only may confi rm 
the diagnosis of major depressive disorder according to DSM-IV-criteria (APA 1994), 
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but also sheds light on milder depressive symptomatology, with emphasis on dimensional 
instead of syndromal properties. Symptoms were dichotomised into ‘absent’ or ‘present’. 
3.3.4 Statistical analysis
For statistical analysis we used the Statistical Package for the Social Sciences (SPSS) for 
Windows version 9.0. Chi-square analysis was used to compare categorical variables and 
the independent samples t-test to compare continuous variables. A principal component 
analysis with varimax rotation was carried out on all depressive symptoms of the SADS 
with prevalence above 10%. Symptoms were added to a factor when factor loading was 
greater than .40. For all factors internal consistency was determined using Cronbach’s α. 
Th e associations between the factor-scores on the one hand and major depression, de-
mentia and the combination of major depression and dementia on the other hand, were 
studied using logistic regression analysis. Next, a discriminant analysis was carried out 
on the basis of the individual items of the SADS. A model was calculated to predict 
whether patients would fall into the depressed or the non-depressed group according to 
the golden standard, i.e. the DSM-criteria. Next, a correlation coeffi  cient with this dis-
criminant function was obtained for each SADS-item and these were grouped in order of 
descending correlation coeffi  cients, i.e. in order of decreasing sensitivity. Wilk’s lambda 
was calculated as a test of discriminant function. Th e correlation coeffi  cients refl ect the 
relative contribution of these items to a diagnosis of MDD. 
3.4 RESULTS
3.4.1 Procedure
In 83 out of 300 patients, there was a clinical suspicion of dementia. Aft er an extended 
neuropsychological evaluation, 71 of them were diagnosed as demented. Fift y-four of 
these patients underwent psychiatric evaluation. In 6 patients, psychiatric evaluation 
could not take place because they died between cognitive evaluation and the scheduled 
psychiatric examination. In the other 11 patients, the severity of the dementia syndrome 
prevented a reliable psychiatric evaluation. Of the 217 patients without clinical suspicion 
of dementia, a sample of 24 patients was drawn. Th us, a total of 78 patients were included 
in the present study. Psychiatric evaluation was performed between 6 and 24 months 
aft er the stroke.
3.4.2 Assessment of affective symptoms
Aff ective assessment of demented and non-demented stroke patients revealed four dif-
ferent groups: A group of 33 patients who were classifi ed as having dementia but no 
major depression. A second group meeting criteria for a major depressive disorder but 
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not for dementia, consisting of 7 patients. A group of patients who met criteria for both 
major depressive disorder and dementia, consisting of 21 patients and fi nally a group 
of 17 patients who did not meet any criteria for depressive disorder nor for dementia. 
Th e clinical characteristics of the demented and non-demented patients are shown in 
table 1. Th e frequency of major and minor depression did not diff er signifi cantly between 
the demented and the non-demented group. Twenty-eight (36%) patients had a major 
depression according to DSM-IV criteria. An additional 14 (18%) patients fulfi lled cri-
teria for a minor depression. Th e frequencies of the diff erent depressive symptoms of the 
SADS for both demented and non-demented patients were assessed and symptoms with 
a frequency of less than 10% were excluded from further analysis. Th ese symptoms were: 
depersonalisation, feelings of guilt, hallucinations, hypochondriasis, increase of appetite, 
obsessions, panic attacks, paranoid thinking, self-dismay and weight increase.
3.4.3 Principal component analysis
A principal component analysis was carried out using symptoms with a minimum 
prevalence of 10% in at least one of both groups, which resulted in six factors (table 2, 
all subjects). Th e fi ft h and sixth factors only consisted of one or two symptoms and were 
therefore excluded from further evaluation. Symptoms on the fi rst factor, accounting 
for 29.9% of the variance, appeared to belong to the “mood” dimension of depression. 
Th e second factor concerned “psychomotor” symptoms and the third factor seemed to 
represent the “vegetative” dimension of depression. Both the second and third factor ex-
plained 8.5% of the variance. Anxiety had a high loading both on the fi rst and the fourth 
factor. Th e symptoms “diminished interest and pleasure” and “insomnia” had a high 
loading on two of the factors and were excluded from further analysis because of lack of 
specifi city. Th e test on internal consistency of the fi rst four factors (consisting of three 
Table 1: Patient characteristics 
 Dementia
N = 54
No dementia
N = 24 P-value
Age 74.3 (7.7) 69.5 (7.7) 0.013
Years of education (mean)  7.2 (3.1)  8.8  (2.2) 0.029
Female sex 29 (54)  8  (33) 0.078 
MMSE 18.7 (6.8) 27.5 (1.9) < 0.001
Depression:
 Major depression 21 (39)  7  (29) 0.287 
 Minor depression 10 (18)  4  (17) 0.559 
MMSE = MiniMentalStateExamination
numbers in brackets indicate SD (means) or percentage (prevalence)
P – values: unpaired t-test with continues variables, Fisher’s exact-test with nominal variables. Signifi cant p-values are 
printed in bold
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or more symptoms) revealed Cronbach’s α's greater than .70 for the fi rst three factors 
(.86, .72, and .70) and .58 for the fourth factor. Th erefore the fourth factor was excluded 
from further analyses. A factor sum-score for each factor was calculated by adding one 
point for each symptom present. Mean factor scores were calculated for demented and 
non-demented stroke patients and are outlined in table 3. Th e only signifi cant diff erence 
was found for the psychomotor factor, which showed a higher mean factor sum score in 
the demented subgroup.
3.4.4 Discriminant analysis
Th e results of the discriminant analysis for a diagnosis of MDD are shown in table 4. 
Wilks’ lambda for this model was highly signifi cant (Λ= 0.153, chi-square =124.71, df 
=19, p < 0.001). In this model 98% of the patients were correctly classifi ed as depressed 
Table 2: principal component analysis of depressive symptoms. Rotated component matrix.
 “mood” “psychomotor” “vegetative”
 I II III IV V VI
Agitation .02 -.10 -.04 .16 -.05 .86
Anger .66 .04 .09 -.24 -.13 .00
Anxiety .42 .04 -.14 .42 -.51 -.03
Diminished interest and pleasure .42 .17 .42 .32 .13 .11
Depressed mood .66 .29 .34 .20 .01 -.06
Increased sleeping at daytime .08 .06 -.07 .14 .83 -.09
Indecisiveness -.09 -.01 .12 .65 .30 .22
Insomnia .06 .52 .42 .03 -.35 .36
Loss of appetite .21 .16 .84 -.11 -.04 .01
Loss of energy .18 .80 .06 -.07 -.02 .01
Negative thoughts .55 .20 .17 -.08 .36 .30
No expectations of the future .74 .13 .11 .38 .11 .10
Observed depression .37 .61 .20 .35 .12 .06
Psychomotor retardation .28 .70 -.02 .31 .21 -.26
Ruminations .76 .29 .21 .07 -.11 -.08
Self-pity .70 .08 .07 -.04 -.08 -.11
Social withdrawal .60 .03 .11 .38 .12 -.22
Suicidal thoughts .59 .23 -.18 .06 -.03 .16
Thinking/concentration disturbances .11 .20 .08 .79 -.15 .04
Weight loss .05 -.05 .83 .25 .02 -.08
Cronbach’s α .86 .72 .70 .58 -- --
Extraction Method: Principal Component Analysis. Rotation Method: Varimax with Kaiser Normalization. Only 
symptoms with a prevalence greater than 10% were included in the analysis. Factor loadings < -.40 and > .40 are 
printed in bold
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or non-depressed. As to be expected, of all the SADS-items, the key-features of MDD, 
depressed mood and loss of interest, were the best discriminators between depressed and 
non-depressed patients. Somatic items, such as loss of appetite and weight, insomnia and 
thinking/concentration disturbances, had low discriminative properties. 
3.5 DISCUSSION
To fi nd out whether subdivision of depressive disorder into diff erent dimensions would 
diff erentiate between post stroke depression and dementia, we compared depressive 
symptoms in a group of stroke patients with and without dementia. Th ree important 
depressive dimensions were found: First, a “mood” one, consisting of depressed mood, 
anger, negative and suicidal thoughts, ruminations and social withdrawal. A second, psy-
chomotor, dimension consisted of psychomotor retardation, observed depression and 
loss of energy. Th e third, vegetative dimension consisted of weight and appetite loss. Us-
ing multiple logistic regression, it was found that all three factors were associated to the 
DSM-diagnosis “major depressive disorder” in these post-stroke patients. Th e psycho-
motor dimension was also fi rmly associated with a diagnosis of “dementia”, in contrast to 
the other two dimensions. 
Th ese fi ndings support the notion that some of the depressive features, in particular the 
psychomotor ones, are at least partly due to the organic brain damage from stroke. Co-
morbid psychological depression will give rise to more and other depressive symptoms, 
as represented in the mood and vegetative dimensions. 
In our study-group, the core symptoms of major depression, depressed mood, loss of 
interest, and no expectations of the future, are most sensitive in predicting a depressive 
disorder. Symptoms such as psychomotor retardation, observed depression and think-
ing/concentration disturbances appeared to be sensitive predictors of both depressive 
disorder and dementia, and will therefore give rise to diffi  culties in clinical decision mak-
ing. Finally, vegetative depressive symptoms, such as insomnia and loss of appetite are 
common in depressed as well as in non-depressed patients with vascular dementia. 
Table 3: Mean factor sum-scores for demented and non-demented stroke patients
Dementia No-dementia P-value
Mood factor 2.06 (2.19) 1.75 (2.61) 0.594
Psychomotor factor 1.59 (1.24) 0.96 (1.04) 0.032
Vegetative factor 0.39 (0.71) 0.33 (0.64) 0.744
Numbers in brackets indicate SD; t-test; Signifi cant p-value printed in bold.
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Our results of the principal component analysis are consistent with those found by Forsell 
and Janzing, although the components of our dimensions diff er in some aspects (Forsell 
et al. 1993; Janzing et al. 1999). Th ese diff erences in symptom profi les can be attributed 
to various factors. In contrast to our patients, Janzing and Forsell studied subjects who 
were living in the community and showed a low prevalence of major depressive disorder, 
whereas our study group was a clinical sample of patients who had recently suff ered a 
stroke, were predominantly demented and had a high prevalence of major depression. 
Moreover, there is an important diff erence in diagnostic instruments used. Furthermore, 
we counted all depressive symptoms analyzing only those that had a prevalence of 10% 
or higher, whereas Forsell and Janzing performed their analyses only with the nine symp-
toms of the DSM-criteria, irrespective of the frequency of their occurrence. Finally, we 
included each factor with an acceptable internal consistency, whereas Forsell and Janzing 
extracted only two factors. 
Th ere are some shortcomings to be noticed in our study. First, a suffi  cient control-
group of patients with a stroke but without dementia is lacking. Th is could have a major 
Table 4: Structure matrix of SADS items, grouped in descending order of correlation within the 
discriminant function. Depressive disorder.
Item Correlation coeffi cient
Depressed mood .55
Loss of interest .40
Ruminations .37
No expectations of the future .33
Observed depression .33
Psychomotor retardation .26
Social withdrawal .25
Negative thoughts .24
Suicidal thoughts .22
Self pity .22
Loss of weight .21
Loss of energy .21
Loss of appetite .20
Insomnia .18
Anger .18
Thinking/concentration disturbance .14
Indecisiveness .05
Increased sleeping -.04
Agitation -.01
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infl uence on our outcome and so a new study with an accurate control group is needed to 
replicate our fi ndings. Other important limitations include the modest group size (type-2 
error) and the cross-sectional design.
It should be emphasised that the prevalence of dementia in general in stroke popula-
tions is only twenty-fi ve percent (Tatemichi et al. 1993). As far as we know, this is the fi rst 
principal component analysis of depressive symptomatology in patients with vascular 
dementia.
Subdivision of depression into mood, psychomotor and vegetative dimensions may be 
useful in predicting the course of depressive disorders in patients with vascular dementia 
and their impact on the rehabilitation process.
However, further investigations are necessary to confi rm our fi ndings. Clinical, bio-
chemical and radiological markers of the mood, psychomotor and vegetative dimensions 
could be of great help in unravelling the clinical problem of post stroke dementia and 
mood disorders in other brain diseases. Finally, both drug and psychotherapeutic clinical 
trials may elucidate whether these interventions are benefi cial for subgroups of patients 
with post stroke dementia or depression.
Chapter 4
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4.1 SUMMARY OF CHAPTER 4
To test the hypothesis that depressive symptoms in dementia refl ect dysfunction in fron-
to-subcortical pathways, associations were computed between measures of depressive 
symptoms and a comprehensive set of neuropsychological tests in a sample of fi ft y-four 
subjects with a post-stroke dementia. Our hypothesis was supported by a negative cor-
relation between scores on the Verbal Fluency Test and the total numbers of motivational 
depressive symptoms. None of the neuropsychological tests was signifi cantly related to the 
number of mood symptoms neither did they correlate with the total number of depressive 
symptoms. Th is study gives further evidence for the assumption that motivational-based 
depressive symptoms partially originate from fronto-subcortical dysfunction.
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4.2 INTRODUCTION
Both depression and dementia frequently complicate the clinical course of stroke. Syndro-
mal or subsyndromal depression occurs in about 40% (Sharpe et al. 1990) and dementia 
in approximately 25% of patients with a recent stroke (Tatemichi et al. 1990; van Kooten 
& Koudstaal 1998). Although little research has been done on the combination of ‘vascu-
lar’ or ‘post-stroke’ dementia and ‘vascular’ or ‘post-stroke’ depression, it is evident from 
clinical practice that there is a major overlap of the cognitive and aff ective symptoms that 
occur aft er stroke. Earlier studies on the symptoms of depression in Alzheimer’s (AD) 
and Post-stroke Dementia suggested two distinct dimensions: (Forsell et al. 1993; Janzing 
et al. 1999a; Naarding et al. 2003)
(a) A factor of mood disturbance consisting of the symptoms dysphoria, feelings of guilt, 
thoughts of death and appetite disturbance. 
(b) A factor of motivational disturbance containing the symptoms loss of interest, psy-
chomotor change, loss of energy and thinking or concentration disturbance.
Studies in dementia, Parkinson’s disease and normal aging have suggested that motiva-
tional depressive symptoms refl ect disturbances in fronto-subcortical circuits. In sub-
jects with Parkinson’s disease most of the motivational symptoms, but none of the mood 
symptoms fl uctuated with changes in other Parkinson’s symptoms or ameliorated on 
dopaminergic medication (Hoogendijk et al. 1998). In normal high-functioning elderly, 
motivational symptoms, but not mood symptoms were found to be associated with MRI 
deep white matter hyperintensities (Nebes et al. 2001). In a former presentation of our 
fi ndings on the phenomenology of depression in patients with post stroke dementia, we 
demonstrated that only the motivational symptoms in this group correlated with the 
presence of dementia (Naarding et al. 2003). Former studies have demonstrated that 
the location of the vascular lesion correlates with the presence and severity of depres-
sive symptoms. Depressive disorder is found to be more frequent and more severe with 
more frontal positioning of the vascular lesion in patients with a post stroke depres-
sion (Robinson et al. 1984a). Although this fi nding is still controversial (Carson et al. 
2000), it would be in line with the assumption that fronto-subcortical dysfunction gives 
rise to motivational depressive symptoms. Consequently, one would expect that these 
fronto-subcortical disturbances were refl ected in disturbances in performance on frontal 
tasks in neuropsychological examinations. In a recent study we found neuropsychologi-
cal support for the relationship between motivational symptoms and fronto-subcorti-
cal disturbance in residents of an elderly home with cognitive dysfunction (Janzing et 
al. chapter 5 this thesis). Subdivision of depressive features that are the direct result of 
the neuro-degenerative or neurovascular damage and features that are the result of the 
psychological impact of the disease and handicap could be of use for everyday clinical 
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management. So far, treatment is similar for post stroke and idiopathic depression, but 
possibly some signs and symptoms would make a certain treatment regime preferable.
In the present study, we investigated the relationship between motivational symp-
toms of depression and fronto-subcortical dysfunction in 54 patients with post stroke 
dementia.
4.3 METHODS
4.3.1 Subjects and procedure
Th e subjects were recruited from the Rotterdam Stroke Databank (RSD), a prospective 
registry of patients with a transient ischemic attack (TIA), cerebral infarction, or primary 
intracerebral hemorrhage who were admitted to the department of Neurology of the Uni-
versity Hospital Rotterdam. From March 1, 1993, until January 15, 1996, all consecutive 
patients who met the criteria for enrolment in the Dutch Vascular factors in Dementia 
Study were included. Characteristics of the design and demographic variables of this 
study are outlined in detail elsewhere (Van Kooten et al. 1998). In short, patients had 
to be 55 years or older and to have had a TIA with neurological signs on examination, a 
cerebral infarction, or intracerebral hemorrhage. Patients were excluded when a reliable 
assessment of dementia could not be made because of aphasia (i.e., a score of less than 
3 on the Aphasia Severity Rating Scale from the Boston Diagnostic Aphasia Examina-
tion (Goodglass & Kaplan 1983)), severe sensory handicaps (e.g., deafness or blindness), 
persistent impairment in consciousness, a history of severe psychiatric symptoms other 
than mood disturbances, or insuffi  cient command of the Dutch language. Additional 
reasons for exclusion were concomitant primary cerebral disorders, or severe co-morbid-
ity with a short life expectancy. Informed consent according to institutional guidelines 
was obtained from all patients or from close relatives in case of impaired judgment in 
the patient. Th e “golden standard” diagnosis of dementia was based on the results of an 
extensive neuropsychological examination, clinical presentation and information from 
a close relative. A diagnostic panel consisting of two neurologists, a neuropsychologist 
and a trained physician made a fi nal judgment. All demented patients were scheduled 
for psychiatric examination. For the diagnosis of dementia, the criteria of the Diagnostic 
and Statistical Manual of Mental Disorders, third edition, Revised, (DSM-III-R) were 
used (APA 1987).
Figure 1 is a schematic representation of the diagnostic procedure. In 83 out of 300 
consecutive admissions of patients with a TIA, cerebral infarction or primary intrace-
rebral hemorrhage, there was a clinical suspicion of dementia. Aft er an extended neu-
ropsychological evaluation, 71 of these were diagnosed as demented. In 6 patients, psy-
chiatric evaluation could not take place because they died between cognitive evaluation 
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and the scheduled psychiatric examination. In the other 11 patients, the severity of the 
dementia syndrome prevented a reliable psychiatric evaluation. Th us, a total of fi ft y-four 
patients underwent an extensive psychiatric evaluation between 6 and 24 months aft er 
the stroke.
4.3.2 Cognitive evaluation
During hospital admission, an interview with a close relative and the score on the 
Blessed Dementia Scale (BDS) established premorbid cognitive functioning (Katzman 
et al. 1983). Education was categorized by the number of years of schooling completed. 
Between 3 and 9 months aft er stroke onset, a neurologist assessed cognitive function, 
based on clinical observation, the information of a close relative, and the score on the 
BDS. In case of any suspicion of cognitive decline, patients were invited for an extensive 
neuropsychological examination, which consisted of the following:
/PDMJOJDBMTVTQJDJPOGPS
EFNFOUJB
/
$MJOJDBMTVTQJDJPOGPS
EFNFOUJB
/
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/
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/
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/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/
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
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
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/
Figure 1: Schematic representation of the diagnostic procedure
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1. An intelligence test (either the shortened version of the Groninger Intelligence Test, 
(Luteijn & Vanderploeg 1983) a Dutch intelligence test, or when this could not be 
administered, Raven’s Colored Matrices, a non-verbal test (Raven 1965)). 
2. Word-fi nding diffi  culties were examined with the shortened form of the Boston Nam-
ing Test (the Consortium to Establish a Registry for Alzheimer’s Disease [CERAD] 
(Morris et al. 1989)).
3. Memory was evaluated with the Word List Memory (CERAD/Morris et al. 1989) and 
the Rivermead Behavioral Memory Test (Wilson et al. 1985).
4. Immediate verbal recall and attentional capacity were measured using Digit Span 
forward and backward (Wechsler Adult Intelligence Scale [WAIS] (Wechsler & Stone 
1955))
5. Frontal, executive functioning was measured with the Verbal Fluency Test (VFT, ani-
mals, occupations and letter B), Stroop color word test part III and Trail-Making Test 
B (Hammes 1978; Reitlan 1958).
6. Visuoconstructive ability was measured by copying the drawing of a circle, diamond, 
two overlapping rectangles, and a cube (CERAD/Morris et al. 1989).
A fi nal judgment of cognitive functioning was made by a diagnostic panel consisting of 
two neurologists, a neuropsychologist and a trained physician. Criteria of the DSM-III-R 
were used (APA 1987). Further sub-classifi cation of dementia took place according to the 
research criteria of the NINDS-AIREN international workshop (Roman et al. 1993).
When tests could not be administered and we were confronted with missing values we 
distinguished between missing values due to cognitive or behavioral disturbances and 
missing values due to other reasons. Th is latter category included communication and 
logistic problems. Th e majority of specifi c tests on executive functioning or “frontal” tests 
were not administrable in demented patients due to cognitive disturbances. We therefore 
included only the scores on semantic and phonological fl uency, as measures of executive 
functioning in our analyses.
4.3.3 Psychiatric evaluation
All psychiatric evaluations were performed in the aft ernoon to prevent results being in-
fl uenced by diurnal variations in mood. Detailed information concerning former depres-
sive or other psychiatric episodes was obtained through an interview with the patients 
and/or their family or the general practitioner.
A semi-structured interview - the aff ective part of the Schedule for Aff ective Disorders 
and Schizophrenia (SADS) - was used to elucidate all depressive symptoms (Endicott & 
Spitzer 1978). With this instrument, a DSM-IV psychiatric diagnosis of major depressive 
disorder (MDD) could be made (APA 1994).
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Moreover, symptoms were dichotomized into ‘absent’ or ‘present’. For each individual 
the following measures of depression were computed by counting the positively rated 
criteria. 
• Depressive symptoms (all criteria of major depressive episode according to 
DSM-IV). 
• Mood symptoms (dysphoria, appetite disturbance, feelings of guilt and thoughts of 
death).
• Motivational symptoms (loss of interest, psychomotor change, loss of energy and 
thinking or concentration disturbance).
4.3.4 Statistical analysis 
For statistical analysis we used the Statistical Package for the Social Sciences (SPSS) for 
Windows version 10.0. For all test scores, means (SD) were calculated. Next, we replaced 
each missing value due to cognitive/behavioral disturbances by the worst performance 
in this study group on that particular test (Smeding & De Koning 2000). Aft er this ad-
justment, we calculated means (SD) of the adjusted scores. To determine the eff ect of 
these adjustments, we computed the eff ect sizes of each test variable. Th e eff ect size can 
be calculated by the diff erence between the observed and the adjusted means divided 
by the observed SD. An eff ect size of 0.8 SD should be considered as large, of 0.5 SD 
as medium and an eff ect size of 0.2 SD as small (Cohen 1988). Also we performed a 
sensitivity analysis to check whether imputation with the average score on the test or a 
score in between the worst and the average (25th percentile) would alter the correlation 
coeffi  cients between the measures of depression and the neuropsychological test scores. 
Chi-square analysis was used to compare categorical variables and the independent 
samples t-test to compare continuous variables. Pearson’s correlation coeffi  cients were 
computed to study the associations between symptom measures of depression and neu-
ropsychological test scores. Tests of signifi cance were two-tailed (P<0.05). 
4.4 RESULTS
In table 1 the baseline characteristics of the participants are presented. In 21 patients 
(39%) a diagnosis of MDD could be made according to DSM-IV criteria. Depressed 
patients tended to be younger and to have had more years of education than non-de-
pressed patients, although this did not reach signifi cance. In table 2, mean scores on 
various neuropsychological tests are reported and the result of adjustment for missing 
values is shown. All neuropsychological tests could be applied to more than 50% of this 
study sample. All patients except fi ve participated in at least two of these tests. Only the 
adjustment aft er imputation of the worst score for the missing values due to cognitive 
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and behavioral reasons is shown. Imputation of neither the average test score nor the 25th 
percentile score did alter the associations shown hereaft er. Th e eff ect size of the adjust-
ment procedure was not acceptable for the BNT, Constructional praxis and WLM and 
therefore these tests were left  out of further analysis.
Associations between measures of depression and neuropsychological test scores are 
presented in table 3. Th ere was a negative correlation between the number of motivation-
al symptoms and the Verbal (semantic) Fluency Tests (animals and professions) scores. 
None of the neuropsychological test results were signifi cantly related to the number of 
mood symptoms, neither did they correlate with the total number of depressive symp-
toms. No association was found between total MMSE score and any of the measures of 
depression.
Table 1: Patient characteristics
All patients
N = 54
MDD
N = 21
No MDD
N = 33
Age (mean) 73.7 (7.7) 71.5 (9.7) 75.2 (5.8) P=0.087
Years of education (mean) 7.2 (3.1) 8.1 (3.4) 6.7 (2.8) P=0.086
Female sex 25 (46) 9 (43) 16 (48) n.s.
MMSE (mean) 19.8 (5.1) 20.3 (4.9) 19.6 (5.4) n.s.
Previous stroke 17 (32) 4 (19) 13 (32) n.s.
number of mood symptoms 0.70 (0.9) 1.52 (0.8) 0.18 (0.5) p < 0.001
number of motivation symptoms 2.13 (1.3) 3.33 (0.7) 1.36 (1.0) p < 0.001
total number of depressive symptoms 2.83 (2.0) 4.86 (1.2) 1.55 (1.0) p < 0.001
MDD = Major Depressive Disorder; MMSE = MiniMentalStateExamination
numbers in brackets indicate SD (means) or percentage (prevalence)
P-value result from chi-square testing (percentages) or t-test (compare means)
Table 2: Observed and adjusted test-results: N =54, post stroke dementia
Tests:
Missing values Observed mean
(SD)
(still) missing 
values
Adjusted mean
(SD)
Effect size
(d)
Boston Naming Test 21 11.6(2.2) 3 9.9(2.8) -0.8
Constructional Praxis 22 7.1(2.1) 3 4.8(3.4) -1.1
Word list memory 21 12.6(3.5) 3 10.2(4.2) -0.7
Word list recall 21 3.2(2.1) 7 2.3(2.3) -0.4
Fluency animals 5 9.8(4.2) 0 9.0(4.7) -0.2
Fluency professions 7 7.3(3.3) 0 6.4(4.0) -0.3
Fluency letter B 11 5.3(3.4) 0 4.4(3.5) -0.3
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4.5 DISCUSSION
Th e primary aim of the present study was to investigate the relationship between 
motivational symptoms of depression and fronto-subcortical dysfunction in 54 patients 
with post stroke dementia. Th e results on verbal semantic fl uency tasks were negatively 
correlated with the number of motivational symptoms, indeed indicating a correlation 
between frontal dysfunction and motivational symptoms of the depressive disorder. 
Furthermore, we found that symptoms indicating motivation disturbance were highly 
prevalent in this group of patients with predominantly vascular dementia, in contrast to 
the symptoms of mood disturbance. Of the total number of depressive symptoms, 75% 
contributed to the factor motivation disturbance in the complete study sample. In 39% of 
the total sample, these symptoms occurred in the context of a major depressive episode. 
In these, the motivation symptoms contributed for as much as 68% to the total number 
of depressive symptoms. Th is is the same fi nding as we had in another group of demented 
subjects, although in that case, the level of dementia as well as that of depression was con-
siderably less severe than in the present study (Janzing et al. 2005/chapter 5 this thesis). 
No signifi cant relationships were observed between the mood symptoms and scores on 
neuropsychological tests and also consistent with earlier studies there was no signifi cant 
correlation between a general measure of depression and specifi c neuropsychological 
tests performance (Kuzis et al. 1999). As was advocated by Smeding and De Koning 
(2000) we included missing values due to behavioural and/or cognitive disturbances. 
Th e eff ect size of this inclusion was medium or large for a large proportion of the tests 
used, but relatively small for the Verbal Fluency Test. Th e VFT is generally considered 
as a test of executive functioning (Lezak 1995). It is a measure of time-restricted genera-
tion of multiple-response alternatives under a constrained search condition. Important 
aspects of task performance are initiation, self-monitoring, retrieval and planning of goal 
Table 3: Correlations between measures of depression and adjusted frontal test results: N = 54 (post 
stroke dementia)
All depressive symptoms Mood symptoms Motivational symptoms
MMSE -0.09[-0.35;0.18] -0.03[-0.30;0.24] -0.11[-0.37;0.16]
Word List Recall -0.13[-0.38;0.14] -0.11[-0.37;0.16] -0.12[-0.38;0.15]
Fluency animals -0.25[-0.49;0.02] -0.14[-0.39;0.13] -0.28[-0.51;-0.01] *
Fluency professions -0.24[-0.48;0.03] -0.10[-0.36;0.17] -0.30[-0.53;-0.04] *
Fluency letter B -0.15[-0.40;0.12] 0.01[-0.34;0.35] -0.23[-0.47;0.04]
* p < 0.05, (two-tailed Pearson)
[Confi dence Intervals in brackets]
Chapter  4
56
directed behaviour. In our study group the VFT seems therefore a reliable and useful test 
to measure frontal dysfunction in even severely demented patients.
Th e results of the present study should be interpreted in the context of the following 
limitations. First, a type 1 error can be expected when applying more than ten statisti-
cal tests on such a small study group. However, the result we found was in line with 
our hypothesis. Second, although the results refer to a clinical sample of subjects with 
post stroke dementia, some of them at least appeared to have a mixed type dementia 
(Vascular Dementia + AD). Moreover, we excluded patients with severe aphasia, thereby 
excluding patients with a specifi c cortical location which could be a possible bias in our 
study. Finally, replacing of missing values (imputation) is a valid statistical method for 
handling missing values, but remains a rather weak problem-solving approach. Th e sen-
sitivity analysis which we performed showed that the results were not infl uenced by the 
height of the value which we chose for replacement. Moreover, the results still remained 
the same, even when we chose no imputation at all. Unfortunately, no specifi c neuropsy-
chological (frontal) test is applicable to all patients in such a severely ill study-group. On 
the contrary, most of them were not useful in this study-group. Nevertheless, newer test 
should be developed, enabling the adequate measurement of frontal functioning in this 
category of patients.
Strengths of this study are that it is among the fi rst to compare the eff ects of a broad 
range of depression parameters on cognitive deterioration in post stroke dementia and 
that it includes both categorical and dimensional measures of depression. Hence, de-
tailed information on depressive symptoms was available, as well as test performance 
on diff erent cognitive tests. Moreover, the group was thoroughly selected and revealed a 
rather large cohort of clearly defi ned clinical subjects. 
Th is is the second study in which we have confi rmed a relationship between low scores 
on the VFT and the motivational dimension of depression (Janzing et al. 2005 / chapter 5 
this thesis). In contrast to our former study, there was no association between the MMSE 
total score and both the total number of depressive symptoms and the number of moti-
vational symptoms. 
Although the correlation between the verbal semantic fl uency and motivational 
symptoms reached statistical signifi cance, the actual correlation coeffi  cients were weak: 
-.28(Confi dence interval (CI) -0.51;-0.01) for VFT animals and -0.30(CI -0.53;-0.04) for 
VFT professions. In terms of clinical relevance this means that around 10% (square num-
ber of correlation coeffi  cient) (CI 0.1%; 25%) of the variance in motivational symptoms 
can be explained by frontal dysfunction. Th at leaves open the question which other fac-
tors would clarify the other 90% of the variance of motivational symptoms. 
Th ere are no other reports of studies on this subject in patients with a diagnosis of 
post stroke dementia, but the fi ndings in the present study are very similar to those of 
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Alexopoulos et al. who studied subjects with late-onset depression of presumed vascular 
origin (Kalayam & Alexopoulos 1999; Alexopoulos et al. 2000). In their studies executive 
dysfunction was found to be associated with poor or delayed antidepressant response in 
depressed elderly patients, with relapse and recurrence of geriatric major depression and 
with residual depressive symptoms. Unfortunately, they did not specify these residual 
symptoms in their study-groups. Our fi ndings are also in line with the hypothesis that 
some features of the depressive disorder are an integral part of the degenerative process 
or illness. Th is is found in normal aging, senile dementia syndromes, or patients with 
subcortical brain diseases such as Huntington’s and Parkinson’s disease (Th ompson et 
al. 2002; Leentjens et al. 2003). It is also in agreement with the “depression-executive 
dysfunction syndrome”, which was proposed by Alexopoulos (2002) and comes very near 
to the concept of apathy, proposed by Marin (1990). Starkstein (2001) showed that the 
apathy syndrome occurred frequently in Alzheimer patients and in a majority of these 
the apathy syndrome co-occurred with a depressive disorder. Demarcation and clinical 
validation of these specifi c subsyndromes (i.e. apathy, low-motivational syndrome etc.) 
are still subject to debate and there may be no major diff erence between the motivation 
concept we used in this study, and the apathy concept postulated by others. For instance 
Kuzis (1999) showed that subjects with AD with a diagnosis of apathy (with or without 
depression) performed worse on the VFT and the Wisconsin Card Sorting Test. Scores 
on tests for memory, naming and block design were unrelated to apathy. Also McPherson 
(2002) found evidence for a specifi c relationship between apathy and neuropsychological 
tests measuring executive dysfunction in patients with AD. Using executive measures 
these authors were able to classify patients as apathetic or non-apathetic with 75% ac-
curacy. Sperry (2001) reported signifi cant correlation between apathy and naming and 
word list learning but the strongest relationship was with the VFT. A fi nal study found 
that apathy scores of AD patients were predicted by verbal fl uency scores but not by 
other neuropsychological tests (Paulsen et al. 1996). Lind (2002) performed a study 
on the relationship between regional brain symptoms and depressive symptomatology. 
Only fi ve symptoms of the Comprehensive Psychopathological Rating Scale (CPRS) were 
assessed: depressed mood, anxiety, suicidal, hypochondriac and paranoid thoughts, but 
unfortunately not the motivational symptoms of depression. Th ey nevertheless found 
that demented patients with a clinically established subcortical syndrome appeared to 
be more susceptible to depressive symptoms, which was not the case in patients with 
a prominent frontal syndrome. Lesser (1996) studied depressive features and cognitive 
function in patients with an early or late onset depression and healthy controls. Th ey con-
cluded that large amounts of white matter hyperintensities are more frequent in patients 
with late-onset depression than in elderly subjects with early-onset or no depression, and 
also that these patients show deterioration in information processing speed and have sig-
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nifi cantly poorer executive function. Th ese white matter hyperintensities are presumable 
of vascular origin and are oft en predominantly located in (frontal)-subcortical regions.
4.6 CONCLUSION
Fronto-subcortical dysfunction is partially responsible for the motivational but not the 
mood symptoms of depressive disorder in a group of patients with post-stroke demen-
tia. Future studies should elucidate which other factors are related to the dimensions of 
depressive disorder in these patients and whether these fi ndings have implications for 
therapeutic interventions.
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5.1 SUMMARY OF CHAPTER 5
It is unknown to what extent depression and cognitive dysfunction are related in subjects 
with dementia. A limitation of earlier studies is that only general measures of depression 
have been studied. In a sample of 60 subjects with dementia according to DSM-III-R cri-
teria depressive symptoms were divided into factors of mood and motivation disturbance 
according to a principal components analysis. Correlations were computed between the 
factor scores and the performance on a number of specifi c neuropsychological tests. As 
the symptom content of motivation disturbance suggests subcorticofrontal dysfunction 
it was hypothesized that this factor is related to impaired executive functions. 
Seventy-seven percent of the depressive symptoms contributed to the dimension of 
motivation disturbance and most of these symptoms occurred outside the context of a 
major depressive episode. Our hypothesis was supported by a signifi cant negative correla-
tion between motivation symptoms and semantic verbal fl uency. Th is relationship seems 
to have specifi city, as both the dimensions of mood symptoms and of general depressive 
symptoms did not correlate signifi cantly with specifi c neuropsychological test scores. 
Th e division of depressive symptoms in factors of mood and motivation disturbance 
contributes to insight into the relationship between depression and cognitive dysfunction 
in dementia. An advantage of the motivation disturbance factor compared to the regular 
apathy scales is that it consists of depressive symptoms. Th erefore it becomes evident that 
apathy or impaired motivation may occur in patients with dementia both in and outside 
the context of a depressive syndrome.
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5.2 INTRODUCTION
Depression frequently complicates the clinical course of dementia. Syndromal and sub-
syndromal depression has been reported in up to 50% of the patients that suff er from 
dementia (Ballard et al.1996; Lyketsos et al.1997; Janzing et al. 2002). A key question 
concerns the relationship between depression and cognitive dysfunction in dementia. 
Studies considering the association between depression and general cognitive function 
have reported equivocal results. Increased prevalence of major depression was found 
in patients with lower (Rovner et al.1989), higher (Pearson et al.1989) and comparable 
(Kuzis et al. 1999) scores on the Mini Mental State. 
Th e results of studies that have focused on the associations between depression and 
more specifi c cognitive defi cits have also been inconclusive. Kuzis et al. (1999) reported 
that depressed and non-depressed patients with dementia were comparable in memory 
and executive functions. It has also been observed that patients with Alzheimer’s Disease 
(AD) with and without depression had similar scores on tests of verbal and spatial 
performance (Berger et al. 2002). As subgroups were rather small, false negative results 
cannot be excluded in this study. In another study AD patients with depression per-
formed more poorly on Block design, Digit Symbol and speeded motor programming, 
but performed better on a test of logical memory than non-depressed AD-patients (Wefel 
et al. 1999). 
In these studies depression was defi ned according to general measures: depressive syn-
drome diagnoses according to the DSM classifi cation system or scores on commonly used 
depression rating scales. An alternative approach is to study associations with qualitative 
measures of depressive symptoms. Recently, factors of mood and motivation disturbance 
have been demonstrated in depressive symptoms of demented subjects. Indeed, these 
factors had distinct associations with clinical characteristics of dementia (Forsell et al. 
1993; Janzing et al.1999a).
Th e present study investigates the relationship between factors of mood and motiva-
tion disturbance and performance on a number of specifi c neuropsychological tests. It is 
hypothesized that the factor of motivation disturbance is most strongly related to cogni-
tive dysfunction. As this factor seems to refl ect subcortico/frontal pathology (Landes et 
al. 2001) it is expected that it particularly relates to impairment of executive functions.
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5.3 METHODS
5.3.1 Subjects
Residents of six homes for the elderly in the region of Nijme gen, the Netherlands partici-
pated in this study. Informed consent was obtained from the subjects themselves or, in 
case of severe cognitive impairment, from close relatives. 
In an earlier phase of the study 201 subjects were selected from a total population of 
601 residents: 91 subjects with and 110 subjects without dementia. Subjects with de-
mentia showed evidence of cognitive impairment according to two screening tests: a 
Mini Mental State Exami nation (MMSE) score ≤24 and Short Blessed Test (SBT) score 
>6 (Folstein et al. 1975; Katzman et al. 1983). In addition, they fulfi lled the DSM-III-
R criteria for dementia (APA 1987) based on information gathered with the Clinical 
Assessment Battery (CAB) of the Consortium to Establish a Registry for Alzheimer's 
Disease (CERAD) (Morris et al.1989). Th e type of dementia was not specifi ed. Collateral 
information was obtained from both staff  members of the homes and relatives of the 
subjects. Subjects without dementia had a normal cognitive function according to the 
screening instruments. 
From the total population 194 residents refused to participate, 33 were unavailable (11 
moved, 17 died, 5 too ill). From the remaining subjects, 76 did not fulfi l the selection 
criteria and 97 were excluded (12 untestable, 37 CVA with normal cognitive function at 
screening, 7 Parkinson’s Disease, 3 choreatic disease, 9 alcoholism, 10 partners of partici-
pants and 16 due to missing values of depressive symptoms). 
Th e present study concerns only the subgroup of residents with dementia. From the 91 
subjects originally selected, 17 refused neuropsychological testing and 14 had incomplete 
neuropsychological assessments. Th ese subjects did not diff er signifi cantly from those 
with complete assessments with respect to demographic, cognitive and depressive char-
acteristics. So the fi nal sample consists of 60 subjects. 
5.3.2 Measures of depression
All subjects underwent a full psychiatric assessment using the Geriatric Mental State 
(GMS community version) (Copeland et al. 1976). 
Factors of mood and motivation disturbance were derived from a principal component 
analysis with varimax rotation on the criteria of DSM-III-R of major depressive episode 
of the original sample of 91 subjects with and 110 subjects without dementia (Janzing et 
al. 1999a). Th ese factors were identical to those found in a larger population based study 
(Forsell et al. 1993). 
For each subject in the present study three sum scores were computed by counting the 
positively rated contributing criteria: 
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(a) Depressive symptoms (sum score of all nine criteria of DSM-III-R major depressive 
episode). 
(b) Mood symptoms (sum score of dysphoria, appetite disturbance, feelings of guilt and 
thoughts of death).
(c) Motivation symptoms (sum score of loss of interest, psychomotor change, loss of 
energy and thinking or concentration disturbance) 
5.3.3 Neuropsychological assessment 
Trained psychologists and medical or psychology students who had shown good inter-
rater reliability administered the Neuropsychological Assessment Battery (NAB) of the 
Consortium to Establish a Registry for Alzheimer’s Disease (CERAD; Morris et al. 1989). 
Assessment was independent from the clinical interview and blinded for its results. 
Th e following tests are included in the NAB:
1. Verbal Fluency; Animal Category (Isaacs et al. 1973). Th is test measures impairment 
in verbal production, semantic memory and language. Subjects are asked to name 
as many animals as possible in 60 seconds. Th e score is the total number of diff erent 
animals named.
2. Modifi ed Boston Naming Test (Kaplan et al.1978). Subjects are asked to name 15 
objects presented as line drawings. A maximum of 10 seconds is allowed for each 
picture. 
3. Word List Memory (Atkinson et al.1971). Th is task assesses the ability to remember 
newly learned information. It consists of 10 printed words presented in three trials 
in a random order. Aft er each trial the subject is asked to recall as many items as 
possible. Th e maximum score is 30 for the three trials. 
4. Constructional Praxis (Rosen et al.1984). In this task four line drawings are presented 
to the subject for copying in an increasing complexity (a circle, a diamond, intersect-
ing rectangle and a cube). Two minutes are allowed for each fi gure.
5. Word List Recall. Delayed recall is tested for the 10 words presented in the Word List 
Memory Task. A maximum of 90 seconds is allowed. 
6. Word List Recognition (Mohs et al.1986). Recognition is tested for the 10 words of 
the Word List Memory Task by presenting them among 10 distracter words. To adjust 
for chance, the total score is the sum of the number of correct answers minus 10.
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5.4 STATISTICAL ANALYSIS
Pearson’s correlation coeffi  cients were computed to study the associations between 
symptom measures of depression and neuropsychological test scores. Tests of signifi -
cance were two-tailed (P<0.05). 
5.5 RESULTS
Sixty subjects were fi nally included in the present study. GMS-AGECAT (Copeland et al. 
1988) diagnosed 55 of them as organic cases (18 level O3, 35 level O4 and 2 level O5). 
From the remaining subjects 2 were organic sub-cases and 3 had no diagnosis at the 
organic cluster according to GMS-AGECAT. 
Th e subjects had a mean age of 86.3 (SD 5.6) years. Fift y-three subjects (88.3%) were 
female. Only 2 (3.3%) were married. On average the subjects had completed 7.2 (SD 2.2) 
years of education. 
Table 1 presents the total number of depressive symptoms and the numbers of mood 
and motivation symptoms. Th e prevalence of depressive symptoms in the study sample 
is rather low. Regarding the nature of the symptoms, it can be concluded that they largely 
consist of motivation-based symptoms (1.0/1.3=77%). It should be noted that the maxi-
mum number of both mood and motivation symptoms is four.
Table 2 shows the neuropsychological test scores. Th e scores are comparable to those 
reported for AD patients with mild to moderate dementia (Morris et al. 1989). Regarding 
the distribution of the scores a fl oor eff ect seems to be present only in the scores for 
recall. 
Th e results regarding the associations between measures of depression and scores on 
neuropsychological test are presented in table 3. A signifi cant negative correlation be-
tween the number of motivation symptoms and the Verbal Fluency Test (VFT) scores 
was found. Th ere was no signifi cant relationship between motivation disturbance and 
performance on the other neuropsychological tests. Also, the correlation between total 
number of depressive symptoms or mood symptoms and neuropsychological test scores 
was insignifi cant. 
5.6 DISCUSSION
Th e main fi nding of this study is a negative correlation between numbers of motivation 
symptoms and Verbal Fluency Test performance. Th is indeed supports our hypothesis 
that these symptoms refl ect subcorticofrontal dysfunction. Furthermore, we found that 
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symptoms indicating motivation disturbance were highly prevalent in patients with de-
mentia, in contrast to the symptoms of mood disturbance. No signifi cant relationships 
were observed between numbers of mood symptoms and scores on neuropsychological 
tests. Consistent with earlier studies there was no signifi cant correlation between a gen-
eral measure of depression and specifi c neuropsychological tests performance (Kuzis et 
al. 1999; Berger et al. 2002). 
A strong point of our study is that we took a radically diff erent approach in considering 
the nature of depressive symptomatology instead of classical depressive syndromes or 
scores on symptom scales. Forsell et al. (1993) originally reported the division of depres-
Table 1: Demographic and diagnostic characteristics of 60 subjects with dementia
Mean (SD)
Age (years) 86.3 (5.6)
Sex (M/F) 7/53
Marital status 2 married / 58 unmarried
Education (years) 7.2 (2.2)
Depressive symptoms (number) 1.3 (1.5)
Mood symptoms (number) 0.3 (0.7)
Motivation symptoms (number) 1.0 (1.2)
Table 2: Test scores on neuropsychological tests of the NAB of 60 subjects with dementia
Neuropsychological test Mean (SD)
Verbal Fluency  7.1 (4.1)
Boston Naming Test  8.5 (2.7)
Constructional Praxis  6.1 (2.6)
Word List Memory  8.2 (3.8)
Word List Recall  0.9 (1.2)
Word List Recognition  4.0 (3.0)
MMSE 16.6 (5.1)
Table 3: Correlations between measures of depression and neuropsychological test scores of 60 
subjects with dementia
VFT BNT WLM CP Recall Recognition MMSE
Depressive symptoms -0.23 -0.08 -0.18 -0.21 0.09 0.00 -0.26*
Mood symptoms -0.05 0.09 -0.06 -0.17 -0.05 0.02 -0.02
Motivation symptoms -0.26* -0.15 -0.20 -0.17 0.14 -0.02 -0.35**
VFT = Verbal Fluency; BNT = Boston Naming Test; WLM = Word List Memory; CP = Constructional Praxis; MMSE = 
Mini Mental State
*P<0.05; ** P<0.01
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sive symptoms into mood and motivation disturbance factors in subjects with dementia. 
Th ese factors have been replicated in a sample including the subjects of the present study 
(Janzing et al. 1999a). Subsequently, comparable dimensions have been demonstrated us-
ing diff erent depression criteria (Janzing et al.1999b) and also in subjects with accurately 
diagnosed vascular dementia. (Naarding et al. 2003). 
For both factors specifi c associations have been demonstrated with clinical charac-
teristics of dementia. Mood symptoms predicted mortality rates of patients with mild 
dementia (Janzing et al.1999b). Motivation symptoms increased with the severity of 
dementia (Forsell et al. 1993; Janzing et al.1999a). 
Considering the content of the motivation disturbance factor more carefully, it appears 
that it represents the core aspects of the syndrome of apathy. Indeed, Marin (1996) has 
shown that depressive symptoms like lack of interest, psychomotor retardation, lack of 
energy and lack of insight may be valid measures of apathy. 
In the present study motivation symptoms predominated mood symptoms. From the 
total number of depressive symptoms 77% contributed to the factor motivation distur-
bance. Only in two subjects these symptoms occurred in the context of a major depres-
sive episode. 
As motivation disturbance is supposed to be the result of subcorticofrontal dysfunction 
it was hypothesized that it relates most specifi cally with neuropsychological tests measur-
ing executive function. Th e association between motivation disturbance and impaired 
semantic verbal fl uency is in support of this hypothesis. Th e VFT is generally considered 
as a test of executive functioning (Lezak 1995). It is a measure of time-restricted genera-
tion of multiple-response alternatives under a constrained search condition. Important 
aspects of task performance are initiation, self-monitoring, retrieval and planning of goal 
directed behaviour.
Observations of specifi c associations between apathy and executive dysfunction in 
dementia are in agreement with our fi ndings. For instance Kuzis et al. (1999) showed 
that subjects with AD with a diagnosis of apathy (with or without depression) performed 
worse on the VFT and the Wisconsin Card Sorting Test. Scores on tests for memory, 
naming and block design were unrelated to apathy. Also McPherson et al. (2002) found 
evidence for a specifi c relationship between apathy and neuropsychological tests measur-
ing executive dysfunction in patients with AD. Using executive measures these authors 
were able to classify patients as apathetic or non-apathetic with 75% accuracy. Sperry 
et al. (2001) reported signifi cant correlation between apathy and naming and word list 
learning but the strongest relationship was with the VFT. A fi nal study found that apathy 
scores of AD patients were predicted by verbal fl uency scores but not by other neuropsy-
chological tests (Paulsen et al. 1996). 
Levels of mood symptoms were unrelated to scores on specifi c neuropsychological 
tests. However, it must be noticed that the variation in mood symptoms was rather low. 
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Associations between mood symptoms and specifi c neuropsychological tests have not 
been reported before. Although important diff erences exist, the dysphoria subscale of 
the Neuropsychiatric Inventory (NPI, Cummings et al. 1994) approaches the content 
of mood symptoms most closely. In agreement with Forsell’s two-factor model it does 
not contain apathy related items. Th e dysphoria subscale contains questions regarding 
sadness, depressed mood, tearfulness, feelings of failure, hopelessness, guilt, and suicidal 
ideation. Using the NPI, McPherson et al. (2002) did not observe specifi c associations 
between dysphoria and executive dysfunction in patients with AD. From the other neu-
ropsychological tests only block design correlated signifi cantly with dysphoria. 
We conclude that the two-factor model of depressive symptoms contributes to our 
insight into the relationship between depression and cognitive dysfunction in dementia. 
Only aft er the division of the criteria of major depressive disorder into qualitatively dif-
ferent factors, an association between motivation disturbance and executive dysfunction 
became observable that seems to be replicable across studies. 
In contrast to measures of apathy like the Apathy Evaluation Scale (Marin et al. 1991) 
or the apathy subscale of the NPI the factor motivation disturbance consists of depressive 
symptoms. Th erefore it is easy to understand that apathy is not just a syndrome associated 
or coexistent with depression, as is suggested by the ‘external’ scales, but may represent 
the core part of a depressive syndrome itself. It is therefore evident that symptoms of 
apathy or impaired motivation may occur in patients with dementia both in and outside 
the context of a depressive syndrome. 
Th ere are a number of limitations to the present study. First the study took place in 
residents of homes for the elderly. Although the two-factor model has proved to be ap-
plicable in diff erent populations, it is unclear to what extent the observed correlation 
between the factors and the neuropsychological performance can be generalized. Sec-
ond, although signifi cant, the correlation between motivation disturbance and verbal 
fl uency was only moderate. As this correlation confi rmed our specifi c hypothesis and 
is in accordance with studies using apathy rating scales we concluded that reporting 
it was relevant. Furthermore, in a diff erent sample consisting of patients with vascular 
dementia we found a correlation of comparable size between motivation symptoms and 
the VFT (Naarding et al. submitted, chapter 4 of this thesis). Th e presence of a fl oor eff ect 
may have obscured possible relationships between the measure of recall and the factors 
of depressive symptoms. Finally, only one measure of executive function was available 
in the CERAD neuropsychological battery. It is clear that to substantiate the fi ndings of 
the present study the assessment of a broader set of tests for executive functions will be 
essential.
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6.1 SUMMARY OF CHAPTER 6
If specifi c symptom profi les of depressive disorders in the elderly are related to a specifi c 
aetiology, this could have implications for everyday clinical practice. We hypothesized 
that a ‘motivational’ profi le, with symptoms such as psychomotor change, loss of interest 
and loss of energy could clinically separate patients with predominantly vascular or de-
generative risk from patients with an infl ammatory risk. A total of 4051 subjects partici-
pated in a study on mental health problems in community dwelling elderly. Information 
on psychiatric symp toms, demographic and medical status, previous history and family 
history was obtained. We distinguished three subgroups according to the predominant 
somatic risk-indicators; a vascular, degenerative and infl ammatory group. Motivational 
symptoms were associated with vascular or degenerative risk-indicators for depression; 
psychomotor change with both indicators, loss of energy specifi cally with the vascular, 
and thinking/concentration disturbance with the degenerative indicator. Th e so-called 
mood symptoms of depression, especially thoughts of death, were more strongly 
associated with the infl ammatory risk-indicator. Melancholic symptoms like appetite and 
sleep disturbances were more strongly associated with the infl ammatory risk-indicator. 
Although etiological classifi cation was not confi rmed by additional investigations such as 
laboratory fi ndings or MRI brain scans, this study showed that in patients with a late-life 
depression specifi c symptoms of the depressive disorder may refl ect the predominant 
underlying pathogenic mechanism.
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6.2 INTRODUCTION
Depressive disorders are among the major causes of disability worldwide (WHO 2001). 
Especially in the elderly, depressive disorders are found in a large number of patients 
who also suff er from other diseases, such as chronic heart disease, stroke or dementia. 
While these diseases increase the risk of developing depression, depression also substan-
tially contributes to morbidity and mortality in patients with somatic disease (Penninx 
et al. 1998;Penninx et al. 1999;Schoevers et al. 2000b). For depressive disorders in the 
elderly, especially those with a late-onset of the depression, three predominant etiological 
paradigms can be used. Th e ‘degenerative’ paradigm is probably the oldest; it regards 
depression in the elderly as a precursor of subsequent cognitive decline and eventually 
dementia (Emery & Oxman 1992). Th e second is the ‘vascular depression’ hypothesis 
that was revitalized some years ago (Alexopoulos et al. 1997). Vascular lesions in the 
brain have long been known to be associated with higher incidence rates for depressive 
disorder, and neuroimaging oft en shows small, ‘silent’ cerebral infarcts and white matter 
lesions in patients with a late-onset depressive disorder (Fujikawa et al. 1993). Finally, the 
‘infl ammatory’ paradigm was introduced, based on the discovery of elevated levels of in-
fl ammatory markers in (elderly) patients with a depressive disorder (Penninx et al. 2003). 
Furthermore, in patients with (auto) infl ammatory diseases like rheumatoid arthritis, an 
increased incidence of depressive disorder is found.
It has been suggested that the nature of depressive symptoms varies with the presumed 
pathogenesis of the depressive disorder. Forsell demonstrated subgroups of depression in 
the elderly, characterized by a ‘low motivation’ or a ‘low mood’ syndrome. An “organic” 
syndrome was more oft en found in patients with predominantly ‘motivational’ than in 
those with predominantly ‘mood’ symptoms (Forsell et al. 1993). Others confi rmed this 
fi nding (Janzing et al. 1999a) and recently we have shown that these symptom profi les 
indeed indicate the extent of vascular damage in a group of patients with post-stroke 
depression (Naarding et al. 2003). Th e “mood” profi le is made up of symptoms such as 
dysphoria, anger, negative and suicidal thoughts, ruminations and social withdrawal. Th e 
“motivation” profi le includes psychomotor retardation, a sad appearance, thinking/con-
centration disturbances, loss of interest and loss of energy. In the present study we set out 
to explore whether the symptom profi le of depression in a large representative sample of 
community-dwelling elderly refl ects the underlying pathogenic mechanisms of depres-
sion. Each subject was scored positive or negative on three risk-indicators, ‘degenerative’, 
‘infl ammatory’ or ‘vascular’. Th e presence of depressive symptoms and syndromes was 
then established for each group. Th e primary aim of this study was to assess whether spe-
cifi c symptom profi les of the depressive disorder are associated with one of the specifi c 
risk-indicators. Our hypothesis was that a ‘motivational’ symptom profi le could clinically 
separate the vascular and degenerative from the infl ammatory group.
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6.3 METHODS
6.3.1 Subjects
Th e Amsterdam Study of the Elderly (AMSTEL) is a prospective study of a large, repre-
sentative sample of community dwelling elderly that assesses mental health problems, 
medical diagnoses and demographic characteristics. Th e sampling and data collection 
procedures have been described elsewhere (Launer et al. 1993; Schoevers et al. 2000a). In 
short, the populati on base for AMSTEL included all non-institutio nal individuals in the 
65-84 age brackets who lived in the city of Amsterdam. Th e profi le of the study sample 
corres ponded to the non-institutionalized Amsterdam population in terms of age and 
gender. An age-stratifi ed sample was drawn. All 4051 subjects (71.5%) who responded 
and gave their informed consent were interviewed at baseline. Non-response in the 
younger old (<75) was associated with poor perform ance on cognitive tests and with 
health problems. In the older old no correlates of non-response were found (Launer et 
al. 1994).
Th e subjects were interviewed to gather information on psychiatric symp toms, demo-
graphic and medical status, previous history and family history. Th e interview was based 
on the Dutch translation of the Mini-Mental State Examination (MMSE) (Folstein et al. 
1975), all Geriatric Mental State (GMS) Examination-items related to organic, aff ective 
and anxiety syndromes (Copeland et al. 1986), the Activities of Daily Living (ADL) scale 
(Katz et al. 1963), the Instrumental Activities of Daily Living (IADL) scale (Lawton & 
Brody 1969), and the CAMDEX-interview (Roth et al. 1986). Th e interview was adminis-
tered during home visits by lay inter viewers who were specially trained using video sessi-
ons and were regularly super vised.
6.3.2 Psychiatric evaluation
Diagnoses of dementia and depression were made according to the GMS-AGECAT sys-
tem (Copeland et al. 1986; Copeland et al. 1988). Th e Dutch language version has proven 
reliability for epidemiological work in replication studies (Hooijer et al. 1991). Apart 
from the GMS-AGECAT diagnosis of dementia, cognitive status was also assessed by the 
MMSE-score (Folstein et al. 1975). Depression case-ness was defi ned as a GMS-AGECAT 
level 3 or higher. A distinction is made between neurotic and psychotic depression, indi-
cating increasing severity levels of depression. As this subdivision of depression is partly 
based on etiological notions and does not completely overlap with the DSM-categories 
of major and minor depression (APA 1987; 1994; Lobo et al. 1995) a separate classifi ca-
tion of depression was also made that refl ects these DSM criteria. If subjects had either 
‘depressed mood’ or ‘loss of interest or pleasure’, and a total of 5 or more of the nine 
DSM-III-R depression symptoms, they were classifi ed as major depression. Subjects who 
had either ‘depressed mood’ or ‘loss of interest or pleasure’ and a total of at least two but 
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no more than four depression symptoms were classifi ed as minor depression. According 
to the profi les found by Forsell and Janzing, for each individual the following measures 
of depression were computed by counting the positively rated criteria (Forsell et al. 1993; 
Janzing et al. 1999a).
• Mood symptoms (dysphoria, appetite disturbance, feelings of guilt and thoughts of 
death).
• Motivational symptoms (loss of interest, psychomotor change, loss of energy and 
thinking or concentration disturbance) 
6.3.3 Pathogenic risk-indicators
Th e presence of chronic diseases was assessed with the pertinent Camdex questions on 
cardiovascular diseases, cancer, lung disease, diabetes, Parkinson’s disease, arthritis and 
epilepsy. Patients were assigned to a subgroup according to the presence of one of the 
three etiological risk-indicators. Th e vascular group contained patients who had suff ered 
a stroke or myocardial infarction. Th e degenerative group comprised patients who ac-
cording to the GMS were “organic” cases, i.e. that the score on this item was 3 or higher 
(GMS-AGECAT)(Copeland et al. 1986). Finally, the infl ammatory group consisted of 
patients with chronic rheumatic disease or arthritis. 
6.4 STATISTICAL ANALYSIS 
For statistical analysis we used the Statistical Package for the Social Sciences (SPSS) for 
Windows version 12.0. Chi-square analysis was used to compare categorical variables 
and the independent samples t-test to compare continuous variables. Prevalence of major 
and minor depression was established for the three risk-groups. Prevalence and odds 
ratio of specifi c depressive symptoms were calculated for the three risk-groups. Multi-
nomial regression analysis was used to fi nd out whether specifi c depressive symptoms or 
a mood/motivation subsyndrome would predict specifi c risk-indicators, controlling for 
potential confounders. A backward stepwise analysis was used to reach the most parsi-
monious model for each risk-indicator.
When the 95% confi  dence interval of the odds ratio did not include 1, the asso ciation 
was regarded to be statis tically signifi cant. Diff erences between strata were considered 
statistically signifi cant according to the criterion that the confi dence intervals of a risk-
indicator mutually exclude the point estimates in one or both of the other diagnostic 
categories (Gardner & Altman 1986). 
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6.5 RESULTS
6.5.1 General characteristics of the study group
Of the total of 4051 subjects, 607(15%) could be classifi ed as ‘vascular’, 694(17%) as 
‘infl ammatory’ and 261(6%) as ‘degenerative’ cases. Th ere was some overlap between 
these categories, as there were subjects who met the criteria for more than one etiologi-
cal category. Aft er excluding these subjects, our study group consisted of 496 vascular, 
171 degenerative and 583 infl ammatory cases. Table 1 shows the general characteristics 
of the original study group and the risk-indicator groups. Th ere were some statistically 
signifi cant diff erences between the three groups as compared to the total study group. 
Subjects with a vascular risk-indicator were more oft en male (chi-square = 63.497, df 1, 
p < 0.001), subjects with a degenerative risk-indicator were older (t = -7.591, df 4049, p < 
0.001), received less years of training (t = 6.267, df 4025, p < 0.001) and had lower MMSE 
scores (t = 38.131, df 4049, p < 0.001), and those with an infl ammatory risk-indicator 
tended to be more oft en female (chi-square = 98.110, df 1, p < 0.001) and were more on 
antidepressant medication. (chi-square = 11.354, df 1, p = .001)
6.5.2 Prevalence of depressive syndromes and symptoms 
Major as well as minor depressive disorders (MajDD and MinDD, respectively) were 
found in signifi cant proportions in all three subgroups (table 2). In agreement with ear-
lier studies, our results indicated that the odds of having a MajDD was about 2 – 3.5 times 
higher in subjects with one of the three specifi c risk-indicators compared to subjects 
with none of the risk-indicators. In the vascular group the odds ratio was 2.39 (95%CI 
1.55 – 3.67), in the degenerative group 3.37 (95% CI 1.91 – 5.93) and in the infl amma-
tory group 2.80 (95% CI 1.89 – 4.15). For MinDD no increased risk was found in the 
degenerative subgroup, while in the vascular subgroup the odds ratio was 1.63 (95% CI 
1.25 – 2.13) and in the infl ammatory subgroup 2.23 (95% CI 1.76 – 2.82). Th e confi dence 
intervals of the vascular subgroup and that of the infl ammatory group mutually excluded 
each others point estimate on behalf of the minor depression. Th e interpretation could be 
that the infl ammatory group is stronger associated with this minor depressive disorder 
than the vascular group. 
Th e results of the bi-variate analysis of individual depressive symptoms and their rela-
tion with the three risk-indicators are shown in Table 3. Virtually all symptoms of depres-
sion were more prevalent in the risk-groups than in the group without any risk, except 
for depressed mood and feelings of guilt in the vascular subgroup and sleep disturbance 
and feelings of guilt in the degenerative subgroup. According to the criterion of con-
fi dence intervals mutually excluding point estimates, the following symptoms showed 
signifi cant statistical diff erences between diff erent strata : loss of interest was associated 
more strongly with the degenerative risk than with the infl ammatory risk; psychomotor 
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change showed a stronger association with the degenerative than with both the vascular 
and infl ammatory risk; thinking/concentration disturbance was most strongly-associ-
ated with the degenerative risk group, but also yielded a stronger association with the 
infl ammatory than with the vascular risk group.
Th e parsimonious models (table 4) for each of the three risk-indicator groups consisted 
of a smaller number of the depressive symptoms that were not the same for each of the 
groups. Th e model fi tted adequately to the data (Pearson’s Goodness-of-fi t chi-square 
12400.58, df 12728, p = 0.981). Th e presence of a vascular risk-indicator was predicted 
by sleep disturbance, psychomotor change and loss of energy. Th e organic risk-indicator 
was predicted by psychomotor change and thinking/concentration disturbance and fi -
nally the infl ammatory risk-indicator was predicted by loss of appetite, sleep disturbance, 
loss of energy, thinking/concentration disturbance and thoughts of death. Clustering of 
symptoms into a mood and motivation component according to Forsell (Forsell et al. 
1993) did not improve the model. (data not shown)
Table 1: General characteristics
Total group No risk-indicator Vascular Degenerative infl ammatory
Group size 4051 1797 496 171 583
Age 75.4 (5.7) 74.8 (5.7) 75.8 (5.5) 78.6 (5.5)* 76.0 (5.6)
Years of education 8.2 (2.5) 8.4 (2.5) 8.1 (2.4) 7.0 (1.9)* 8.0 (2.5)
Female sex (%) 62.4 61.9 46.2* 66.7 80.8*
Antidepressant use (%) 4.1 3.5 3.2 5.8 6.7*
MMSE 26.9 (3.8) 27.8 (2.1) 26.4 (4.4) 17.6 (8.1)* 26.9 (3.3)
MMSE = MiniMentalStateExamination
Numbers in brackets indicate SD (means)
In the risk-indicator groups only the ‘pure’ risk-indicator cases are included
* differ signifi cantly (p at least smaller than 0.05) from total group based on t-test (means) and x2-test (percentages) 
(see text)
Table 2: Prevalence of major and minor depressive disorder in LLD with a vascular, degenerative or 
infl ammatory risk-indicator
 N = Maj DD Odds ratio Min DD Odds ratio
N (%) N (%)
Total group 4051 217 (5.4) -- 660 (16.3) --
No risk-indicator 1797 57 (3.2) -- 224 (12.5) --
Vascular 496 36(7.3) 2.39 [1.55 – 3.67] 94(19.0) 1.63 [1.25 – 2.13]
Degenerative 171 17(9.9) 3.37 [1.91 – 5.93] 28(16.4) 1.37 [0.89 – 2.10]
Infl ammatory 583 49(8.4) 2.80 [1.89 – 4.15] 141(24.2) 2.23 [1.76 – 2.82]
LLD = late-life depression; Maj DD = Major depressive disorder; Min DD = Minor depressive disorder
Odds ratios were calculated comparing one of the risk-groups to subjects with none of the risk-indicators
95% Confi dence Intervals (CI) are shown in bracket
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6.6 DISCUSSION
In this population-based study, we investigated whether in subjects with depression the 
clinical psychiatric profi le was related to the risk-indicators for the depressive disorder. 
Th is study showed that indeed some of the motivational symptoms, i.e. psychomotor 
change and loss of energy were more strongly associated with the vascular and degenera-
tive risk-indicator than with the infl ammatory risk-indicator. Mood symptoms, especially 
thoughts of death and also melancholic symptoms like sleep and appetite disturbances 
were more strongly-related with infl ammatory risk as opposed to both the degenerative 
and vascular risk.
Although depression comprises various symptoms that are traditionally grouped in 
diff erent clusters, the concept of depression as a single syndrome that represents a fi nal 
common pathway of a broad range of biological as well as psychological factors has be-
come widely accepted over recent decades (Parker 2000). Th is ‘single syndrome’ concept 
is refl ected in the current classifi cation systems DSM-IV and ICD-10. Especially in sub-
jects for whom a specifi c cause is presumed, specifi c clinical profi les may be detected, and 
therefore it has been suggested that old paradigms should be revived (Parker 2000). More 
accurate defi nitions of the subgroups and also more accurate demarcation of diff erent 
depressive syndromes will become possible, with the advent of new neuroimaging and 
Table 4. Adjusted Odds ratios (ORs) of vascular, degenerative or infl ammatory risk-indicators according 
to depressive symptom profi le (N = 3047, most parsimonious models with p in < 0.05, p out > 0.10, 
backstep procedure)
Risk-indicator
DSM-IV symptom
Vascular Degenerative infl ammatory
Age -- 1.08 [1.04 – 1.12] 1.02 [1.00 – 1.04]
Sex 2.22 [1.82 – 2.78] -- 2.17 [1.72 – 2.75]
Education level -- -- --
Antidepressant use -- -- --
MMSE 1.18 [1.14 – 1.22] 1.45 [1.39 – 1.52] 0.89 [0.86 – 0.93]
Appetite disturbance -- -- 1.91 [1.28 – 2.83] §
Sleep disturbance 1.44 [1.13 – 1.83] § -- 1.29 [1.04 – 1.61] *
Psychomotor change 1.78 [1.22 – 2.60] § 2.06 [1.13 – 3.75] * --
Loss of energy 1.83 [1.45 – 2.31] # -- 1.73 [1.39 – 2.14] #
Thinking/concentration -- 1.72 [ 1.12 – 2.65] * 1.26 [1.00 – 1.59] *
Thoughts of death -- -- 1.49 [1.10 – 2.03] *
Odds ratios are adjusted by age, sex, education-level, anti-depressant use and score on MiniMental State Examination 
(MMSE).
* p<.05; §p <.01; # p<.001
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laboratory investigations. Clustering of symptoms into specifi c symptom dimensions can 
increase the likelihood of a familial and possibly genetic etiology (Korszun et al. 2004).
In our previous studies we showed a relationship between a specifi c ‘motivation’ com-
ponent and neurodegenerative or vascular damage of the brain (Janzing et al. 1999;Naard-
ing et al. 2003). Others have mentioned an ‘apathetic’ sub-syndrome that was related with 
degenerative brain diseases (Marin 1996;Starkstein et al. 2001). It has been suggested that 
the ‘mood’ symptoms represent a more psychological reaction to the consequences of a 
chronic disease and that one would need a brain that works relatively well to develop 
these mood or cognitive symptoms. Th is has fostered the notion that these mood symp-
toms can be predominantly found in a subgroup of patients with comparable disability 
and suff ering, but with intact brain function, represented by the infl ammatory group 
in the current study. On the other hand, recent studies have shown that infl ammation, 
vascular and cellular degeneration are all interrelated, and perhaps even share a common 
pathogenesis (Jerrard-Dunne et al. 2004;van den Biggelaar et al. 2004). Despite the fact 
that there is overlap between the various groups, our study showed that the distinct risk-
indicators we used were associated with distinct symptom profi les of depression.
Th e clinical relevance of our fi ndings is that when etiological risk-indicators can be 
linked to the clinical presentation of depressive disorder in the elderly, therapeutic as 
well as preventive strategies can be better adjusted to the specifi c needs of the individual 
subject. In case of a predominant ‘motivational’ profi le, special attention should be paid 
to the presence of vascular risk and the probability of an imminent degenerative disease 
should be taken into account. 
Our study has several limitations. Most importantly, etiological classifi cation was not 
confi rmed by additional investigations such as laboratory fi ndings for the infl ammatory 
group, or brain MRI for the vascular or degenerative group. We have previously found 
that the concordance between self-reported physical illness and the data supplied by 
the GP’s was satisfactory and was not aff ected by levels of depression (Kriegsman et al. 
1996). It is therefore very unlikely that misclassifi cation of risk-indicator status has had 
a major infl uence on our results (Rothman & Greenland 1998). However, the fi ndings 
need replication in a study with more elaborate measures of risk-indicators. A second 
limitation of our study is that the cross-sectional design of this study does not allow the 
ascertainment of causal and temporal relationships. However, as there is no reason to 
believe that lack of data on temporal relationships would diff erentially aff ect any of the 
three risk-indicators under study, the eff ect on the current results is probably limited. 
Finally, early stages of dementia may not be classifi ed as organic cases in our study. It 
is well known that there is a great deal of crossover of symptoms of depression with 
mild cognitive impairment or subjective memory complaints. To our knowledge, not 
only the GMS-AGECAT diagnostic procedure is particularly sensitive to this problem, 
but it would be the case with other diagnostic instruments. Moreover, misclassifi cation 
83
A study on symptom profi les of late-life depression
of subjects would lead to leveling of diff erences and therefore it is unlikely that it has had 
a major infl uence on the fi nal results.
One of the strengths of our study is that we studied a relatively large group of subjects, 
who were representative of the general population. Our subgroups with the three risk-in-
dicators were large enough to analyze reliably, especially because the overlap between the 
three groups was quite modest. Furthermore, the diagnostic procedure for psychiatric 
and organic disorder was quite detailed and accurate. 
In conclusion, our study suggests that in patients with late-life depression specifi c 
symptoms of the depressive disorder may be used as indicators of the predominant un-
derlying pathogenic factor. If replicated, this may have important implications for our 
understanding of the nature of depression and the associations with diff erent pathophysi-
ological disease mechanisms. Th is may be important for the adjustment of therapeutic as 
well as preventive strategies for these patients.
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7.1 SUMMARY OF CHAPTER 7
Vascular depression is regarded as a subtype of depression, especially in - but not strictly 
reserved to - the elderly, characterized by a specifi c clinical presentation and an association 
with (cerebro)vascular risk and disease. It could have major implications if subjects at risk 
for such a depression could easily be identifi ed by their clinical presentation in general prac-
tice. We therefore studied the symptom profi le of depression in subjects with and without 
vascular risk in two large community studies, the Rotterdam Study and the Amstel study, in 
the Netherlands. We used the original description of vascular depression by Alexopoulos. 
We could not confi rm the specifi c symptom profi le in depressed subjects with vascular 
risk factors in either of the two cohorts. In the Rotterdam Study, depressed subjects with 
vascular risk factors showed more loss of energy and more disability. Presumed specifi c 
symptoms of vascular depression, psychomotor changes and anhedonia, however, were 
not signifi cantly associated with any of the vascular risk indicators. Loss of energy showed 
a signifi cant association with myocardial infarction and peripheral arterial disease in this 
sample. In the Amstel study, a signifi cant association between vascular risk factors and loss 
of energy and appetite disturbance was found in all subjects, either depressed or not.
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7.2 INTRODUCTION
Th e vascular depression hypothesis states that especially in the elderly a subtype of de-
pressive disorder exists that is caused by vascular brain disease. Th is hypothesis is a very 
old one. Around 1900, a German psychiatrist named Gaupp (1905) already mentioned 
‘atherosclerotic depression’. Th e concept was revitalized by Krishnan et al. (1997) and 
Alexopoulos et al. (1997a; 1997b) in the 1990s, boosted by the development of new imag-
ing techniques. Krishnan coined this entity “MRI defi ned vascular depression”, with the 
vascular lesions on MRI as the obligatory fi nding. Next to the vascular characteristics, 
this group of patients could be recognized by a specifi c symptom profi le of the depres-
sion. According to Alexopoulos the characteristics of this vascular depression include 
more pronounced psychomotor change, greater overall cognitive impairment and 
disability, fewer feelings of guilt and greater lack of insight. Th e MRI-defi ned vascular 
depression group of Krishnan showed a similar picture; the subjects in his study were 
older, had a later age of depression-onset and showed more anhedonia and disability. 
Furthermore, he found that the non-psychotic symptoms prevailed whereas a family his-
tory of mental illness was less common. Both studies were conducted in hospital based 
settings which limits generalization to the general population. Th e clinical importance of 
recognizing vascular depression as a subtype of aff ective disorder would be enhanced if it 
were possible to identify patients by simple tests or procedures, such as through specifi c 
symptoms or risk-profi les. Th e recognition of such a specifi c subtype of depression could 
be of major importance in predicting the course of illness and the eff ect of medication 
and other therapeutic interventions. In the present study, we tried to assess these phe-
nomenological characteristics of depressed subjects with and without vascular disease in 
the general population. If the vascular depression hypothesis is correct, subjects with a 
vascular risk would show more anhedonia and psychomotor change, and less feelings of 
guilt. Furthermore, we expected them to show more disability. 
7.3 METHODS
7.3.1 Subjects and procedures
Subjects were recruited from two large samples of community dwelling elderly, Th e 
Amsterdam Study of the Elderly (AMSTEL) and the Rotterdam Study. Th e AMSTEL 
study is a prospective study that assesses mental health problems, medical diagnoses and 
demographic characteristics. Th e sampling and data collection procedures have been 
described elsewhere (Schoevers et al. 2000a). In short, the population base for AMSTEL 
included all non-institutional individuals in the 65-84 age brackets who lived in the city 
of Amsterdam. Th e profi le of the study sample corresponded to the non-institution alized 
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Amsterdam population in terms of age and gender. An age-stratifi ed sample was drawn. 
All 4051 subjects (71.5%) who responded and gave their informed consent were inter-
viewed at baseline. Non-response in the younger old (<75) was associated with poor 
performance on cognitive tests and with health problems. In the older aged no correlates 
of non-response were found (Launer et al. 1994).
Th e subjects were interviewed to gather information on psychiatric symptoms, demo-
graphic and medical status, previous history and family history. Th e interview was based 
on the Dutch translation of the Mini-Mental State Examination (MMSE) (Folstein et 
al. 1975), all Geriatric Mental State (GMS) Examination-items related to organic, aff ec-
tive and anxiety syndromes (Copeland et al. 1986), the Activities of Daily Living (ADL) 
scale (Katz et al. 1963), the Instrumental Activities of Daily Living (IADL) scale (Law-
ton & Brody 1969), and the CAMDEX-interview (Roth et al. 1986). Th e interview was 
 administered during home visits by lay interviewers who were specially trained using 
video sessions and were regularly supervised.
Th e aim of the Rotterdam Study is to investigate determinants of chronic and disabling 
diseases. Th e study started in 1990, when all inhabitants 55 years old and above in Om-
moord, a district of Rotterdam, the Netherlands, were invited to participate. Sampling 
procedure and response rate have also been described elsewhere (Hofman et al. 1991). 
In this paper, data of 4603 subjects is used from the second follow-up survey in 1997 to 
1999. In this survey assessment of depressive symptoms was added to the study protocol. 
In addition, the total cohort is continuously being monitored for major morbidity and 
mortality through linkage of general practitioner and municipality records. Both studies 
were approved by the local Medical Ethics Committee and written informed consent was 
obtained from all participants.
7.3.2 Psychiatric evaluation
In the AMSTEL study, diagnoses of dementia and depression were made according to the 
GMS-AGECAT system (Copeland et al. 1986; Copeland et al. 1988). Th e Dutch language 
version has proven reliability for epidemiological work in replication studies (Hooijer et 
al. 1991). Apart from the GMS-AGECAT diagnosis of dementia, cognitive status was also 
assessed by the MMSE-score (Folstein et al. 1975). ‘Depressive caseness’ (i.e. depression 
warranting intervention as defi ned by psychiatrists) was defi ned as a GMS-AGECAT 
level 3 or higher. 
In the Rotterdam Study diagnosis of depression was assessed by a two-step procedure. 
First, participants completed the Dutch version of the Center for Epidemiological Studies 
Depression Scale (CES-D) during the home interview. We used a score of 16 as a cut-
off  to indicate depressive symptoms. Th is cutoff  had a very high sensitivity for major 
depression in another Dutch study in the elderly (Beekman et al. 1997b). In a second 
step, screen-positive subjects had a psychiatric workup. Of the 4603 subjects, 364 (7.9 
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%) were screened positive as measured by the CES-D and the psychiatric work-up was 
performed in 333 of the remaining participants. Th ey were studied with the Dutch ver-
sion of the Present State Examination, a semi-structured psychiatric interview included 
in the Schedules for Clinical Assessment in Neuropsychiatry (SCAN) (WHO 1997). All 
interviews were conducted by one of two experienced clinicians. Depressive disorders 
were classifi ed according to the DSM-IV (APA 1997) criteria with an algorithm based on 
the GMS-scores (AMSTEL) and SCAN scores (Rotterdam Study). If subjects had either 
‘depressed mood’ or ‘loss of interest or pleasure’, and a total of 5 or more of the nine 
DSM-IV depression symptoms, they were classifi ed as major depression. Subjects who 
had either ‘depressed mood’ or ‘loss of interest or pleasure’ and a total of at least two but 
no more than four depression symptoms were classifi ed as minor depression. According 
to the profi les found by Forsell and Janzing, for each individual the following measures 
of depression were computed for both study groups (AMSTEL and ERGO) by counting 
the positively rated criteria (Forsell et al. 1993; Janzing et al. 1999a). 
• Mood symptoms: Dysphoria, appetite disturbance, feelings of guilt and thoughts of 
death.
• Motivational symptoms: loss of interest, psychomotor change, loss of energy and 
thinking or concentration disturbance.
Finally, we dichotomized subjects according to the presence of some of the typical 
symptoms of “vascular depression” that were reported in the literature: anhedonia, psy-
chomotor change and loss of energy.
7.3.3 Vascular risk
In the original study by Alexopoulos vascular risk was defi ned according to the score 
on the Cumulative Illness Rating Scale (CIRS) (Miller et al.1992). Th e original CIRS 
consists of multiple organ-specifi c categories, but for the vascular depression categoriza-
tion only the vascular subscale was used by Alexopoulos. A score equal to or greater than 
1 on the CIRS assigned the subject to the vascular group. We have classifi ed our subjects 
from both the Amstel and the Rotterdam study on the same criteria yielding comparable 
‘vascular’ and ‘non-vascular’ groups. Next, we have divided our sample in (1) a group of 
patients without any vascular risk factor, (2) a group of patients with only vascular risk 
factors, but no apparent vascular disease and (3) a group of patients with evident vascular 
disease. In the end, this more detailed subdivision had no infl uence on the results, so we 
have only used the original categorization following Alexopoulos.
In addition, in the Rotterdam Study, vascular risk was studied more extensively. Of 
the depressed subjects (N=333) who participated in the home interview, 246 came to 
the research centre for non-invasive assessments of atherosclerosis. Th e 87 subjects with 
no assessment of atherosclerosis were on average older (79 vs. 74 years) and had more 
depressive symptoms (total number of depressive symptoms 3.2 [SD 2.3] vs. 2.5 [SD 2.0], 
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overall total number 2.7 [SD 2.1]). Th ere was no diff erence in gender between the partici-
pants and non-participants (78% female, vs. 74%).
We measured atherosclerosis non-invasively with 4 established methods, i.e. the ankle-
brachial blood pressure index, intima-media thickness in the common carotid arteries, 
the presence of plaques in the carotid arteries and aortic atherosclerosis. Th ese measures 
assess extra-coronary atherosclerosis at diff erent locations in the body. All measures are 
strongly associated with incident cerebrovascular and coronary artery disease (Witteman 
et al. 1986; McKenna et al. 1991; Hollander et al. 2002). Details of these assessments are 
outlined in an earlier publication (Tiemeier et al. 2004).
7.3.4 Other measurements 
In both studies confounders were assessed in very similar manners. Age, sex, educa-
tion, cognitive function, cigarette smoking, blood pressure, diabetes mellitus, history of 
myocardial infarction and/or stroke, total cholesterol level, body mass index and use of 
antidepressant medication were all accounted for. Education was dichotomized into low 
(only primary school or less) or high education. Depression severity was measured only 
in the Rotterdam Study with the Hamilton Depression Rating Scale (HAMD) (Hamilton 
1960). Cigarette smoking was coded into categories of current, former or never smoker. 
History of myocardial infarction or stroke was only considered positive when it was veri-
fi ed by a physician. Total cholesterol level was only assessed in the Rotterdam Study and 
was analyzed in fasting blood samples by an automatic enzymatic procedure. Body mass 
index was calculated using the Quetelet method (weight in kilograms divided by the 
square of height in meters) and was only done in the Rotterdam study. Information on 
antidepressant medication was obtained in the home-interviews and in the Rotterdam 
study it was secured by a cabinet check. 
7.4 STATISTICAL ANALYSIS 
For statistical analysis we used the Statistical Package for the Social Sciences (SPSS) for 
Windows version 12.0. Chi-square analysis was used to compare categorical variables 
and the independent samples t-test to compare continuous variables. Prevalence of major 
and minor depression was established for the vascular and the non-vascular group and 
also the mean total number of depressive symptoms as well as the specifi c mean number 
of mood and motivation symptoms were counted. Th e vascular depression hypothesis 
was tested fi rst by replicating the method of Alexopoulos et al. Prevalence of specifi c de-
pressive symptoms was calculated for both the vascular and non-vascular groups. Next, 
prevalence of vascular risk-factors was calculated for subgroups of patients with specifi c 
depression symptoms, which would be more prevalent in ‘vascular depression’: anhedo-
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nia and psychomotor change. A logistic regression analysis was carried out controlling 
for confounding eff ects of the signifi cant diff erences found in the bivariate analysis.
7.5 RESULTS
7.5.1 General characteristics of the study groups (table 1)
In the AMSTEL study we identifi ed a total of 523 subjects who fulfi lled the diagnosis of 
depressive disorder according to the AGECAT system (‘depressive caseness’). Two-hun-
dred and twenty of these fulfi lled vascular criteria (42%). Th e vascular subgroup diff ered 
from the non-vascular in that there were more males (chi-square = 21.910, df 1, p<0.001) 
and they had lower scores on the I-ADL measure (t=63.292, df 1, p=0.04). In the Rot-
terdam Study, we identifi ed 333 subjects with depressive symptoms (cut-off  score on the 
CES-D ≥ 16). Of these, 167 fulfi lled vascular criteria (50%). In this group the subjects 
in the vascular subgroup were older (t=577.086, df 1, p<0.001), more males (chi-square 
=7.656, df 1, p=0.006), had more impairments on ADL (t=3.406, df 1, p=0.014) and I-
ADL scores (t=137.761, df 1, p=0.011).
In both studies, no diff erences were found in prevalence of major or minor depressive 
disorder, nor were there any diff erences in total number of depressive symptoms, number 
of mood or motivation symptoms.
7.5.2 Clinical profi le of vascular and non-vascular depression
Th e prevalence of DSM-IV depressive symptoms in both the vascular and non-vas-
cular depressed subjects of both community studies are shown in table 2. Both in the 
AMSTEL and the Rotterdam study subjects in the vascular subgroup showed more loss 
of energy (Amstel: chi-square=4.138, df 1, p=0.04; Rotterdam study: chi-square=4.709, 
df 1, p=0.03). In the Amstel study, subjects in the vascular subgroup also showed more 
appetite disturbance (chi-square=4.558, df 1, p=0.03). Th e mood or motivation profi le 
was of no adjunctive value in distinguishing vascular from non-vascular depression in 
both study-groups.
7.5.3 Symptom profi les of subjects with and without vascular risk factors
Figure 1 is a bar-chart representing the prevalence of specifi c depressive symptoms in 
subjects with and without a vascular risk profi le, based on the CIRS. In the total sample of 
the AMSTEL study (N=4051), 2232 (55%) had, and 1819 (45%) had no vascular risk. Vas-
cular subjects showed more loss of energy (chi-square=21.880, df 1, p<0.001) and more 
appetite disturbance (chi-square=12.629, df 1, p<0.001) than non-vascular subjects.
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7.5.4 Vascular risk-profi le in patients with predominant ‘vascular depression’ symptoms
In table 3, the vascular risk-profi le of subjects of the Rotterdam Study with and without 
certain depressive symptoms is shown. All three symptom-groups were more severely 
depressed and more cognitively disturbed. Depressed persons with anhedonia used more 
antidepressant medication than those without anhedonia (chi-square = 10.105, df 1, 
p=0.001). Depressed persons with loss of energy more oft en had myocardial infarction 
and peripheral arterial disease than those without loss of energy (chi-square = 5.241, df 1, 
p=0.022). No other associations were found. Subgroups of persons with anhedonia, psy-
chomotor change or loss of energy showed similar levels of depression, as measured with 
the HAMD and also similar levels of cognitive functioning, as measured with the MMSE.
Table 1: Demographic and clinical characteristics of Elderly patients with presumed Vascular and 
Nonvascular depressive disorder in both ERGO and AMSTEL community study-group.
The Rotterdam Study AMSTEL
Vascular
(N=167)
Nonvascular 
(N=166)
Vascular
(N=220)
Nonvascular 
(N=303)
Mean SD Mean SD p-value Mean SD Mean SD p-value
Age (yrs) 76.5 7.2 73.9 7.6 0.001 75.5 5.7 75.9 5.6 0.36
Sex (%female) 68 82 0.006 73 90 < 0.001
ADL 2.0 0.7 1.8 0.7 0.014 11.0 1.6 11.3 1.5 0.08
I-ADL 21.1 4.7 22.4 4.5 0.011 12.8 3.9 13.5 3.6 0.04
MMSE  26.4  3.0 26.9 3.0 0.18 25.8 4.3 26.0 4.2 0.48
Hamilton score 7.9 5.0 7.5 4.9 0.45
Diagnosis of major 
depression (%)
21 19 0.60 33 33 0.99
Diagnosis of minor 
depression (%)
17 21 0.47 10 11 0.81
Total number 
of depressive 
symptoms
2.0 2.2 1.9 2.0 0.81 3.0 1.8 2.8 1.7 0.21
Total number of 
mood symptoms
0.9 1.1 0.8 1.0 0.27 1.3 1.0 1.2 1.0 0.44
Total number of 
motivation symptoms
1.1 1.2 1.1 1.2 0.79 1.7 1.2 1.5 1.2 0.23
Depressive disorder is defi ned as a CES-D score > 16 (The Rotterdam Study) or GMS-AGECAT screen positive 
(AMSTEL).
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7.6 DISCUSSION
We found no grounds for a specifi c symptom profi le for depression in subjects with vascu-
lar risk-factors in two large population based cohorts. Th is fi nding is in line with an earlier 
Table 2: Prevalence of individual symptoms of depression in patients with Vascular and Nonvascular 
depressive disorder
The Rotterdam Study AMSTEL
Vascular 
(N=167)
Nonvascular 
(N=166)
p-value* Vascular 
(N=220)
Nonvascular 
(N=303)
p-value*
DSM-IV mood-item: % % % %
Depressed mood 38 33 0.32 51 51 0.96
Loss of interest 37 39 0.70 25 23 0.48
Appetite disturbance 18 14 0.31 20 13 0.03
Sleep disturbance 73 71 0.69 51 57 0.20
Psychomotor change 20 25 0.28 32 32 0.90
Loss of energy 39 28 0.03 59 51 0.04
Feelings of guilt 6 7 0.65 11 11 0.99
Thinking / 
concentration
14 13 0.86 48 47 0.90
Thoughts of death 26 31 0.35 48 48 0.94
Depressive disorder is defi ned as CES-D score > 16 (ERGO) or GMS-AGECAT screen positive (AMSTEL).
* Chi-square (Pearson); analysis by logistic regression adjusting for age, sex, ADL and I-ADL in the Rotterdam Study, 
and for sex and I-ADL in the Amstel study
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Figure 1: Depression symptoms of vascular and non-vascular subjects of the AMSTEL study.
Vascular subjects had a score of >= 1 on the CIRS; N = 2232; Non-vascular subjects had a score of 0 on the CIRS; 
N = 1819.
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Table 3: Vascular risk characteristics of subjects with and without anhedonia, psychomotor change or 
loss of energy.
The Rotterdam Study
No anhedonia 
(N=159) 
Anhedonia
(N=87)
No psychomotor 
change (N=196)
Psychomotor 
change (N=50)
No loss of energy 
(N=172)
Loss of energy 
(N=74)
Characteristic:
Age, mean (SD), years 73.8 (6.9) 73.8 (7.1) 73.9 (7.1) 73.5 (6.4) 73.5 (7.0) 74.5 (6.8)
Sex, % female 76 71 75 72 73 77
Primary education only, % 61 56 60 57 58 61
MMSE-score, mean (SD) 27.1 (2.6) 26.2 (3.4)# 27.0 (2.8) 26.0 (3.4)# 27.2 (2.2) 25.9 (4.1) †
Hamilton-score, mean (SD) 5.4 (3.4) 11.4 (4.7) † 6.9 (4.9) 9.8 (4.1) † 6.0 (3.6) 11.0 (5.5) †
History of stroke, % 6 8 8 2 7 7
History of MI, % 9 12 11 6 9 19#
Smoking:
 Current smoker, % 18 23 17 28# 20 19
 Ex-smoker, % 42 41 44 38 43 42
Antidepressant medication, % 6 20† 11 12 9 16
Blood pressure, mean (SD), 
mmHg
 Diastolic 72 (11) 74 (13) 72 (11) 76 (13) 74 (12) 71 (12)
 Systolic 142 (21) 140 (26) 140 (22) 144 (27) 142 (21) 139 (27)
Total cholesterol, mean (SD) 
mmol/l
5.8 (0.9) 5.9 (1.0) 5.8 (0.9) 5.9 (1.1) 5.9 (1.0) 5.7 (0.8)
Body Mass Index, mean (SD) 27.1 (4.0) 26.7 (3.9) 26.9 (3.8) 27.0 (4.6) 27.0 (4.0) 27.0 (4.1)
Diabetes Mellitus, % 12 6 11 6 10 10
Common carotid intima-media 
thickness, mean (SD), mm
0.88 (0.16) 0.90 (0.16) 0.88 (0.15) 0.91 (0.17) 0.88 (0.15) 0.88 (0.17)
Peripheral arterial disease*, % 23 22 24 15 18 31#
Carotid plaques, %
 None 29 28 28 28 28 29
 Mild 17 18 16 21 16 19
 Moderate 33 35 35 28 35 31
 Severe 22 20 21 23 21 21
Aortic calcifi cations, %
 None 18 16 18 15 17 16
 Mild 30 33 32 27 29 34
 Moderate 28 17 22 34 29 15
 Severe 25 34 29 24 25 34
Abbreviations: MI, myocardial infarction; MMSE, Mini-Mental State Examination
* defi ned as an ankle-brachial blood pressure index below 0.9.
# p < 0.05; † p < 0.001
Continuous variables were analyzed by analysis of covariance using t-test, and categorical variables by logistic 
regression, adjusted for age, sex, Hamilton and MMSE scores when appropriate.
Numbers of aortic calcifi cations were 212 in all three groups, for carotid plaques 237. Group percentages did not 
differ signifi cantly from the total group that was screened and no correlation was found between severity of aortic 
calcifi cation or carotid plaques in any of three groups (Spearman’s rho).
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study on the vascular depression hypothesis in the community (Licht-Strunk et al. 2004).
Th e two presumed specifi c symptoms of vascular depression, anhedonia and psycho-
motor disturbance, were not any more prevalent in the vascular than in the non-vascular 
subjects in either of the two cohorts. We found that depressed persons with an increased 
vascular risk showed more loss of energy in both cohorts, and in the Amstel cohort this 
vascular depressed group also showed more appetite disturbance. Loss of energy and 
appetite disturbance was associated with vascular risk-factors in the Amstel study ir-
respective of concomitant depressive disorder. Also with the use of a more extensive 
set of vascular risk measures in the Rotterdam Study, no relation was found between 
the presumed specifi c symptoms of vascular depression, anhedonia and psychomotor 
change, with these specifi c vascular risk-factors, except for the fi nding that subjects with 
psychomotor change were more ‘current smokers’ than those without. Th e symptom ‘loss 
of energy’ was particularly associated with myocardial infarction and peripheral arterial 
disease.
Th is association of vascular risk and loss of energy was also found by Licht-Strunk et 
al. (2004) and in addition, like in our study, depressed subjects with vascular risk showed 
more disability as measured with ADL and I-ADL scales. Sato et al. (1999) suggested that 
the functional consequences of cerebrovascular disease may be the causal pathway by 
which basal ganglia and non-basal-ganglia lesions are associated with depressive symp-
tomatology.
Many studies have been conducted on the subject of vascular depression. Th ey address 
the relationship of vascular lesions in the brain and depression, a specifi c symptom profi le 
of vascular depression or the age-of-onset as a specifi c marker of (vascular) depression. 
Th e vast amount of literature illustrates the ongoing debate around the vascular depres-
sion concept. Level of caseness, depression diagnosis and referral bias are the major fac-
tors that aff ect fi ndings and conclusions of diff erent studies. 
By using two large community studies we have tried to overcome the problem of referral 
bias. We strictly followed the defi nition of vascular depression according to Alexopoulos, 
by studying only subjects who fulfi lled criteria for major depression and combining this 
with scores on the CIRS. Because of the fact that our study did not support the literature 
on vascular depression and the probability that this could be caused by diff erences in 
level of caseness of both depression and vascular risk, we have subsequently analyzed our 
study groups with diff erent defi nitions of both depression and vascular risk. Regarding 
the diagnosis of depression we applied various defi nitions including ‘depressive caseness’ 
(AGECAT / Amstel), major and minor depression and special symptom profi les. None of 
these had a major eff ect on the results. We think that for general practice our use of ‘de-
pressive caseness’ (Amstel) and screen-positive subjects (CES-D ≥ 16, Rotterdam Study) 
was more appropriate because these are the subjects that might consult their General 
Practitioner with their depressive complaints. Regarding the defi nition of vascular risk 
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the CIRS may not be sensitive enough for use in general practice. However, our subdivi-
sion into two groups with or without vascular risk factors and a third group with evident 
vascular disease also did not signifi cantly change our main results. Moreover, the mean 
scores on the Hamilton Depression Rating Scale in each symptom-group shows that there 
are no major diff erences in depression severity between the three symptom-groups.
Some authors have focused on the concept of apathy rather than on depression aft er 
stroke, stating that the vascular “depression” actually concerns apathy rather than depres-
sion (Starkstein et al. 1993). Apathy is defi ned as the absence or lack of feeling, emotion, 
interest or concern which expresses itself in emotion, behavior or social interaction 
(Marin 1990). It was found to co-occur with depression as a consequence of stroke and 
is also found in other neuropsychiatric diseases like Huntington and Parkinson disease. 
It has also been found as a consequence of stroke, without co-existing depression (Stark-
stein et al. 1993). It has been stated that apathy results from impaired neural processing 
of novel events caused by dysfunction of the frontal-subcortical system, for example by 
vascular defects in these regions (Yamagata et al. 2004). New syndromes like the ‘depres-
sive-executive dysfunction syndrome’ (DEDS), in which the core symptoms are psycho-
motor disturbances, loss of interest and a mild vegetative syndrome have been released, 
by Alexopoulos, and several others (Alexopoulos et al. 2002; Vataja et al. 2005). Subjects 
with this syndrome demonstrate multiple defects in neuropsychological functioning; 
they show impaired results on tests of fl uency, visual naming, abstract thinking, planning, 
executive complex behavior and concept shift ing. Th is DEDS was also found to be more 
common in subjects with brain infarcts that aff ected the fronto-subcortical pathways in 
some way (Vataja et al. 2005) and it is suggested that in this syndrome dopamine agonists 
could be helpful in relieving the ‘depressive’ features (Alexopoulos 2001).
Krishnan et al. have shown that especially apathy was more prevalent in subjects with a 
late-onset of the depression as compared to those with an early-onset, although they state 
that it is hard to demarcate these two groups from each other (Krishnan et al. 1995). 
Our results do not defi nitively disprove the concept of vascular depression. A ‘vascu-
lar’ etiology of the depression is probably associated with a more chronic course of the 
depressive disorder (Mast et al. 2004a) and might be a predictor for poor response to 
antidepressant medication (Fujikawa et al. 1996). It is also associated with poor outcome 
as indicated by higher levels of mortality, higher incidence of new vascular events and 
higher incidence of subsequent cognitive decline (Baldwin et al. 1993; Penninx et al. 
1998b; Penninx et al. 2001; Pohjasvaara 2002). What remains is the challenge to detect 
subjects with a vascular risk in the general population. Th e clinical features of these sub-
jects are still ill defi ned and not very specifi c. Better use of refi ned psychiatric tools with 
emphasis on dimensional rather than syndromal diagnosis could be of great importance 
to detect special subgroups of subjects with depression, for example those with vascu-
lar damage of the brain. Furthermore, not only vascular changes are of importance in 
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provoking depressive symptoms and signs in (elderly) subjects suff ering of a vascular 
burden; external motivation for depression can not be denied and for psychiatry the 
challenge remains to come to a full understanding of biological and social determinants 
of behavior and their interaction (Kandel 1998).

Chapter 8
General Discussion
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Th is thesis addresses the relationship between depression and vascular risk factors in 
general and vascular damage of the brain more specifi cally. Th e main focus is on symptom 
profi les of depression. In this general discussion, I will fi rst start with a summary of the 
most important fi ndings of the studies described in this thesis. Next, I will discuss some 
methodological and conceptual issues that are important for an accurate interpretation 
of the fi ndings and determination of their clinical relevance. Th e key-concepts in this will 
be ‘complex disorders’ and ‘levels of explanation’. Finally, I will outline my suggestions 
for future research on this topic.
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8.1 SUMMARY OF THE MAIN FINDINGS
8.1.1 Disease-specifi c properties of depression rating scales in patients with stroke. (Chapter 2)
Th e Hamilton Rating Scale for Depression (HAMD) is oft en used in research into 
post stroke depression (PSD). Although this rating scale was originally designated to 
measure the severity of depressive disorders, it is oft en used for diagnostic purposes in 
PSD research. We have studied the psychometric properties of this rating scale for three 
diff erent diseases of the brain, stroke, Alzheimer’s disease (AD) and Parkinson disease 
(PD). We found that the concurrent validity of the HAMD with the DSM-IV criteria of 
major depressive disorder was high in each of these groups, but that the use of this scale 
in patients with stroke or another organic brain disease will require the application of 
disease-specifi c cut-off  scores for screening, diagnostic and dichotomization purposes. 
Th ese disease-specifi c cut-off  scores were highest in PD and lowest in stroke patients, and 
those of AD patients lay in-between.
8.1.2 Depression in vascular dementia: phenomenology and association with fronto-
subcortical dysfunction. (Chapter 3, 4 and 5)
In patients suff ering from vascular dementia, aff ective disturbances are oft en encountered, 
probably more oft en than in Alzheimer’s disease (Newman 1999). It has been suggested 
that the nature of symptomatology can help to distinguish organic from psychological 
depression. Vascular depression is defi ned as having more psychomotor disturbance and 
more loss of interest (anhedonia). In our study on vascular demented subjects we have 
used the subdivision of Forsell et al. (1993), who described ‘low motivation’ and ‘low 
mood’ syndromes in demented, depressed subjects. Patients with predominantly ‘moti-
vational’ symptoms are more likely to have an organic etiology for their depression. Th e 
specifi c features of these subsyndromes are:
• Mood disturbance: dysphoria, feelings of guilt, thoughts of death and appetite distur-
bance. 
• Motivational disturbance: loss of interest, psychomotor change, loss of energy and 
thinking or concentration disturbance.
In our clinical group of patients from a specialised stroke-unit we have assessed the inter-
relationship of depression and dementia post-stroke. A principal component analysis 
of the psychiatric symptoms and signs revealed three distinct sub-syndromes: one with 
predominantly mood symptoms, one with essentially psychomotor symptoms, and one 
with vegetative symptoms. Mood, psychomotor and vegetative symptoms were all inde-
pendently and strongly related to the diagnosis of major depressive disorder according to 
DSM-III-R criteria. Moreover, the psychomotor factor was the only factor that was also 
fi rmly associated with dementia. In a further analysis we have tried to unravel whether 
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the relationship between the aff ective and cognitive features of these patients is mediated 
by fronto-subcortical dysfunction. Associations were computed between measures of de-
pressive symptoms and a comprehensive set of neuropsychological tests. Our hypothesis 
was supported by a negative correlation between scores on the Verbal Fluency Test and 
the total number of motivational depressive symptoms. None of the neuropsychological 
tests was signifi cantly related to the number of mood symptoms nor did they correlate 
with the total number of depressive symptoms. Th e results indicate that diff erent dimen-
sions of depression can be discerned in a group of patients with vascular dementia and 
that the symptom profi le of depression in these patients can be aff ected by the presence 
and severity of dementia and especially by fronto-subcortical dysfunction.
8.1.3 Symptom profi les in subjects with vascular risk-factors in the general population. 
The “vascular depression” concept. (Chapter 6 and 7)
If specifi c symptom profi les of depressive disorders in the elderly are related to a specifi c 
etiology, this could have implications for everyday clinical practice. Th e vascular depres-
sion hypothesis states that especially in the elderly a sub-type of depressive disorder 
exists that is caused by vascular brain disease. Subjects with a vascular risk would show 
more anhedonia, psychomotor change and less feelings of guilt, than subjects without 
a vascular risk. In the fi rst place, this hypothesis was tested by comparing the symptom 
profi les of subjects in the general population with predominantly vascular, degenerative 
or infl ammatory risk factors. Motivational symptoms were associated with vascular or 
degenerative risk-indicators for depression; psychomotor change with both indicators; 
loss of energy with the vascular, but also with the infl ammatory indicator and thinking/
concentration disturbance with the degenerative indicator. Th e so-called mood symp-
toms of depression, especially thoughts of death, and melancholic symptoms like appetite 
and sleep disturbances were more strongly related with the infl ammatory risk-indicator. 
From this study it can be concluded that in patients with a late-life depression, specifi c 
symptoms of the depressive disorder may refl ect the predominant underlying pathogenic 
mechanism, but next to the symptoms of loss of interest (anhedonia) and psychomotor 
disturbances, loss of energy (lassitude) and appetite disturbance may be important in the 
vascular profi le. To further test the vascular depression hypothesis, we have studied the 
phenomenological characteristics of subjects with and without vascular disease and with 
and without depressive disorder in the open population.
Th e main fi ndings were that we could not confi rm the specifi c symptom profi le of 
vascular depression with predominant anhedonia and psychomotor disturbance. Neither 
of these were more prevalent in the vascular groups than in the non-vascular groups of 
both our population-based studies. We did fi nd that depressed persons with a vascular 
risk showed more loss of energy in both study-groups, and appetite disturbance in the 
other. Conversely, we found that the presumed specifi c symptoms of vascular depression, 
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anhedonia and psychomotor change, did not have any relation with specifi c vascular 
risk-factors, except for the fi nding that subjects with psychomotor changes were more 
‘current smokers’ than subjects without psychomotor changes. Loss of energy was as-
sociated with myocardial infarction and peripheral arterial disease. In the total group of 
subjects, including depressed as well as non-depressed subjects there were also associa-
tions between the symptoms loss of energy and appetite disturbance and the group with 
vascular risk.
8.2 METHODOLOGICAL AND CONCEPTUAL CONSIDERATIONS
In this section, the methodological strengths and limitations of the way the various 
studies were designed are discussed and some conceptual considerations are outlined.
8.2.1 Symptom profi les of depression
As stated in Chapter 1, it is necessary to use adequate and well-known measures of de-
pression to allow meaningful interpretations of the research fi ndings. However, the main 
aim of this thesis was to determine distinct symptom profi les for subjects with vascular 
risk or vascular brain damage. We therefore chose to follow a parallel route. We did not 
only use the established classifi cation system to come to the detection and classifi cation 
of major and minor depressive disorder, but we also applied a dimensional approach, 
based on the reports from Forsell, Alexopoulos and Krishnan (Forsell et al. 1993; Alexo-
poulos et al. 1997b; Krishnan et al. 1997). Forsell has subdivided demented subjects with 
a depressive disorder into subjects with predominant mood and predominant motiva-
tional disturbances. Th e mood profi le consisted of psychological, or ‘positive’ symptoms 
of depression like dysphoria, negative thoughts, guilt feelings and suicidal ideation. Th e 
motivational profi le on the other hand consisted of an apathy-like syndrome, or ‘negative’ 
syndrome with loss of interest (anhedonia), psychomotor retardation and indecisiveness 
(Forsell et al. 1993). Especially the motivational profi le not only has much in common 
with the concept of apathy (Marin 1990) but also with the symptom profi le of vascular 
depression, as defi ned by Alexopoulos and Krishnan (see also Chapter 1) (Alexopoulos 
et al. 1997b; Krishnan et al. 1997). No specifi c instruments are available for the measure-
ment of these new dimensional concepts. Moreover, because we used diff erent groups of 
subjects for our analysis, measurement of depression was done by using various meth-
ods. For Chapter 2, 3 and 4 the aff ective part of the Schedule for Aff ective Disorders 
and Schizophrenia (SADS) was used to elucidate all depressive symptoms (Endicott & 
Spitzer 1978). Th e SADS is a semi-structured interview, which enables the confi rmation 
of the diagnosis of major depressive disorder according to DSM-IV-criteria (APA 1994). 
In the Nijmegen and Amstel study, diagnosis of depression was made according to the 
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GMS-AGECAT system (Copeland et al. 1986; Copeland et al. 1988).  Th e Dutch language 
version has proven reliability for epidemiological work in replication studies (Hooijer 
et al. 1991). Finally, in the Rotterdam Study diagnosis of depression was assessed by a 
two-step procedure. First, participants completed the Dutch version of the Center for 
Epidemiological Studies Depression Scale (CES-D). A score of 16 was used as a cut-off  to 
indicate depressive symptoms (Beekman et al. 1997b). In a second step, screen-positive 
subjects were studied with the Dutch version of the Present State Examination, a semi-
structured psychiatric interview included in the Schedules for Clinical Assessment in 
Neuropsychiatry (SCAN) (WHO 1997). 
All instruments not only diagnose major and minor depression but also shed light 
on milder depressive symptomatology, enabling emphasis on dimensional instead of 
syndromal properties. Th is is one of the major strengths of this thesis. As a matter of 
defi nition, incomplete depressive disorders are more common than the category of major 
depression. Th is ‘level of caseness’ is of major importance for the results. Th e application 
of stricter criteria for depression will weaken the association found between physical 
illness and depressive disorder and thus, subjects with a vascular risk or with a PSD 
have strong associations with certain symptoms (for example: psychomotor changes), 
a milder association with a certain profi le (the motivation profi le) and the weakest as-
sociation with an aff ective syndrome according to DSM-criteria (major depression). Th is 
was confi rmed by our fi ndings. Th e same might be true for the cognitive features and 
as a result, fi ndings on co-morbidity of aff ective and cognitive disorders in post-stroke 
subjects or subjects with a high vascular risk, are also strongest at the symptom-level and 
will probably weaken when stricter criteria for both depression and dementia are applied. 
As a matter of fact, applying a more sophisticated concept of depression or dementia on 
these subjects instead of just aff ective or cognitive symptoms or signs is more in line with 
the complex reality. Looking at only symptoms and their relation with vascular lesions 
is just one piece of the complex puzzle and only addresses one level of explanation (see 
paragraph 8.2.2).
We could not address the question of specifi c localisation that would render specifi c 
symptoms or symptom profi les, but this still remains interesting. Apart from specifi city 
of localisation the factor of vascular load has been introduced (Krishnan & McDonald 
1995). A critical level of damage to certain systems in the brain should be reached to 
bring about depressive symptomatology (also known as the redundancy eff ect). Th e 
systems at play would be fronto-subcortical systems, which are norepinephrine systems. 
Damage therefore will lead to reduced norepinephrine turnover and this will induce 
depression-proneness in these subjects. Others have mentioned a ‘built-up’ of symptoms 
in a hierarchical way (Parker et al. 2003). Mood features would be followed by psycho-
motor features and eventually, psychotic features could complete the major depressive 
disorder. 
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8.2.2 Levels of explanation
At fi rst, the clinical discovery of PSD has evoked a lot of research and has fuelled the 
long existing dissension on organic and functional disorders. In earlier days, organic 
psychiatric disorders were defi ned by a clear neuropathological substrate. An example 
for this is Parkinson disease, in which selective neuronal loss leads to comprehensible 
clinical phenomena. Functional disorders, like schizophrenia, did not have such a sub-
strate. In modern times, the extra connotation given to a functional disorder is that it 
merely pertains disturbances of function, which can be induced by psychosocial fac-
tors. Divergent concepts like this were the logical consequence of Cartesian dualism and 
have prevailed for a long time in psychiatry. With the upcoming psychopharmacology, 
neurobiology and structural and functional brain imaging techniques, knowledge about 
the pathophysiology of mental disorders has been boosted enormously. It is now clear 
that all mental processes are the result of neuronal processes in the brain, and mind and 
brain are commensurable. Th e distinction between mind and brain has been a hindrance 
for scientifi c progress (Kandel 1998). Human fi rst-person world of experience might be 
unique but it emerges from and is total dependent upon brain function, although on the 
other hand, brain function can be a reaction to social and cultural processes. Th us the 
mental (functional) and biological (organic) become diff erent levels of viewing the same 
subject (circular interaction). A risk of these new insights is that in research the signifi -
cance of biological factors is exaggerated, as some have stated that psychiatry cannot be 
too biological (Guze 1989). Biological reductionism is certainly a risk that is involved in 
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Figure 1: Level of caseness and inter-relationship of cognitive and affective features following 
cerebrovascular lesions
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this thesis too. Although the precipitation of depression by stroke as in PSD suggests a 
causal relationship, not all subjects suff ering from stroke will develop PSD. Th e same is 
true for elderly subjects with vascular risk factors; not all subjects with a major vascular 
risk will develop a depression. As was stated before, most psychiatric disorders are of 
the complex type, which means that no single cause will be responsible. Th e new philo-
sophical structure that has to be set in psychiatry has to contain some major propositions 
(Kendler 2005):
1. Psychiatry is irrevocably grounded in mental, fi rst-person experiences.
2. Cartesian substance dualism is false.
3. Epiphenomenalism is false.
4. Both brain-mind and mind-brain causality are real.
5. Psychiatric disorders are etiologically complex.
6. Explanatory pluralism is preferable to monistic explanatory approaches, especially 
biological reductionism.
7. Psychiatry needs to move from a prescientifi c “battle of paradigms” toward a more 
mature approach that embraces complexity along with empirically rigorous and plu-
ralistic explanatory models.
8. Accept “patchy reductionism” with the goal of piecemeal integration in trying to 
explain the complex etiological pathways to psychiatric illness a little bit at a time.
An elegant example of this approach is delivered on the complex relationship between 
depression and mortality by Schulz et al. (2002) (fi g. 2). Not only will behavioural risk 
factors increase the risk of developing depression, but moreover, they will increase the 
risk of developing other (sub)clinical diseases, for instance vascular brain disease and 
thus contribute to an increased risk of death. Th e authors not only address plain cerebro-
vascular and other somatic illness but also lifestyle factors, stressing the inter-relation-
ship of these factors.
Th e results of this thesis thus can contribute to a part of the complex, explanatory, etio-
logical pathway that leads to the development of PSD or vascular depression. Th ere will 
be lots of small explanations, from a variety of explanatory perspectives, each addressing 
a part of this complex disorder. Th ese etiological pathways will not be simple, linear and 
one-way interactions, but complex and interacting, like networks. Th e basic attitude that 
is needed is explanatory, integrative pluralism. In PSD and vascular depression some of 
the pieces of the puzzle will be for instance: (a) Predisposition of men to depression by 
foetal undernutrition, stressing an environmental factor in early life which could infl u-
ence the programming of the hypothalamic-pituitary-adrenal (HPA) axis (Th ompson 
et al. 2001). (b) Impairment in executive functioning and attention in patients with a 
late-life depression, suggesting involvement of specifi c neuronal circuits (Lockwood et 
al. 2002; Rapp et al. 2005). (c) One of the latest replication studies on the relationship 
between white matter hyperintensities and depressive features (the level of the brain 
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and brain function) in mid-adult life stresses the importance of the mediating role of 
physical disability in this association (the level of the social system) (Jorm et al. 2005). 
(d) Th e prediction of shorter time to remission by greater intrinsic religiosity, pointing 
at a transcendent factor that might infl uence the subjective suff ering from depression 
(Koenig et al. 1998). 
8.2.3 Statistical issues
Some of the statistical methods used in this thesis need some extra comment. In this 
paragraph these comments will concern (1) ROC-curves, (2) factor analysis, (3) data 
imputation and (4) specifi city of symptoms.
8.2.3.1 ROC curves
In order to determine and compare the sensitivity and specifi city of a diagnostic instru-
ment and to obtain optimal cut-off  scores, we plotted ‘receiver operating characteristic’ 
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Figure 2: Complex interrelationship between depression and mortality (Schulz et al. 2002)
Level Research fi ndings
Molecular / DNA Genetic alterations, linkage disequilibrium and association of certain DNA 
profi les with endophenotypes
Cellular / Neurotransmitters Altered levels of neurotransmitters, cellular degeneration or dysfunction
Brain structures / Neuronal circuits Localised functions, neuropsychological defi cits
Whole brain / Organism Unique personal experience: psychiatric features and phenomena 
including somato-visceral symptoms
Social system / Family, work etc. ADL and I-ADL shortcomings, interaction problems with spouse, family 
members, change of roles
Cultural and transcendental systems Specifi c elements in art, religion, folklore and rites
Figure 3: Levels of explanation
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curves (ROC curves) (Murphy et al. 1987). Th ese curves yielded the ‘sensitivity’ versus 
‘1 minus the specifi city’ for every possible cut-off  point. Th e optimal cut-off  point was 
determined visually by assessing which score combined maximum sensitivity with op-
timal specifi city. Th e area under the curve (AUC) is an indicator of the ability of the 
scale to distinguish between depressed and non-depressed patients. Optimal cut-off 
scores were determined for each group of patients, including cut-off  scores that could 
be used for a screening, diagnostic and dichotomization (i.e. discriminating depressed 
from non-depressed patients) purposes. In order to determine whether the HAMD could 
be used as a predictive test for these three groups of patients, positive predictive (PPV) 
and negative predictive values (NPV) were calculated for diff erent cut-off  scores in the 
central range of the scale. Th e validity of the ROC curves can be compared in pairs with 
the Hosmer-Lemeshow goodness-of-fi t test (Hosmer et al. 1988). Th e major problem of 
using these kinds of statistics is that they involve the risk of circular reasoning. It can be 
argued that one should not use the DSM-criteria as the golden standard in these somatic 
disorders, because various somatic and psychomotor symptoms should not be counted 
as depressive features and therefore wrongfully account for the major part of depressive 
symptom score on the HAMD. However, there are no more suitable alternatives for the 
golden standard diagnosis and as a matter of fact, our results did show that this concern 
is more a theoretical than a clinical / practical problem, because higher scores had a high 
predictive value for depression in all three groups of patients. In theory, it still remains 
possible that some patients do have a high score on the HAMD, but will not suff er from 
one of the key-features of depression, i.e. depressed mood or anhedonia. Th erefore, some 
authors have stated that depression only could be diagnosed when a minimum score 
on the HAMD was reached and if one of these key-features is present (Leentjens et al. 
2003).
8.2.3.2 Factor and discriminant analysis
Th e primary aim of a factor analysis is to obtain a data reduction and to uncover un-
derlying structure of the data. Th e purpose of data reduction is to remove redundant 
(highly correlated) variables from the data fi le, perhaps replacing the entire data fi le with 
a smaller number of uncorrelated variables. Th e purpose of structure detection is to 
examine the underlying (or latent) relationships between the variables. Th ere are several 
assumptions to be made, before one should apply this statistical method to the available 
data. One should know how many factors are needed to represent the variables and what 
these factors will represent in the population under study. We have chosen the method 
of Forsell et al. (1993) who had found two distinct symptom clusters of depression in a 
group of demented subjects. 
Th e factor analysis that we used in this thesis is a principal component analysis with 
varimax rotation. We were looking for dimensional clusters of symptoms that would 
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correlate with neurobiological markers and unlike the prevailing cluster(s) of the DSM-
classifi cation, similar to the earlier fi ndings of Forsell. Symptoms were added to a factor 
when factor loading was greater than .40, which is arbitrary, but common practice in 
factor analysis. Because our fi ndings supported the earlier fi ndings the study could be 
considered a replication, although in another group of subjects. Th erefore, the procedure 
is, although precarious, justifi ed. 
8.2.3.3 Data imputation
Imputation of data means the replacement of missing values in the dataset. Missing data 
can be due to multiple causes. In our study-group we were confronted by a large propor-
tion of subjects that were not able to participate in neuropsychological testing, while this 
was our main topic of interest (chapter 4). In this study we replaced values only due to 
cognitive/behavioral disturbances by the worst performance in this study group on that 
particular test, assuming that these subjects belonged to this worst group of subjects. To 
determine the eff ect of the adjustments, the so-called eff ect size can be computed for each 
test variable. Th is is calculated by the diff erence between the observed and the adjusted 
means divided by the observed SD. An eff ect size of 0.8 SD should be considered as large, 
of 0.5 SD as medium and an eff ect size of 0.2 SD as small (Cohen 1988). We performed 
a sensitivity analysis to check whether imputation with the average score on the test or 
a score in between the worst and the average (25th percentile) would alter the correla-
tion coeffi  cients between the measures of depression and the neuropsychological test 
scores, but it did not. Although these methods have been used elsewhere before and have 
proven to be reliable, the amount of missing data in our study suggested that most of the 
neuropsychological tests were of no use in this study-group and thus imputation remains 
precarious. Unfortunately, no specifi c neuropsychological (frontal) test is applicable to all 
patients in such a severely ill study-group. Nevertheless, newer test should be developed, 
enabling the adequate measurement of frontal functioning in this category of patients. 
For this thesis, although with shortcomings, no better solution was within reach.
8.2.3.4 Specifi city of symptoms
In chapter 6 and 7 we have tried to fi nd specifi c symptoms of depressed subjects with 
vascular risk factors or vascular disease. Th e only signifi cant association that was found 
concerned the symptom of loss of energy. Statistical signifi cance, however, is not equal 
to clinical signifi cance. Only when a symptom or marker has a very high specifi city will 
a positive fi nding rule in the diagnosis (of vascular depression). Similarly, when a symp-
tom or marker has a very high sensitivity, a negative result will rule out the diagnosis. 
Th e Likelihood-ratio is calculated by dividing the chance that someone with a marker 
has the disease by the chance that someone without this marker has the disease. Th e 
likelihood ratio incorporates both the sensitivity and specifi city of the test and provides 
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a direct estimate of how much a test result will change the odds of having a disease. Th e 
likelihood ratio for a positive result (LR+) tells you how much the odds of the disease 
increase when a test is positive. Th e likelihood ratio for a negative result (LR-) tells you 
how much the odds of the disease decrease when a test is negative. 
Specifi city of lassitude for vascular risk in the total, general population is only 48%, 
combined with a sensitivity of 61% giving a positive Likelihood-ratio (LR+) of only 
1.15. When we do this analysis on the depressed subgroup in the general population, 
specifi city rises to 60%, but sensitivity is only 50%, leading to a LR+-ratio of 1.22, which 
is also not a very useful result for everyday practice. Th e post-test probability will only 
rise from 50% to 54%. We could not analyse such symptom-specifi city in our clinical 
groups, because we only had clinical subjects with a vascular disease of the brain and no 
non-vascular group to compare with. Th ese calculations lead us to the conclusion that 
we need more markers or a set of markers to come to a satisfactory predictive profi le for 
clinical practice. 
8.2.4 Data-resources
Th e subjects under study in this thesis were from various sources. For the study on the 
validity of the HAM-D subjects of diff erent clinical trials were used. In the study on 
depressive symptoms in vascular dementia and their relationship with neuropsychologi-
cal dysfunction subjects from a clinical stroke-unit were used. Finally, for associations 
of vascular risk factors with the depression symptom profi le we used data out of two 
large community studies. Because the information out of diff erent resources is support-
ing the same hypothesis, this is a strong point of this thesis. On the other hand a major 
shortcoming is that, being data from various sources, this makes them at some point 
incomparable. 
As was stated in the introduction, clinical and community studies both have their own 
methodological problems. Inherent to all community studies, participation rate can be a 
problem; although in both our community studies, the participation rate was acceptable, 
attrition is still a risk. Th is would mean that the most severely-ill subjects dropped out 
of (or: did not enter) the study, which could weaken the possible association between 
vascular risk-factors and depressive symptoms. As a consequence, the real association 
could be stronger than the one we found in this study. In clinical studies, especially those 
in tertiary settings, only the most severely ill subjects will enter the study. Th is selection-
bias would mean that a stronger relation is found in the study than in reality exists. In 
our clinical study, the selection was made only concerning the cerebrovascular illness. 
Although the Rotterdam Stroke Databank was designed to non-selectively include all 
consecutive stroke patients, referral to this stroke-unit was diff erential in that younger 
subjects and subjects with a presumed, rare cause of stroke were overrepresented. Th is 
might have infl uenced our results, although the direction of this infl uence is not certain. 
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8.3 CLINICAL RELEVANCE
8.3.1 Transference to clinical practice
1. Diagnosis of depression in patients who suff ered from a stroke can be diffi  cult. Over-
lap of physical symptoms with melancholic or autonomous symptoms of depression 
can be a problem, although in comparison to Alzheimer’s and Parkinson’s disease, 
this is less a problem in stroke. Rating scales like the HAM-D can be of help for both 
screening and diagnostic purposes, unless one uses the appropriate cut-off  scores as 
recommended in this thesis.
2. In a specialised stroke unit, we found that the depression profi le is associated with the 
cognitive state of the patient. Subjects with more cognitive deterioration show more 
motivational symptoms. Th is association is likely to be mediated by frontal-subcorti-
cal dysfunction, although in severely demented patients, this function is diffi  cult to 
measure. 
3. In the general population our results do imply that certain profi les of depression, 
especially in the elderly, indeed might be a predictor of vascular brain disease or even 
vascular dementia. Our fi ndings are not conclusive on specifi c symptom profi les of 
depression in subjects with vascular risk or vascular brain disease. It is a risk that GPs 
by all means should be aware of, when elderly subjects with no psychiatric personal 
history present themselves with depressive complaints, especially when other vascu-
lar risk factors are at hand.
8.3.2 Clinical relevance of these fi ndings
Th e association of cerebrovascular disease and depression has been a subject of interest 
for a long time. Both PSD and vascular depression have been studied extensively. In this 
thesis we have tried to fi nd further support for a specifi c clinical psychiatric presentation 
of the aff ective disturbances. We found additional evidence for the existence of such a 
specifi c clinical presentation, although these fi ndings were much weaker in the general 
population than in our clinical sample. Our fi ndings suggested that in vascular disease of 
the brain the prominent symptoms of depression are the so-called ‘motivational’ symp-
toms, such as loss of interest (anhedonia), psychomotor changes, loss of energy (lassitude) 
and thinking / concentration disturbances. In the general population this association was 
much weaker and actually remained signifi cant only for the rather non-specifi c symptom 
of lassitude. Th is would mean that there indeed might be a kind of vascular gradient and 
that the more severe the vascular disease of the brain is, the more evident this vascular 
depression profi le will manifest itself, probably in cohesion with cognitive decline. For 
clinical practice, this means that in everyday practice, no clear clinical profi le can be 
given to easily recognize the depressed patient with a vascular risk, although with promi-
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nent lassitude, there is a higher risk. If one would like to use such a symptom as a marker 
for vascular risk, it should be specifi c for this risk, which is not the case. 
8.4 FUTURE RESEARCH
As was outlined in paragraph 8.2.2 psychiatric research can only be helped forward by 
explanatory pluralism. Searching for and developing one fi nal theory is attractive but 
also unrealistic. In a structure of overlapping fi ndings from research on diff erent levels 
of explanation, we will probably be able to come to a piecemeal integration and fi nally 
to a full causal network for vascular and post-stroke depression. In the fi eld of fi rst-per-
son phenomenology this will mean that further clarifi cation and defi nition of diff erent 
dimensions of depression is still of major importance. Linkage of these dimensions to 
other levels of explanation, like the neuropsychological, neuronal circuitry level or the 
functional-anatomic brain level still has to be elaborated. Next, an important clinical 
implication could be that specifi c treatment modalities can be studied in clearly-defi ned 
subgroups. Th is would imply for instance investigating whether a group of stroke pa-
tients with predominant motivational or apathetic symptoms would benefi t from specifi c 
interventions, for instance serotonergic antidepressants or maybe even dopamine-en-
hancing medications like buproprion. Th e same kind of study would be interesting in 
elderly subjects with presumed vascular depression with predominant motivational and 
apathetic symptoms. Th us, new studies would need a very strict psychiatric diagnostic 
procedure, again not only addressing DSM-categories, but also apathy, mood and moti-
vation sub-syndromes. A thorough neuropsychological evaluation will render more fi rm 
data, which could be correlated to the psychiatric fi ndings. Correlation with new, more 
detailed and functional neuro-imaging data would complete the study and so this study 
could contribute to the understanding of how neuronal circuits work together in the de-
velopment of depressive disorders in men and give support to evidence-based treatment 
of PSD and vascular depression.
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INLEIDING
Dit proefschrift  gaat over de klinische verschijningsvorm van depressie bij personen 
met cerebro-vasculaire stoornissen. Enerzijds betreft  het depressies die ontstaan na een 
beroerte (ook wel aangeduid met cerebrovasculair accident of kortweg CVA), anderzijds 
ook depressies die optreden bij personen die in meer of mindere mate vasculaire risico-
factoren hebben of bij wie op MRI of CT-scan aanwijzingen zijn voor doorbloedings-
stoornissen van de hersenen. Hoofdstuk 1 geeft  achtergrondinformatie over dit onder-
werp. Achtereenvolgens wordt eerst algemene informatie over depressie, in het bijzonder 
depressie bij ouderen en over cerebrovasculaire stoornissen gegeven. Daarna worden de 
mogelijke combinaties van deze twee belangrijke volksgezondheidsproblemen bespro-
ken. “Post-stroke depressie” en “vasculaire depressie” zijn twee belangrijke termen die in 
dit onderzoek gebruikt worden. Beide begrippen worden toegelicht en het onderzoek dat 
tot op heden hierover is gedaan wordt kort samengevat. De belangrijkste methodologi-
sche problemen waarop men stuit bij het onderzoeken van personen met een depressieve 
stoornis in combinatie met doorbloedingsstoornissen van de hersenen worden daarna 
uiteengezet. Het gaat daarbij om de volgende vragen: Welke defi nitie wordt er gehanteerd 
voor de depressie? Hoe is het tijdsverband tussen de depressieve verschijnselen en de 
cerebrovasculaire stoornissen? Welke groepen worden er onderzocht en welke andere 
factoren dan de neurobiologische spelen een rol bij het ontstaan van depressie bij ou-
deren met bijkomende cerebrovasculaire stoornissen? De volgende vragen staan aan de 
basis van dit proefschrift :
1. Kan de Hamilton Depression Rating Scale (HAMD) gebruikt worden als diagnostisch 
instrument bij patiënten met een depressie na een beroerte?
2. Hebben patiënten die een ernstig beroerte hebben doorgemaakt en daarbij een de-
pressieve stoornis hebben, een specifi ek symptoomprofi el?
3. Bestaat er een relatie tussen de aff ectieve en de cognitieve gevolgen van een beroerte?
4. Kan de ‘vasculaire depressie’ in de algemene bevolking als aparte entiteit herkend 
worden op basis van het symptoomprofi el?
DE STUDIES
Om bovenstaande vragen te beantwoorden zijn in dit proefschrift  data uit uiteenlopende 
studies gebruikt. Hier wordt in het kort even op deze studies ingegaan.
De Dutch Vascular factors in Dementia Study betreft  een onderzoek bij opgenomen pa-
tiënten in een tertiaire, academische setting. De patiënten waren 55 jaar of ouder en had-
den bij opname een TIA (met neurologische afwijkingen bij lichamelijk onderzoek), een 
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cerebraal infarct of een intracerebrale bloeding. Het belangrijkste doel van het onderzoek 
was om inzicht te verkrijgen in de invloed die een breed scala van vasculaire factoren 
hebben op andere risicofactoren, eigenschappen van de beroerte zelf en het optreden van 
dementie na een beroerte. Het onderzoek vond plaats op de afdeling Neurologie van het 
Erasmus Medisch Centrum te Rotterdam. 
De Depression in Dementia Study is een longitudinale studie die werd uitgevoerd door de 
afdeling Psychiatrie van het Universitair Medisch Centrum St. Radboud te Nijmegen. De 
dataverzameling vond plaats tussen 1990 en 1994. Het doel van het onderzoek was om de 
samenhang tussen dementie en andere vormen van psychopathologie (in het bijzonder 
depressie) in prospectieve zin te bestuderen. In deze studie werden 91 bewoners van ver-
zorgingshuizen met dementie en 110 bewoners zonder dementie gedurende 12 maanden 
gevolgd.  In die periode vonden 3 gedetailleerde metingen plaats van de psychiatrische 
status met speciale aandacht voor dementie en depressiesymptomen en neuropsycholo-
gische functies. De studie werd gesubsidieerd door de JANIVO stichting.     
De Amsterdam Study of the Elderly (AMSTEL) betreft  een groot bevolkingsonderzoek 
dat plaatsvond tussen 1990-1994. In totaal werden 4051 thuiswonende ouderen in Am-
sterdam thuis opgezocht door getrainde interviewers. Doel van het onderzoek was het 
in kaart brengen van een breed scala aan demografi sche, somatische en psychiatrische 
gegevens. Het onderzoek gaat uit van de vakgroep psychiatrie van de Vrije Universiteit 
Amsterdam en is ingebed in het onderzoeksprogramma van het EMGO instituut. Het 
onderzoek werd fi nancieel gesteund door het S.G.O. programma (Stimulering Gezond-
heidszorg Onderzoek) vanuit het ministerie van VWS. Dit liep af in 1994. Sindsdien 
wordt het onderzoek verder gefi nancierd via projectsubsidies van o.a. het Nationaal 
Fonds Geestelijke Volksgezondheid, en N.W.O. 
De Erasmus Rotterdam Gezondheid en Ouderen (ERGO) studie betreft  eveneens een 
grootschalig, langlopend bevolkingsonderzoek. Het onderzoek is gestart in 1990 en mo-
menteel is de vierde follow-up ronde gaande. In dit proefschrift  worden data uit de derde 
onderzoeksronde gebruikt. In het onderzoek zijn alle personen van 55 jaar en ouder 
uit de wijk Ommoord te Rotterdam betrokken. Doel van het onderzoek is het in kaart 
brengen van de incidentie en prevalentie van risicofactoren voor chronische ziekten bij 
ouderen. Het onderzoek gaat uit van de vakgroep Epidemiologie en Biostatistiek van de 
Erasmus Universiteit te Rotterdam. Het onderzoek wordt fi nancieel ondersteund vanuit 
het Research Institute of Diseases in the Elderly (RIDE, ZonMW). Additionele onder-
steuning voor het depressie-onderzoek werd gegeven door Numico Research BV en voor 
het arterioscleroseonderzoek door een extra subsidie van NWO, 904-61-091.
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ONDERZOEKSVRAGEN
Hoofdstuk 2 beschrijft  het onderzoek naar de validiteit van de Hamilton depressievra-
genlijst (Hamilton Depression Rating Scale, HAMD) bij patiënten met een beroerte. In de 
dagelijkse praktijk wordt dit instrument vaak gebruikt bij patiënten met een depressieve 
stoornis. De vragenlijst is ontworpen om bij patiënten bij wie een depressie is vastgesteld 
een indruk van de ernst van de depressieve klachten te krijgen en om eventueel ook 
de therapie mee te monitoren. In verschillende onderzoeken naar het vóórkomen van 
depressie na een beroerte wordt de HAMD ook regelmatig gebruikt, maar dan ook vaak 
als diagnostisch hulpmiddel. In principe is deze schaal hier niet voor bedoeld. 
Van drie onderzoeksgroepen met patiënten met verschillende, cerebrale aandoenin-
gen (beroerte, de ziekte van Parkinson en de ziekte van Alzheimer), waren gegevens van 
de HAMD en van depressiediagnostiek voorhanden. Met behulp van ROC-curves kon 
worden vastgesteld welke cut-off  score voor de verschillende ziektebeelden gehanteerd 
zou moeten worden om tot een optimale sensitiviteit en specifi citeit te komen. De validi-
teit van de HAMD bleek voor alle drie patiëntengroepen goed te zijn, waarbij voor elke 
groep wel een andere, ziekte-specifi eke, cut-off  score gehanteerd dient te worden. Om de 
HAMD als diagnostisch instrument in het kader van depressiediagnostiek bij beroerte-
patiënten te gebruiken, is de optimale cut-off  score bij 10-11 punten gelegen.
Hoofdstuk 3 beschrijft  het onderzoek dat gedaan werd naar de fenomenologie van depres-
sie bij patiënten met een beroerte die tevens cognitieve problemen hebben (vasculaire de-
mentie). Hiertoe werden 78 patiënten uit de Rotterdamse studie naar vasculaire factoren 
bij dementie (Dutch Vascular Factors in Dementia study) betrokken in een aanvullend 
psychiatrisch onderzoek. Het merendeel van deze groep (N=54) kreeg de diagnose ‘vas-
culaire dementie’. Een gedetailleerd onderzoek van de stemming vond plaats met behulp 
van de Schedule for Aff ective Disorders and Schizophrenia (SADS). Hierdoor werd niet 
alleen tot een DSM-classifi catie van ‘major’ en ‘minor’ depressie verkregen, maar kon 
ook op symptoom en symptoomclusterniveau nader onderzoek naar correlaties plaats-
vinden. Met behulp van een factoranalyse werden drie afzonderlijke factoren verkregen. 
De eerste factor werd de ‘stemmings’ factor (stemming in engere zin) genoemd en deze 
bestond uit de symptomen somberheid, geprikkeldheid, piekeren / tobben, negatieve en 
suïcidale gedachten en het terugtrekken uit sociale contacten. De tweede factor werd de 
‘motivatie’ factor genoemd. Deze bestond uit psychomotore remming, anergie en een 
gebrek aan mimiek / een somber uiterlijk. De laatste factor werd de ‘vegetatieve’ factor 
genoemd en deze bestond uit anorexie en gewichtsvermindering. Een aantal symptomen 
bleek niet specifi ek voor één van deze factoren en werd om die reden van verdere analyse 
uitgesloten. Het betrof slapeloosheid, anhedonie en angst. Alle drie de gevonden factoren 
hadden een sterke correlatie met de diagnose ‘depressie’, wat niet verwonderlijk is, gezien 
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het feit dat het in feite subsyndromen van de depressie betreft . Daarnaast werd gevon-
den dat de motivatie-factor een sterke correlatie vertoonde met de diagnose ‘dementie’, 
terwijl zowel de stemmings- als de vegetatieve factor deze correlatie niet hadden. Een 
aanvullende discriminant-analyse liet zien dat motivationele symptomen inderdaad veel 
voorkwamen bij zowel depressieve als niet-depressieve patiënten met vasculaire hersen-
schade (en bijkomende dementie) en dat deze dus een lagere discriminerende waarde 
hebben dan de stemmingssymptomen in engere zin.
In hoofdstuk 4 wordt de in hoofdstuk 3 beschreven groep nader onderzocht. Wij ver-
onderstelden dat de overlap tussen depressie en dementie bij de onderzochte groep pa-
tiënten veelal uit de motivationele symptomen van de depressie bestaat. Daarbij gaat het 
om een symptoomcluster dat grote overeenkomst vertoont met de fronto-subcorticale 
symptomen van dementie.We onderzochten of er inderdaad een correlatie was tussen 
de motivationele symptomen en slecht presteren op die cognitieve tests die de fronto-
subcorticale functies betreff en. In het onderzoek waren 54 patiënten met een post-stroke 
dementie betrokken. Bij allen was naast uitvoerige diagnostiek rondom de stemming 
ook uitgebreid onderzoek naar de cognitieve functies gedaan. Het betrof een groep van 
matig ernstig dementerende patiënten, met een gemiddelde score op de MMSE van 19.8 
punten (SD 5.0). Van deze groep voldeden 21 (39%) aan de criteria van een depressieve 
stoornis volgens de DSM-IV. Hoewel een uitgebreide neuropsychologische testbatterij 
werd afgenomen, bleek een groot aantal van deze patiënten niet al deze tests te kunnen 
doen. De enige test die bij vrijwel alle patiënten betrouwbaar kon worden afgenomen, 
was de Verbal Fluency Test (VFT). Deze test wordt in de literatuur beschouwd als een 
belangrijke maat voor het frontaal functioneren, in het bijzonder voor de zogenaamde 
‘executieve functies’. In onze onderzoeksgroep bleek een negatieve correlatie te bestaan 
tussen de score op de VFT en de motivationele symptomen van depressie. Dat wil dus 
zeggen dat patiënten met een hoge score op VFT (wat duidt op ‘goede’ executieve func-
tie) minder motivationele symptomen vertonen dan patiënten met een lage score. Dit 
ondersteunt de hypothese dat er een verband bestaat tussen deze fronto-subcorticale, 
executieve functies en de motivationele symptomen van de depressie. 
Ook in hoofdstuk 5 gaat het om de vraag in hoeverre aff ectieve en cognitieve symptomen 
aan elkaar gerelateerd zijn bij patiënten met een beginnende cognitieve achteruitgang. 
In dit onderzoek zijn 60 patiënten met dementie betrokken uit het Nijmeegse onderzoek 
onder bewoners van een verzorgingshuis. DSM-III-R criteria van depressie werden on-
derverdeeld in ‘stemmings’ en ‘motivatie’ symptomen. Het is opvallend dat 77% van de 
depressieve symptomatologie bij deze groep bestond uit de ‘motivationele’ symptomen, 
meestal buiten de context van een depressieve stoornis.  Daarbij werd een negatieve cor-
relatie gevonden tussen de aanwezigheid van deze ‘motivationele’ symptomen enerzijds 
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en de score op de Verbal Fluency Test anderzijds. Ook met deze studie wordt het verband 
tussen cognitieve (executieve) functies en aff ectieve (motivationele) stoornissen beves-
tigd. Daarnaast lijkt het om een tamelijk specifi ek verband te gaan, want met andere 
(niet-frontale) neuropsychologische testen werd geen relatie gevonden en de ‘mood’ 
symptomen vertoonden geen verband met de Verbal Fluency Test, noch met andere 
neuropsychologische testen. 
De beide laatste hoofdstukken gaan over symptoomprofi elen van depressie bij ouderen 
in de algemene bevolking. In hoofdstuk 6 werd onderzocht in hoeverre het symptoom-
profi el verschillend is in groepen depressieve ouderen met verschillende somatische ri-
sicofactoren. Uit de AMSTEL studie werden die ouderen met depressieve verschijnselen 
geselecteerd die een verhoogd risico hadden op vasculair, degeneratief of infl ammatoir 
gebied. Vervolgens onderzochten we in hoeverre de symptomatologie per groep ver-
schillend was. Zoals uit eerder onderzoek al bekend was, werd ook in deze studie voor 
alledrie de groepen een verhoogd risico op het ontwikkelen van een depressieve stoornis 
(DSM-diagnose) gevonden. Daarnaast werd op symptoom- en symptoomclusterniveau 
gevonden dat de ‘motivationele’ symptomen van depressie (psychomotore remming, 
interesse- en energieverlies) een sterkere associatie met zowel de vasculaire als degene-
ratieve groep vertoonden, terwijl de ‘stemmings’ symptomen (somberheid, ontstemming 
en suïcidaliteit) evenals de ‘melancholische’ symptomen (slapeloosheid, gebrek aan eet-
lust en gewichtsvermindering) een sterker verband met de infl ammatoire groep hadden. 
Uit deze studie komt naar voren dat specifi eke depressieve symptomatologie bij ouderen 
een indicatie kan zijn voor onderliggende, somatische/organische factoren.
Hoofdstuk 7 beschrijft  een onderzoek naar het symptoomprofi el bij depressieve ouderen 
met vasculaire risicofactoren. Uitgangspunt bij deze studie was de ‘vasculaire depressie’ 
hypothese van Alexopoulos en Krishnan (beide 1997). Deze veronderstelt een specifi ek 
subsyndroom van de depressie (meestal, maar niet uitsluitend bij ouderen), welke ver-
oorzaakt wordt door atherosclerotische veranderingen van de hersenen. Hierbij staan 
psychomotore remming en anhedonie op de voorgrond, terwijl schuldgevoelens en 
suïcidaliteit minder voorkomen. In twee grote bevolkingsstudies, de AMSTEL en ERGO 
studie, werden deze specifi eke symptoomprofi elen echter niet teruggevonden. In zowel 
de AMSTEL als de ERGO studie werd bij depressieve ouderen met vasculaire risicofac-
toren vaker moeheid gevonden. In de AMSTEL studie had deze groep ook meer last 
van gebrek aan eetlust, in vergelijking met depressieve ouderen zonder deze vasculaire 
risicofactoren. In de AMSTEL studie werden deze symptomen overigens ook meer ge-
zien bij alle ouderen met vasculaire risicofactoren, dus ongeacht de aanwezigheid van een 
volledig depressief syndroom.
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CONCLUSIE
Hoofdstuk 8 geeft  op basis van de bevindingen die in dit proefschrift  zijn gemeld ant-
woorden op de vragen die bij aanvang zijn gesteld. Methodologische en conceptuele 
problemen van de studies uit dit proefschrift  worden besproken. Er wordt ingegaan op 
de zin en onzin van symptoomprofi elen, problemen rond de ‘gouden standaard’ en op de 
verschillende niveaus waarop naar een probleem als ‘post-stroke’ of ‘vasculaire depressie’ 
gekeken kan worden. Tot slot wordt het belang van de hier beschreven studies genoemd 
en wordt een voorstel gedaan voor verder onderzoek.
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INTRODUCTION
Th is thesis is focused on the clinical presentation of depression in subjects with cerebro-
vascular disease, either patients with post-stroke depression (PSD), depression in subjects 
with vascular riskfactors like hypertension or diabetes, or with vascular lesions on MRI- 
or CT-scan. Chapter 1 provides background information on the topic, on depressive 
disorder in general and more specifi cally on depression in the elderly and in relation with 
cerebrovascular disorders in general. Next, the combination of these two major general 
health problems, depression and cerebrovascular disease, is discussed. Post-stroke de-
pression and ‘vascular depression’ are two important concepts that are commonly used in 
research. I discuss both concepts and summerize previous research on these topics. Im-
portant methodological problems that are encountered in these studies on subjects with 
depressive disorder in combination with vascular disease of the brain are explained. Next, 
I discuss the following aspects: Which defi nitions are used for depression? What is the 
temporal relationship between the depressive symptoms and the cerebrovascular lesions? 
Which groups are studied and what factors, other than neurobiological factors, can play 
a role in the development of depression in the elderly with concomitant cerebrovascular 
disease? I end up with the following questions that provide the basis for this thesis:
• What is the diagnostic value of the HAM-D for subjects who suff ered from stroke and 
can this instrument be used for the purpose of screening and diagnosis of depression 
in these patients?
• Is there a distinct clinical symptom profi le of depression for patients who suff er from 
severe vascular brain disease?
• Are the aff ective and cognitive sequelae of vascular brain damage interrelated? 
• Can “vascular depression” be recognised as a distinct entity in the general population 
based on clinical depressive symptoms?
THE STUDIES
To answer the above-mentioned questions, I have used data of the following studies in 
this thesis: 
Th e Dutch Vascular factors in Dementia Study concerns a study on patients who were 
admitted to a specialized, neurological university ward of the Erasmus Medical Center in 
Rotterdam, Th e Netherlands. Patients had to be 55 years or older and to have had a TIA 
with neurological signs on examination, a cerebral infarction, or intracerebral hemor-
rhage. Th e main purpose of this study was to gain insight in the infl uence of a broad 
spectrum of vascular factors on other risk factors, properties of the stroke itself and the 
occurrence of post-stroke dementia. 
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Th e Depression in Dementia Study concerns a longitudinal study that was carried out by 
the department of Psychiatry of the University Medical Center “St. Radboud” in Nijme-
gen, Th e Netherlands. Data collection took place from between 1990 – 1994. Th e purpose 
of this study was to prospectively investigate the connection between dementia and other 
psychiatric disorders, especially depression. In this study, 91 residents of a nursery home 
with dementia and 110 without were followed during 12 months. During this period 3 
detailed examinations of psychogeriatric status were carried out, with special regard to 
symptoms and signs of dementia and depression and with neuropsychological tests. Th e 
study was funded by the JANIVO foundation.
 
Th e Amsterdam Study of the Elderly (AMSTEL) is a large population-based study that 
was carried out between 1990 – 1994. A total of 4051 subjects participated in a com-
munity dwelling study on mental health problems in the elderly. Trained interviewers 
examined them during home visits. Th e purpose of this study was to collect informa-
tion on psychiatric symp toms, demographic and medical status, previous history and 
family history. It was carried out by the department of psychiatry of the Free University 
of Amsterdam, Th e Netherlands, embedded in the research program of the EMGO-insti-
tute. It was fi nancially supported by the S.G.O. program (Stimulering Gezondheidszorg 
Onderzoek) of the ministry of VWS (health, welfare and sports). Th is ended in 1994 and 
since then the study was fi nanced by the Nationaal Fonds Geestelijke Volksgezondheid 
and N.W.O. 
Th e Rotterdam Study, in the Netherlands also known as ERGO, is also a large, prospec-
tive population-based cohort study. It started in 1990 and at this moment the fourth 
follow-up round is carried out. In this thesis, data from the third round are used. In 
this study, all subjects of 55 years old and over out of the suburb Ommoord, Rotterdam, 
Th e Netherlands were involved. Th e main objective of the Rotterdam Study is to investi-
gate the prevalence and incidence of and risk factors for chronic diseases in the elderly. 
Among the chronic diseases of interest are cardiovascular and neurological diseases. Th e 
study is carried out by the department of Epidemiology and Biostatistics of the Erasmus 
University Medical Center Rotterdam, Th e Netherlands. It was fi nancially supported by 
the Research Institute of Diseases in the Elderly (RIDE, ZonMW). Additional funding 
for the depression study was given by Numico Research BV and for the atherosclerosis 
study by an extra gift  by NOW, grant 904-61-091. 
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RESEARCH QUESTIONS
In Chapter 2 I describe a study on the validity of the Hamilton Depression Rating Scale 
(HAMD) in subjects who suff ered from a stroke. In everyday practice this rating scale 
is oft en used in subjects with a depressive disorder. It is constructed to be used in these 
patients for the purpose of measuring the severity of depressive symptoms and to moni-
tor therapeutic eff ects of medication. In various studies on the prevalence of post-stroke 
depression the HAMD also frequently is used as a diagnostic tool. Actually, this is not 
permitted, because no reliable data are at hand on the psychometric properties on the 
subject of construct validity of this scale in this group of patients. 
Data of the HAMD and thorough psychiatric examination were available from three 
diff erent studies on subjects with various neurological disorders (stroke, Parkinson’s 
disease and Alzheimer’s disease). By means of ROC-curves cut-off  scores for optimal 
sensitivity and specifi city in the three disorders could be established. We found that the 
validity of the HAMD was good for all three patient groups, although for each group dif-
ferent, disease-specifi c cut-off  scores should be used. As a diagnostic tool for depressive 
disorder in stroke patients, the optimal HAMD cut-off  score was 10-11 points. 
In chapter 3 a study on phenomenology of depression in subjects with a stroke and 
concomitant cognitive disturbances (vascular dementia) is described. We included 78 
subjects from the Dutch Vascular Factors in Dementia study in a subsequent psychiatric 
diagnostic interview. Th e majority of these subjects (N=54) fulfi lled the NINDS-AIREN 
criteria for ‘vascular dementia’. Detailed study of aff ective symptoms was done with help 
of the Schedule for Aff ective Disorders and Schizophrenia (SADS). Th is allowed us not 
only to establish a DSM-classifi cation of major and minor depression, but also to study 
the prevalence and correlations of individual symptoms and various symptom-clusters. 
Using factor-analysis we found three diff erent factors of depression. Th e fi rst we called 
the ‘mood’ factor (mood in a strict sense) and this factor consisted of the symptoms sad-
ness, dysphoria, ruminations, negative and suicidal thoughts and social withdrawal. Th e 
second factor was called the ‘motivation’ factor and consisted of psychomotor changes, 
anergia and a sad appearance. Th e third was called the ‘vegetative’ factor and consisted 
of anorexia and loss of weight. A few symptoms were not specifi c for one of these three 
factors and were therefore excluded from further analysis, namely insomnia, anhedonia 
and anxiety. All three selected factors had a strong correlation with the DSM-diagnosis 
“major depression”. Th is is not surprising, because all three can be considered sub-syn-
dromes of the full, major depressive syndrome. Th e motivation factor also had a strong 
correlation with the diagnosis of vascular dementia, whereas both the mood and the 
vegetative factor did not show such a correlation. Th e subsequent discriminant-analysis 
showed that motivational symptoms were indeed more frequent in the total group of 
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subjects with stroke (and additional dementia) in both depressed and non-depressed 
subjects. Th erefore these symptoms show lower discriminant power than the symptoms 
of the ‘mood’ factor.
In chapter 4, I provide an additional analysis of the study population of chapter 3. We 
assumed that the overlap between depression and dementia in this studygroup would 
foremost be determined by the motivational symptoms of depression. It is a subsyndrome 
of depression that has a remarkable resemblance to the frontal-subcortical symptoms 
of dementia or other neuro-degenerative disorders. We studied the correlation of the 
motivational symptoms of depression on one hand and the results on cognitive tests on 
frontal-subcortical functioning on the other. In this study, 54 subjects with post-stroke 
(vascular) dementia were included, in all of whom a careful diagnostic procedure was 
performed regarding cognitive as well as aff ective state. It concerned a group of subjects 
with moderate/severe dementia and mean scores on MMSE of 19.8 points (SD 5.0). Of 
this group 21 subjects (39%) fulfi lled criteria of major depression according to DSM-IV. 
Although a comprehensive set of neuropsychological tests was presented to all subjects, a 
large proportion of them could not complete all tests because of severity of the cognitive 
problems. Th e only test that eventually could be applied to all subjects was the Verbal Flu-
ency Test (VFT). Th is test is described as an important measure of frontal functioning, 
especially for the so-called ‘executive functions’. In our study group we found a negative 
correlation between the score on the VFT and the motivational symptoms of depression. 
Th is means that subjects with a high score on the VFT (an indication of ‘good’ executive 
functioning) show less oft en motivational symptoms than subjects with low scores on the 
VFT. Th is supports our hypothesis that these frontal-subcortical, executive functions are 
implicated in the motivational symptoms of depression. 
In chapter 5, I address again the question on the interrelationship of aff ective and cogni-
tive symptoms in subjects with mild cognitive impairment. In this study, 60 subjects with 
dementia from the Nijmegen study on depression in dementia were involved. DSM-III-R 
criteria of depression were divided into mood and motivation symptoms. A striking 
fi nding was that 77% of the depressive features in this group were actually motivational 
symptoms, mostly not in the context of a full depressive disorder. In addition, we found 
a negative correlation between the presence of these motivational symptoms on the one 
hand and the score on the Verbal Fluency Test (VFT) on the other, similar as described 
in chapter 4. Th erefore, this study confi rmed a relationship between cognitive (execu-
tive) function and aff ective (motivational) disorder, also since with other (non-frontal) 
cognitive tests no such a relationship was found for the ‘motivational’ symptoms and the 
‘mood’ symptoms were neither related with the VFT nor with any other neuropsycho-
logical test.
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Th e last two chapters focus on symptom profi les of depression in the elderly in the general 
population. Chapter 6 describes our study on symptom profi les in groups of depressed 
elderly subjects with various somatic risk-indicators. From the AMSTEL study we se-
lected those subjects with an increased risk of vascular, degenerative or infl ammatory 
disease. Next, we investigated the depressive symptoms and we looked for diff erences 
in the profi les. From earlier studies it is known that all three somatic groups share an 
increased risk for developing depression. Th is was confi rmed in our study. On the symp-
tom and symptom cluster level, we found that the ‘motivational’ symptoms of depression 
(psychomotor changes, loss of interest and loss of energy) were associated with both the 
vascular and the degenerative group, whereas the ‘mood’ symptoms (sadness, dysphoria 
and suicidal thoughts) as well as the ‘melancholic’ symptoms (insomnia, anorexia and 
loss of weight) showed an association with the infl ammatory group. From this study we 
conclude that the depressive symptom profi le in the elderly could be an indication of the 
underlying somatic/organic disease.
Chapter 7 describes a study on the symptom profi le of depressed elderly with vascular 
risk-factors. Th e starting point of this study was the ‘vascular depression’ hypothesis of 
Alexopoulos en Krishnan (both 1997). Th is hypothesis presumes a specifi c subsyndrome 
of depression (mostly in, but not restricted to the elderly) that is brought about by athero-
sclerotic changes of the brain. Th is syndrome has prominent psychomotor changes 
and anhedonia as major symptoms, whereas guilt feelings and suicidal ideation are less 
evident. In two large population-based studies, the AMSTEL and the Rotterdam Study, 
this specifi c symptom profi le could not be found. In the AMSTEL as well as the Rot-
terdam study we found lassitude as the most prominent symptom in depressed elderly 
with vascular risk factors. In the AMSTEL study this group also showed anorexia more 
oft en compared with depressed elderly without vascular risk factors. However, in the 
AMSTEL study these symptoms were more frequent in all subjects with vascular risk 
factors, regardless of de presence of a complete depressive disorder.
CONCLUSION
In Chapter 8 I summarize the fi ndings of this thesis and discuss methodological and 
conceptual aspects. Th e usefulness of the presented symptom profi les, problems with the 
‘golden standard’ of depression and the various levels at which the clinical problem of 
‘post stroke depression’ and ‘vascular depression’ can be studied are discussed. Finally, 
I discuss the clinical relevance of the fi ndings in this thesis and make suggestions for 
further research.
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Graag wil ik op deze plaats iedereen bedanken die heeft  bijgedragen aan het totstand-
komen van dit proefschrift . Het plan om te promoveren bestond al (zeer) lang en door 
de wisselende werkplekken die ik in de afgelopen 8 jaar heb gehad, is het een traject met 
horten en stoten geworden. Soms zijn wat zijwegen bewandeld en steeds weer kwamen 
nieuwe mensen in beeld. Ik heb deze contacten meestal als plezierig en opbouwend in 
het kader van mijn wetenschappelijke ontwikkeling ervaren. Op het gevaar af iemand te 
vergeten of tekort te doen, wil ik graag een aantal personen speciaal noemen.
In de eerste plaats mijn beide promotoren, Peter Koudstaal en Aartjan Beekman. Peter 
en Aartjan, het doet mij bijzonder veel genoegen dat jullie beide met mij deze promotie 
hebben willen aangaan. Naast dat jullie beide op werkelijk verbluff end snelle en adequate 
manier al mijn geschrijf hebben geredigeerd en becommentarieerd, tref ik in jullie een 
neuroloog en een psychiater die beide voor mij een belangrijk voorbeeld zijn en aan wie 
ik me als professional graag spiegel. Peter, jou ken ik al vanuit de studententijd en ik mag 
wel zeggen dat het een zeer gelukkig toeval was dat ik me, samen met Eveline, meldde bij 
deze jonge, zeer enthousiaste neuroloog (destijds zelf nog promovendus) met de vraag of 
we konden participeren in enig onderzoek. Hoewel we daar zelf nauwelijks een idee over 
hadden, gaf je ons een kans. Dit resulteerde in een heus artikel over TIA’s en was de start 
van een voor mij altijd prettige en zeer stimulerende samenwerking. Aartjan, jou ken 
ik vanuit de tijd dat de werkgroep ‘depressie bij ouderen’ van de Leo Cahnstichting nog 
actief was en jij daar de enthousiaste voorzitter van was. Deze werkgroep heeft  ondertus-
sen al heel wat vruchten afgeworpen en heeft  voor mij ook het platform geboden om 
mijn eigen plannen verder uit te werken. Je bent voor mij het toonbeeld van de ‘moderne 
psychiater’, hoewel ik niet denk dat je van alle collega’s kunt verwachten dat ze in zo’n 
ruime mate over alle “kerncompetenties” beschikken als jij dat doet. 
Ik wil graag de leden van de leescommissie, Prof. Dr. M.M.B. Breteler, Prof. Dr. M.W. 
Hengeveld en Prof. Dr. P.A. van Doorn bedanken voor hun werk aan dit proefschrift .
Van de mede-auteurs is collega Joost Janzing van groot belang geweest voor de door-
start van mijn onderzoekscarrière. Joost, we hebben slechts een korte tijd voor dezelfde 
werkgever gewerkt, maar dit is geresulteerd in een zeer vruchtbare samenwerking, maar 
vooral ook in een goede vriendschap. Beide zetten we wat mij betreft  de komende tijd 
voort.
De overige mede-auteurs van de artikelen in dit proefschrift  wil ik ook graag bedanken 
voor hun inzet en ondersteuning. Niet alleen bestond dit uit het meedenken over de data 
en het schrijven van de stukken, maar soms ook in het beschikbaar stellen van data. Som-
migen zullen spreken van ‘parasitair’ onderzoek, maar ik prijs mezelf gelukkig dat ik bij 
een aantal belangrijke onderzoeksgroepen van harte welkom bleek te zijn en men mij ten 
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volle liet profi teren van de know-how die op deze plaatsen voorhanden was. In dit kader 
wil ik de collega’s van het Rotterdamse stroke onderzoek (Dutch Vascular Factors in De-
mentia Study), Fop van Kooten, Inge de Koning en Diederik Dippel van harte bedan-
ken. Daarnaast de collega’s van het Amsterdamse AMSTEL project, Robert  Schoevers 
en Prof. Dr. C. Jonker en de collega’s van het Rotterdamse ERGO project, Henning 
Tiemeier en Prof. Dr. M.M.B. Breteler. Voor hun bijdrage aan het eerste artikel in dit 
proefschrift  wil ik ook de Maastrichtse collega’s Frans Verhey en Albert Leentjens van 
harte dank zeggen. Albert, in jou trof ik ook een goed en terzake kundig klankbord voor 
mijn ideeën die dan aangevuld werden met weer nieuwe, vaak betere ideeën. 
Rond 1999 ontstond het plan om een ander promotie-traject te gaan starten. Het on-
derzoek naar psychopathologie bij de ziekte van Huntington is nog steeds gaande. De 
samenwerking met Berry Kremer hierin is zeer plezierig geweest en ik ben ervan over-
tuigd dat ook dat project nog op een fraaie wijze uitgewerkt gaat worden. Berry, ik hoop 
dat we ons werk voor deze moeilijke, maar wetenschappelijk gezien zeer interessante 
patiëntengroep voort kunnen zetten en ik heb veel waardering voor de manier waarop jij 
mij mijn eigen koers voor wat betreft  mijn promotietraject liet kiezen. 
De afgelopen jaren ben ik door Spatie, Centrum voor Geestelijke Gezondheid te Apel-
doorn, op een zeer goede manier in staat gesteld om stevig door te werken aan dit 
proefschrift . Ik ben Willem Mossink dankbaar voor het feit dat hij het aandurfde mij op 
die manier aan te nemen. Michiel Roest is naast een voortreff elijke waarnemer op mijn 
‘wetenschapsdagen’, ook van grote waarde als ervaren klankbord en vraagbaak voor mijn 
werk als psychiater op de ‘intensive care unit’ van Spatie. 
Jan Bruijn, Roos van der Mast en Walter van den Broek zijn drie collega’s die als su-
pervisor voor mij van grote waarde zijn geweest tijdens mijn opleiding en in die zin aan 
de basis van mijn huidige carrière hebben gestaan. Jan, je wist mij tijdens de junior-
co-schappen enthousiast te maken voor de psychiatrie en was ook daarna diegene die 
me de opleiding ‘binnenloodste’. Een mooie gelegenheid om je daar nog eens voor te 
bedanken.
Bij het vervaardigen van het proefschrift  werd ik voor wat betreft  het engels bijgestaan 
door mijn broer Martijn Naarding (‘Babeltrans’) en door zijn collega Ken Sutherland 
(‘el Caterano’). Beiden wil ik hier nog eens voor bedanken. 
Bert Klaaysen wil ik bedanken voor het geslaagde ontwerp van de cover; het is mooi 
om in de praktijk te mogen ontdekken dat een goede buur inderdaad beter is dan een 
verre vriend.
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Tot slot de belangrijke mensen uit mijn privé-leven. Ik vind het ontzettend leuk dat twee 
van mijn ‘oude’ studievrienden me bij de promotie bijstaan. Wilfred en Kees, paranim-
fen, het is niet alleen leuk maar ook zeker een steun om door twee zulke vertrouwde 
vrienden bijgestaan te worden. Hoewel we ondertussen een stuk verder uit elkaar wonen, 
ieder ook zeer drukke agenda’s hebben en elkaar daardoor niet eens echt vaak zien, loopt 
onze vriendschap als ‘vanzelf ’ door en dat vind ik mooi. Wilfred, het volgende feestje is 
bij jou!
Met geen pen te beschrijven is wat vooral Eveline, maar natuurlijk ook Iris, Th ijs, Koen 
en Nina voor me betekenen. Het schrijven van het proefschrift  moest erbij tussendoor, 
en zo hoort het ook.
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Paul Naarding werd op 7 april 1966 geboren in Apeldoorn. In 1984 behaalde hij zijn 
VWO diploma aan de Koninklijke Scholengemeenschap te Apeldoorn. Datzelfde jaar 
startte hij met de studie Geneeskunde aan de Erasmus Universiteit te Rotterdam, welke 
in 1990 werd afgerond met het artsendiploma. Vervolgens werkte hij als AGNIO 1 jaar 
op de afdeling Psychiatrie, 1 jaar op de afdeling Neurologie en een half jaar binnen de 
Medisch-Psychiatrische en Psychologische Dienst, allen van het Dijkzigt-ziekenhuis te 
Rotterdam.
In 1993 startte hij met de basis-opleiding tot psychiater op de afdeling Psychiatrie van 
het Academisch Ziekenhuis “Dijkzigt” te Rotterdam (opleider: Prof. Dr. W.J. Schudel). 
De stage Sociale Psychiatrie werd gedaan bij de Riagg Rijnmond Noord-West (Opleider: 
Dr. M.J.A.M. Coopmans). Als keuze-stage werd gekozen voor de Ouderenpsychiatrie en 
deze werd ingevuld bij de afdeling ouderen van het toenmalige Psychiatrisch Spectrum 
Gelderland Oost (PSGO, tegenwoordig GGNet), te Warnsveld (Stage begeleider: Drs.
W.M.H. de Ruijter). Nadat in 1997 de registratie als psychiater een feit was, begon hij 
als afdelingspsychiater op de Geriatrische Afdeling van het Psychiatrisch Ziekenhuis 
(GAPZ) van het toenmalige Psychiatrisch Ziekenhuis Amsterdam (PZA, tegenwoordig 
Mentrum). Vervolgens maakte hij in 1999 de overstap naar de afdeling Psychiatrie van het 
Academisch Ziekenhuis “St. Radboud” te Nijmegen. Daar werkte hij op de polikliniek. 
Gelijktijdig had hij een deeltijdaanstelling bij Spatie te Apeldoorn en gaf hij daar mede 
gestalte aan een deeltijdbehandeling voor ouderen. Vanaf 2001 ging hij voltijds bij Spatie 
werken; het eerste jaar binnen cluster Ouderen, op de deeltijdbehandeling in combinatie 
met de polikliniek, vanaf 2002 tot op heden binnen het cluster Acute Psychiatrie, op 
de opname-afdeling volwassenen. Hij is mede-oprichter en voorzitter van de Medische 
Staf van Spatie. Vanaf 1 januari 2006 zal hij als A-opleider in dienst treden van Mediant, 
Centrum voor GGZ Oost- en Midden-Twente.
Paul Naarding woont in Apeldoorn, samen met Eveline en hun vier kinderen, Iris, 
Th ijs, Koen en Nina.
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